Source Name Characteristics[organism] Characteristics[taxonomy_id] Characteristics[collection_date] Characteristics[geo_loc_name] Characteristics[age] Characteristics[disease] Characteristics[disease_stage] Characteristics[isolate] Characteristics[tissue] Characteristics[disease_time_point] Comment[BioSample] Comment[sample_title] Comment[description] Protocol REF Sample Name Protocol REF Parameter Value[Post extraction] Parameter Value[Derivatization] Extract Name Protocol REF Parameter Value[Chromatography instrument] Parameter Value[Autosampler model] Parameter Value[Column model] Parameter Value[Column type] Parameter Value[Temperature] Unit[temperature] Parameter Value[Guard column] Labeled Extract Name Label Protocol REF Parameter Value[Scan polarity] Parameter Value[Scan m/z range] Parameter Value[Instrument] Parameter Value[Ion source] Parameter Value[Mass analyzer] Assay Name Comment[technical_replicate] Raw Data File Protocol REF Processed Data File Processed Data File Protocol REF Metabolite Assignment File Comment[maf_value_unit] Factor Value[disease_time_point] C1 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 11 serum Days 16-18 SAMD01814353 COVID-19_Lipid_C1 Serum sample from individuals with COVID-19 Sample collection C1 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C1_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C1_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C10 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 19 serum Days 13-15 SAMD01814354 COVID-19_Lipid_C10 Serum sample from individuals with COVID-19 Sample collection C10 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C10_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C10_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C100 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 26 serum Days 13-15 SAMD01814355 COVID-19_Lipid_C100 Serum sample from individuals with COVID-19 Sample collection C100 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C100_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C100_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C101 Homo sapiens 9606 2020 Japan 40 SARS-CoV-2 COVID-19 28 serum Days 10-12 SAMD01814356 COVID-19_Lipid_C101 Serum sample from individuals with COVID-19 Sample collection C101 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C101_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C101_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C102 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 16 serum beyond Day 25 SAMD01814357 COVID-19_Lipid_C102 Serum sample from individuals with COVID-19 Sample collection C102 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C102_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C102_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C103 Homo sapiens 9606 2020 Japan 71 SARS-CoV-2 COVID-19 20 serum beyond Day 25 SAMD01814358 COVID-19_Lipid_C103 Serum sample from individuals with COVID-19 Sample collection C103 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C103_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C103_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C104 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 26 serum Days 16-18 SAMD01814359 COVID-19_Lipid_C104 Serum sample from individuals with COVID-19 Sample collection C104 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C104_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C104_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C105 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 23 serum Days 19-24 SAMD01814360 COVID-19_Lipid_C105 Serum sample from individuals with COVID-19 Sample collection C105 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C105_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C105_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C106 Homo sapiens 9606 2020 Japan 89 SARS-CoV-2 COVID-19 27 serum Days 16-18 SAMD01814361 COVID-19_Lipid_C106 Serum sample from individuals with COVID-19 Sample collection C106 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C106_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C106_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C107 Homo sapiens 9606 2020 Japan 76 SARS-CoV-2 COVID-19 22 serum Days 19-24 SAMD01814362 COVID-19_Lipid_C107 Serum sample from individuals with COVID-19 Sample collection C107 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C107_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C107_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C108 Homo sapiens 9606 2020 Japan 65 SARS-CoV-2 COVID-19 25 serum Days 16-18 SAMD01814363 COVID-19_Lipid_C108 Serum sample from individuals with COVID-19 Sample collection C108 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C108_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C108_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C109 Homo sapiens 9606 2020 Japan 65 SARS-CoV-2 COVID-19 25 serum Days 19-24 SAMD01814364 COVID-19_Lipid_C109 Serum sample from individuals with COVID-19 Sample collection C109 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C109_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C109_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C11 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 15 serum Days 16-18 SAMD01814365 COVID-19_Lipid_C11 Serum sample from individuals with COVID-19 Sample collection C11 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C11_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C11_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C110 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 21 serum beyond Day 25 SAMD01814366 COVID-19_Lipid_C110 Serum sample from individuals with COVID-19 Sample collection C110 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C110_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C110_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C111 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 26 serum Days 19-24 SAMD01814367 COVID-19_Lipid_C111 Serum sample from individuals with COVID-19 Sample collection C111 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C111_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C111_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C113 Homo sapiens 9606 2020 Japan 40 SARS-CoV-2 COVID-19 28 serum Days 16-18 SAMD01814368 COVID-19_Lipid_C113 Serum sample from individuals with COVID-19 Sample collection C113 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C113_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C113_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C114 Homo sapiens 9606 2020 Japan 89 SARS-CoV-2 COVID-19 27 serum Days 19-24 SAMD01814369 COVID-19_Lipid_C114 Serum sample from individuals with COVID-19 Sample collection C114 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C114_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C114_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C115 Homo sapiens 9606 2020 Japan 40 SARS-CoV-2 COVID-19 28 serum Days 19-24 SAMD01814370 COVID-19_Lipid_C115 Serum sample from individuals with COVID-19 Sample collection C115 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C115_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C115_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C116 Homo sapiens 9606 2020 Japan 68 SARS-CoV-2 COVID-19 1 serum beyond Day 25 SAMD01814371 COVID-19_Lipid_C116 Serum sample from individuals with COVID-19 Sample collection C116 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C116_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C116_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C117 Homo sapiens 9606 2020 Japan 76 SARS-CoV-2 COVID-19 22 serum beyond Day 25 SAMD01814372 COVID-19_Lipid_C117 Serum sample from individuals with COVID-19 Sample collection C117 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C117_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C117_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C118 Homo sapiens 9606 2020 Japan 89 SARS-CoV-2 COVID-19 27 serum beyond Day 25 SAMD01814373 COVID-19_Lipid_C118 Serum sample from individuals with COVID-19 Sample collection C118 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C118_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C118_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C119 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 26 serum beyond Day 25 SAMD01814374 COVID-19_Lipid_C119 Serum sample from individuals with COVID-19 Sample collection C119 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C119_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C119_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C12 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 15 serum Days 19-24 SAMD01814375 COVID-19_Lipid_C12 Serum sample from individuals with COVID-19 Sample collection C12 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C12_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C12_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C120 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 29 serum pre-onset SAMD01814376 COVID-19_Lipid_C120 Serum sample from individuals with COVID-19 Sample collection C120 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C120_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C120_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 pre-onset C121 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 29 serum Days 1-3 SAMD01814377 COVID-19_Lipid_C121 Serum sample from individuals with COVID-19 Sample collection C121 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C121_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C121_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 1-3 C122 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 29 serum Days 4-6 SAMD01814378 COVID-19_Lipid_C122 Serum sample from individuals with COVID-19 Sample collection C122 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C122_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C122_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C123 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 29 serum Days 7-9 SAMD01814379 COVID-19_Lipid_C123 Serum sample from individuals with COVID-19 Sample collection C123 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C123_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C123_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C124 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 29 serum Days 10-12 SAMD01814380 COVID-19_Lipid_C124 Serum sample from individuals with COVID-19 Sample collection C124 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C124_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C124_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C125 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 29 serum Days 13-15 SAMD01814381 COVID-19_Lipid_C125 Serum sample from individuals with COVID-19 Sample collection C125 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C125_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C125_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C126 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 29 serum Days 16-18 SAMD01814382 COVID-19_Lipid_C126 Serum sample from individuals with COVID-19 Sample collection C126 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C126_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C126_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C127 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 29 serum Days 19-24 SAMD01814383 COVID-19_Lipid_C127 Serum sample from individuals with COVID-19 Sample collection C127 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C127_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C127_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C128 Homo sapiens 9606 2020 Japan 24 SARS-CoV-2 COVID-19 3 serum beyond Day 25 SAMD01814384 COVID-19_Lipid_C128 Serum sample from individuals with COVID-19 Sample collection C128 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C128_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C128_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C129 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 17 serum beyond Day 25 SAMD01814385 COVID-19_Lipid_C129 Serum sample from individuals with COVID-19 Sample collection C129 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C129_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C129_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C13 Homo sapiens 9606 2020 Japan 76 SARS-CoV-2 COVID-19 18 serum Days 10-12 SAMD01814386 COVID-19_Lipid_C13 Serum sample from individuals with COVID-19 Sample collection C13 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C13_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C13_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C130 Homo sapiens 9606 2020 Japan 40 SARS-CoV-2 COVID-19 28 serum beyond Day 25 SAMD01814387 COVID-19_Lipid_C130 Serum sample from individuals with COVID-19 Sample collection C130 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C130_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C130_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C131 Homo sapiens 9606 2020 Japan 65 SARS-CoV-2 COVID-19 25 serum beyond Day 25 SAMD01814388 COVID-19_Lipid_C131 Serum sample from individuals with COVID-19 Sample collection C131 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C131_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C131_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C132 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 23 serum beyond Day 25 SAMD01814389 COVID-19_Lipid_C132 Serum sample from individuals with COVID-19 Sample collection C132 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C132_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C132_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C133 Homo sapiens 9606 2020 Japan 77 SARS-CoV-2 COVID-19 6 serum beyond Day 25 SAMD01814390 COVID-19_Lipid_C133 Serum sample from individuals with COVID-19 Sample collection C133 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C133_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C133_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C137 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 31 serum Days 4-6 SAMD01814391 COVID-19_Lipid_C137 Serum sample from individuals with COVID-19 Sample collection C137 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C137_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C137_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C138 Homo sapiens 9606 2020 Japan 92 SARS-CoV-2 COVID-19 32 serum Days 4-6 SAMD01814392 COVID-19_Lipid_C138 Serum sample from individuals with COVID-19 Sample collection C138 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C138_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C138_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C139 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 33 serum pre-onset SAMD01814393 COVID-19_Lipid_C139 Serum sample from individuals with COVID-19 Sample collection C139 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C139_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C139_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 pre-onset C140 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 33 serum Days 4-6 SAMD01814395 COVID-19_Lipid_C140 Serum sample from individuals with COVID-19 Sample collection C140 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C140_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C140_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C141 Homo sapiens 9606 2020 Japan 92 SARS-CoV-2 COVID-19 31 serum Days 7-9 SAMD01814396 COVID-19_Lipid_C141 Serum sample from individuals with COVID-19 Sample collection C141 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C141_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C141_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C142 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 32 serum Days 7-9 SAMD01814397 COVID-19_Lipid_C142 Serum sample from individuals with COVID-19 Sample collection C142 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C142_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C142_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C145 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 30 serum Days 16-18 SAMD01814398 COVID-19_Lipid_C145 Serum sample from individuals with COVID-19 Sample collection C145 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C145_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C145_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C146 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 33 serum Days 10-12 SAMD01814399 COVID-19_Lipid_C146 Serum sample from individuals with COVID-19 Sample collection C146 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C146_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C146_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C148 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 30 serum Days 19-24 SAMD01814400 COVID-19_Lipid_C148 Serum sample from individuals with COVID-19 Sample collection C148 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C148_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C148_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C149 Homo sapiens 9606 2020 Japan 76 SARS-CoV-2 COVID-19 31 serum Days 10-12 SAMD01814401 COVID-19_Lipid_C149 Serum sample from individuals with COVID-19 Sample collection C149 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C149_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C149_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C15 Homo sapiens 9606 2020 Japan 76 SARS-CoV-2 COVID-19 18 serum Days 16-18 SAMD01916070 COVID-19_Lipid_C15 Serum sample from individuals with COVID-19 Sample collection C15 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C15_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C15_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C150 Homo sapiens 9606 2020 Japan 92 SARS-CoV-2 COVID-19 32 serum Days 13-15 SAMD01814402 COVID-19_Lipid_C150 Serum sample from individuals with COVID-19 Sample collection C150 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C150_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C150_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C151 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 33 serum Days 13-15 SAMD01814403 COVID-19_Lipid_C151 Serum sample from individuals with COVID-19 Sample collection C151 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C151_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C151_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C152 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 33 serum Days 16-18 SAMD01814404 COVID-19_Lipid_C152 Serum sample from individuals with COVID-19 Sample collection C152 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C152_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C152_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C153 Homo sapiens 9606 2020 Japan 92 SARS-CoV-2 COVID-19 32 serum Days 16-18 SAMD01814405 COVID-19_Lipid_C153 Serum sample from individuals with COVID-19 Sample collection C153 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C153_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C153_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C154 Homo sapiens 9606 2020 Japan 74 SARS-CoV-2 COVID-19 34 serum Days 10-12 SAMD01814406 COVID-19_Lipid_C154 Serum sample from individuals with COVID-19 Sample collection C154 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C154_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C154_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C155 Homo sapiens 9606 2020 Japan 74 SARS-CoV-2 COVID-19 34 serum Days 13-15 SAMD01814407 COVID-19_Lipid_C155 Serum sample from individuals with COVID-19 Sample collection C155 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C155_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C155_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C156 Homo sapiens 9606 2020 Japan 92 SARS-CoV-2 COVID-19 32 serum Days 19-24 SAMD01814408 COVID-19_Lipid_C156 Serum sample from individuals with COVID-19 Sample collection C156 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C156_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C156_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C157 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 33 serum Days 19-24 SAMD01814409 COVID-19_Lipid_C157 Serum sample from individuals with COVID-19 Sample collection C157 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C157_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C157_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C158 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 29 serum beyond Day 25 SAMD01814410 COVID-19_Lipid_C158 Serum sample from individuals with COVID-19 Sample collection C158 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C158_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C158_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C159 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 35 serum Days 10-12 SAMD01814411 COVID-19_Lipid_C159 Serum sample from individuals with COVID-19 Sample collection C159 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C159_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C159_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C16 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 17 serum Days 10-12 SAMD01814412 COVID-19_Lipid_C16 Serum sample from individuals with COVID-19 Sample collection C16 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C16_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C16_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C160 Homo sapiens 9606 2020 Japan 74 SARS-CoV-2 COVID-19 34 serum Days 16-18 SAMD01814413 COVID-19_Lipid_C160 Serum sample from individuals with COVID-19 Sample collection C160 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C160_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C160_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C161 Homo sapiens 9606 2020 Japan 87 SARS-CoV-2 COVID-19 36 serum Days 7-9 SAMD01814414 COVID-19_Lipid_C161 Serum sample from individuals with COVID-19 Sample collection C161 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C161_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C161_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C162 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 30 serum beyond Day 25 SAMD01814415 COVID-19_Lipid_C162 Serum sample from individuals with COVID-19 Sample collection C162 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C162_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C162_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C163 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 35 serum Days 13-15 SAMD01814416 COVID-19_Lipid_C163 Serum sample from individuals with COVID-19 Sample collection C163 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C163_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C163_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C164 Homo sapiens 9606 2020 Japan 66 SARS-CoV-2 COVID-19 37 serum Days 13-15 SAMD01814417 COVID-19_Lipid_C164 Serum sample from individuals with COVID-19 Sample collection C164 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C164_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C164_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C165 Homo sapiens 9606 2020 Japan 74 SARS-CoV-2 COVID-19 34 serum Days 19-24 SAMD01814418 COVID-19_Lipid_C165 Serum sample from individuals with COVID-19 Sample collection C165 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C165_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C165_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C166 Homo sapiens 9606 2020 Japan 66 SARS-CoV-2 COVID-19 37 serum Days 16-18 SAMD01814419 COVID-19_Lipid_C166 Serum sample from individuals with COVID-19 Sample collection C166 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C166_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C166_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C167 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 35 serum Days 16-18 SAMD01814420 COVID-19_Lipid_C167 Serum sample from individuals with COVID-19 Sample collection C167 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C167_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C167_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C168 Homo sapiens 9606 2020 Japan 92 SARS-CoV-2 COVID-19 32 serum beyond Day 25 SAMD01814421 COVID-19_Lipid_C168 Serum sample from individuals with COVID-19 Sample collection C168 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C168_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C168_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C169 Homo sapiens 9606 2020 Japan 38 SARS-CoV-2 COVID-19 38 serum Days 10-12 SAMD01814422 COVID-19_Lipid_C169 Serum sample from individuals with COVID-19 Sample collection C169 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C169_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C169_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C17 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 17 serum Days 13-15 SAMD01814423 COVID-19_Lipid_C17 Serum sample from individuals with COVID-19 Sample collection C17 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C17_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C17_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C170 Homo sapiens 9606 2020 Japan 34 SARS-CoV-2 COVID-19 39 serum Days 7-9 SAMD01814424 COVID-19_Lipid_C170 Serum sample from individuals with COVID-19 Sample collection C170 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C170_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C170_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C171 Homo sapiens 9606 2020 Japan 66 SARS-CoV-2 COVID-19 37 serum Days 19-24 SAMD01814425 COVID-19_Lipid_C171 Serum sample from individuals with COVID-19 Sample collection C171 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C171_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C171_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C172 Homo sapiens 9606 2020 Japan 87 SARS-CoV-2 COVID-19 36 serum Days 10-12 SAMD01814426 COVID-19_Lipid_C172 Serum sample from individuals with COVID-19 Sample collection C172 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C172_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C172_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C173 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 33 serum beyond Day 25 SAMD01814427 COVID-19_Lipid_C173 Serum sample from individuals with COVID-19 Sample collection C173 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C173_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C173_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C174 Homo sapiens 9606 2020 Japan 87 SARS-CoV-2 COVID-19 36 serum Days 16-18 SAMD01814428 COVID-19_Lipid_C174 Serum sample from individuals with COVID-19 Sample collection C174 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C174_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C174_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C175 Homo sapiens 9606 2020 Japan 51 SARS-CoV-2 COVID-19 40 serum Days 4-6 SAMD01814429 COVID-19_Lipid_C175 Serum sample from individuals with COVID-19 Sample collection C175 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C175_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C175_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C176 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 35 serum Days 19-24 SAMD01814430 COVID-19_Lipid_C176 Serum sample from individuals with COVID-19 Sample collection C176 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C176_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C176_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C177 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 40 serum Days 1-3 SAMD01814431 COVID-19_Lipid_C177 Serum sample from individuals with COVID-19 Sample collection C177 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C177_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C177_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 1-3 C178 Homo sapiens 9606 2020 Japan 87 SARS-CoV-2 COVID-19 36 serum Days 13-15 SAMD01814432 COVID-19_Lipid_C178 Serum sample from individuals with COVID-19 Sample collection C178 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C178_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C178_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C179 Homo sapiens 9606 2020 Japan 61 SARS-CoV-2 COVID-19 41 serum Days 4-6 SAMD01814433 COVID-19_Lipid_C179 Serum sample from individuals with COVID-19 Sample collection C179 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C179_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C179_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C18 Homo sapiens 9606 2020 Japan 77 SARS-CoV-2 COVID-19 6 serum Days 13-15 SAMD01814434 COVID-19_Lipid_C18 Serum sample from individuals with COVID-19 Sample collection C18 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C18_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C18_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C180 Homo sapiens 9606 2020 Japan 61 SARS-CoV-2 COVID-19 41 serum Days 7-9 SAMD01814435 COVID-19_Lipid_C180 Serum sample from individuals with COVID-19 Sample collection C180 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C180_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C180_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C181 Homo sapiens 9606 2020 Japan 61 SARS-CoV-2 COVID-19 41 serum Days 10-12 SAMD01814436 COVID-19_Lipid_C181 Serum sample from individuals with COVID-19 Sample collection C181 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C181_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C181_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C182 Homo sapiens 9606 2020 Japan 47 SARS-CoV-2 COVID-19 42 serum Days 7-9 SAMD01814437 COVID-19_Lipid_C182 Serum sample from individuals with COVID-19 Sample collection C182 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C182_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C182_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C183 Homo sapiens 9606 2020 Japan 47 SARS-CoV-2 COVID-19 42 serum Days 10-12 SAMD01814438 COVID-19_Lipid_C183 Serum sample from individuals with COVID-19 Sample collection C183 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C183_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C183_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C184 Homo sapiens 9606 2020 Japan 84 SARS-CoV-2 COVID-19 43 serum Days 7-9 SAMD01814439 COVID-19_Lipid_C184 Serum sample from individuals with COVID-19 Sample collection C184 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C184_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C184_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C185 Homo sapiens 9606 2020 Japan 38 SARS-CoV-2 COVID-19 44 serum Days 10-12 SAMD01814440 COVID-19_Lipid_C185 Serum sample from individuals with COVID-19 Sample collection C185 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C185_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C185_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C186 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 45 serum Days 4-6 SAMD01814441 COVID-19_Lipid_C186 Serum sample from individuals with COVID-19 Sample collection C186 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C186_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C186_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C187 Homo sapiens 9606 2020 Japan 84 SARS-CoV-2 COVID-19 43 serum Days 10-12 SAMD01814442 COVID-19_Lipid_C187 Serum sample from individuals with COVID-19 Sample collection C187 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C187_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C187_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C188 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 45 serum Days 7-9 SAMD01814443 COVID-19_Lipid_C188 Serum sample from individuals with COVID-19 Sample collection C188 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C188_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C188_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C189 Homo sapiens 9606 2020 Japan 65 SARS-CoV-2 COVID-19 46 serum Days 4-6 SAMD01814444 COVID-19_Lipid_C189 Serum sample from individuals with COVID-19 Sample collection C189 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C189_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C189_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C19 Homo sapiens 9606 2020 Japan 77 SARS-CoV-2 COVID-19 6 serum Days 16-18 SAMD01814445 COVID-19_Lipid_C19 Serum sample from individuals with COVID-19 Sample collection C19 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C19_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C19_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C190 Homo sapiens 9606 2020 Japan 65 SARS-CoV-2 COVID-19 46 serum Days 7-9 SAMD01814446 COVID-19_Lipid_C190 Serum sample from individuals with COVID-19 Sample collection C190 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C190_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C190_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C191 Homo sapiens 9606 2020 Japan 80 SARS-CoV-2 COVID-19 47 serum Days 4-6 SAMD01814447 COVID-19_Lipid_C191 Serum sample from individuals with COVID-19 Sample collection C191 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C191_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C191_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C192 Homo sapiens 9606 2020 Japan 80 SARS-CoV-2 COVID-19 47 serum Days 7-9 SAMD01814448 COVID-19_Lipid_C192 Serum sample from individuals with COVID-19 Sample collection C192 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C192_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C192_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C193 Homo sapiens 9606 2020 Japan 84 SARS-CoV-2 COVID-19 43 serum Days 13-15 SAMD01814449 COVID-19_Lipid_C193 Serum sample from individuals with COVID-19 Sample collection C193 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C193_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C193_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C194 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 48 serum Days 10-12 SAMD01814450 COVID-19_Lipid_C194 Serum sample from individuals with COVID-19 Sample collection C194 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C194_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C194_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C195 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 48 serum Days 13-15 SAMD01814451 COVID-19_Lipid_C195 Serum sample from individuals with COVID-19 Sample collection C195 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C195_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C195_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C196 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 48 serum Days 16-18 SAMD01814452 COVID-19_Lipid_C196 Serum sample from individuals with COVID-19 Sample collection C196 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C196_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C196_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C197 Homo sapiens 9606 2020 Japan 84 SARS-CoV-2 COVID-19 43 serum Days 16-18 SAMD01814453 COVID-19_Lipid_C197 Serum sample from individuals with COVID-19 Sample collection C197 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C197_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C197_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C198 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 45 serum Days 10-12 SAMD01814454 COVID-19_Lipid_C198 Serum sample from individuals with COVID-19 Sample collection C198 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C198_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C198_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C199 Homo sapiens 9606 2020 Japan 65 SARS-CoV-2 COVID-19 46 serum Days 10-12 SAMD01814455 COVID-19_Lipid_C199 Serum sample from individuals with COVID-19 Sample collection C199 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C199_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C199_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C2 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 13 serum Days 7-9 SAMD01814456 COVID-19_Lipid_C2 Serum sample from individuals with COVID-19 Sample collection C2 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C2_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C2_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C20 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 17 serum Days 16-18 SAMD01814457 COVID-19_Lipid_C20 Serum sample from individuals with COVID-19 Sample collection C20 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C20_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C20_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C200 Homo sapiens 9606 2020 Japan 87 SARS-CoV-2 COVID-19 49 serum Days 4-6 SAMD01814458 COVID-19_Lipid_C200 Serum sample from individuals with COVID-19 Sample collection C200 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C200_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C200_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C201 Homo sapiens 9606 2020 Japan 87 SARS-CoV-2 COVID-19 49 serum Days 10-12 SAMD01814459 COVID-19_Lipid_C201 Serum sample from individuals with COVID-19 Sample collection C201 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C201_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C201_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C202 Homo sapiens 9606 2020 Japan 80 SARS-CoV-2 COVID-19 47 serum Days 10-12 SAMD01814460 COVID-19_Lipid_C202 Serum sample from individuals with COVID-19 Sample collection C202 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C202_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C202_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C203 Homo sapiens 9606 2020 Japan 65 SARS-CoV-2 COVID-19 46 serum Days 13-15 SAMD01814461 COVID-19_Lipid_C203 Serum sample from individuals with COVID-19 Sample collection C203 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C203_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C203_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C204 Homo sapiens 9606 2020 Japan 74 SARS-CoV-2 COVID-19 34 serum beyond Day 25 SAMD01814462 COVID-19_Lipid_C204 Serum sample from individuals with COVID-19 Sample collection C204 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C204_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C204_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C205 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 48 serum Days 19-24 SAMD01814463 COVID-19_Lipid_C205 Serum sample from individuals with COVID-19 Sample collection C205 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C205_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C205_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C206 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 45 serum Days 13-15 SAMD01814464 COVID-19_Lipid_C206 Serum sample from individuals with COVID-19 Sample collection C206 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C206_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C206_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C207 Homo sapiens 9606 2020 Japan 84 SARS-CoV-2 COVID-19 43 serum Days 19-24 SAMD01814465 COVID-19_Lipid_C207 Serum sample from individuals with COVID-19 Sample collection C207 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C207_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C207_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C208 Homo sapiens 9606 2020 Japan 87 SARS-CoV-2 COVID-19 49 serum Days 13-15 SAMD01814466 COVID-19_Lipid_C208 Serum sample from individuals with COVID-19 Sample collection C208 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C208_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C208_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C209 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 50 serum Days 10-12 SAMD01814467 COVID-19_Lipid_C209 Serum sample from individuals with COVID-19 Sample collection C209 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C209_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C209_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C21 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 7 serum Days 10-12 SAMD01814468 COVID-19_Lipid_C21 Serum sample from individuals with COVID-19 Sample collection C21 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C21_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C21_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C210 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 50 serum Days 13-15 SAMD01814469 COVID-19_Lipid_C210 Serum sample from individuals with COVID-19 Sample collection C210 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C210_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C210_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C211 Homo sapiens 9606 2020 Japan 87 SARS-CoV-2 COVID-19 49 serum Days 16-18 SAMD01814470 COVID-19_Lipid_C211 Serum sample from individuals with COVID-19 Sample collection C211 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C211_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C211_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C212 Homo sapiens 9606 2020 Japan 80 SARS-CoV-2 COVID-19 47 serum Days 16-18 SAMD01814471 COVID-19_Lipid_C212 Serum sample from individuals with COVID-19 Sample collection C212 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C212_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C212_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C213 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 45 serum Days 19-24 SAMD01814472 COVID-19_Lipid_C213 Serum sample from individuals with COVID-19 Sample collection C213 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C213_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C213_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C214 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 50 serum Days 13-15 SAMD01814473 COVID-19_Lipid_C214 Serum sample from individuals with COVID-19 Sample collection C214 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C214_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C214_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C215 Homo sapiens 9606 2020 Japan 87 SARS-CoV-2 COVID-19 49 serum Days 19-24 SAMD01814474 COVID-19_Lipid_C215 Serum sample from individuals with COVID-19 Sample collection C215 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C215_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C215_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C216 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 50 serum Days 16-18 SAMD01814475 COVID-19_Lipid_C216 Serum sample from individuals with COVID-19 Sample collection C216 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C216_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C216_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C217 Homo sapiens 9606 2020 Japan 48 SARS-CoV-2 COVID-19 42 serum beyond Day 25 SAMD01814476 COVID-19_Lipid_C217 Serum sample from individuals with COVID-19 Sample collection C217 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C217_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C217_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C218 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 50 serum Days 19-24 SAMD01814477 COVID-19_Lipid_C218 Serum sample from individuals with COVID-19 Sample collection C218 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C218_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C218_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C219 Homo sapiens 9606 2020 Japan 66 SARS-CoV-2 COVID-19 37 serum beyond Day 25 SAMD01814478 COVID-19_Lipid_C219 Serum sample from individuals with COVID-19 Sample collection C219 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C219_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C219_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C22 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 7 serum Days 13-15 SAMD01814479 COVID-19_Lipid_C22 Serum sample from individuals with COVID-19 Sample collection C22 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C22_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C22_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C220 Homo sapiens 9606 2020 Japan 74 SARS-CoV-2 COVID-19 53 serum SAMD01814480 COVID-19_Lipid_C220 Serum sample from individuals with COVID-19 Sample collection C220 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C220_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C220_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 missing C221 Homo sapiens 9606 2020 Japan 19 SARS-CoV-2 COVID-19 52 serum SAMD01814481 COVID-19_Lipid_C221 Serum sample from individuals with COVID-19 Sample collection C221 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C221_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C221_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 missing C222 Homo sapiens 9606 2020 Japan 87 SARS-CoV-2 COVID-19 49 serum beyond Day 25 SAMD01814482 COVID-19_Lipid_C222 Serum sample from individuals with COVID-19 Sample collection C222 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C222_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C222_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C223 Homo sapiens 9606 2020 Japan 74 SARS-CoV-2 COVID-19 53 serum SAMD01814483 COVID-19_Lipid_C223 Serum sample from individuals with COVID-19 Sample collection C223 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C223_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C223_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 missing C224 Homo sapiens 9606 2020 Japan 74 SARS-CoV-2 COVID-19 53 serum SAMD01814484 COVID-19_Lipid_C224 Serum sample from individuals with COVID-19 Sample collection C224 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C224_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C224_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 missing C225 Homo sapiens 9606 2020 Japan 92 SARS-CoV-2 COVID-19 54 serum Days 7-9 SAMD01814485 COVID-19_Lipid_C225 Serum sample from individuals with COVID-19 Sample collection C225 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C225_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C225_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C226 Homo sapiens 9606 2020 Japan 84 SARS-CoV-2 COVID-19 43 serum beyond Day 25 SAMD01814486 COVID-19_Lipid_C226 Serum sample from individuals with COVID-19 Sample collection C226 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C226_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C226_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C227 Homo sapiens 9606 2020 Japan 19 SARS-CoV-2 COVID-19 52 serum SAMD01814487 COVID-19_Lipid_C227 Serum sample from individuals with COVID-19 Sample collection C227 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C227_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C227_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 missing C229 Homo sapiens 9606 2020 Japan 92 SARS-CoV-2 COVID-19 54 serum Days 4-6 SAMD01814488 COVID-19_Lipid_C229 Serum sample from individuals with COVID-19 Sample collection C229 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C229_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C229_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C23 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 7 serum Days 16-18 SAMD01814489 COVID-19_Lipid_C23 Serum sample from individuals with COVID-19 Sample collection C23 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C23_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C23_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C230 Homo sapiens 9606 2020 Japan 54 SARS-CoV-2 COVID-19 55 serum Days 7-9 SAMD01814490 COVID-19_Lipid_C230 Serum sample from individuals with COVID-19 Sample collection C230 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C230_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C230_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C231 Homo sapiens 9606 2020 Japan 54 SARS-CoV-2 COVID-19 55 serum Days 10-12 SAMD01814491 COVID-19_Lipid_C231 Serum sample from individuals with COVID-19 Sample collection C231 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C231_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C231_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C232 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 40 serum beyond Day 25 SAMD01814492 COVID-19_Lipid_C232 Serum sample from individuals with COVID-19 Sample collection C232 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C232_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C232_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C233 Homo sapiens 9606 2020 Japan 87 SARS-CoV-2 COVID-19 36 serum beyond Day 25 SAMD01814493 COVID-19_Lipid_C233 Serum sample from individuals with COVID-19 Sample collection C233 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C233_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C233_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C234 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 41 serum beyond Day 25 SAMD01814494 COVID-19_Lipid_C234 Serum sample from individuals with COVID-19 Sample collection C234 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C234_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C234_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C235 Homo sapiens 9606 2020 Japan 65 SARS-CoV-2 COVID-19 46 serum beyond Day 25 SAMD01814495 COVID-19_Lipid_C235 Serum sample from individuals with COVID-19 Sample collection C235 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C235_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C235_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C236 Homo sapiens 9606 2020 Japan 92 SARS-CoV-2 COVID-19 54 serum Days 10-12 SAMD01814496 COVID-19_Lipid_C236 Serum sample from individuals with COVID-19 Sample collection C236 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C236_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C236_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C237 Homo sapiens 9606 2020 Japan 54 SARS-CoV-2 COVID-19 55 serum Days 13-15 SAMD01814497 COVID-19_Lipid_C237 Serum sample from individuals with COVID-19 Sample collection C237 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C237_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C237_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C238 Homo sapiens 9606 2020 Japan 56 SARS-CoV-2 COVID-19 53 serum Days 7-9 SAMD01814498 COVID-19_Lipid_C238 Serum sample from individuals with COVID-19 Sample collection C238 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C238_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C238_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C239 Homo sapiens 9606 2020 Japan 56 SARS-CoV-2 COVID-19 53 serum Days 10-12 SAMD01814499 COVID-19_Lipid_C239 Serum sample from individuals with COVID-19 Sample collection C239 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C239_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C239_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C24 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 7 serum Days 19-24 SAMD01814500 COVID-19_Lipid_C24 Serum sample from individuals with COVID-19 Sample collection C24 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C24_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C24_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C240 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 57 serum Days 7-9 SAMD01814501 COVID-19_Lipid_C240 Serum sample from individuals with COVID-19 Sample collection C240 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C240_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C240_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C241 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 57 serum Days 10-12 SAMD01814502 COVID-19_Lipid_C241 Serum sample from individuals with COVID-19 Sample collection C241 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C241_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C241_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C242 Homo sapiens 9606 2020 Japan 54 SARS-CoV-2 COVID-19 55 serum Days 16-18 SAMD01814503 COVID-19_Lipid_C242 Serum sample from individuals with COVID-19 Sample collection C242 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C242_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C242_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C243 Homo sapiens 9606 2020 Japan 92 SARS-CoV-2 COVID-19 54 serum Days 16-18 SAMD01814504 COVID-19_Lipid_C243 Serum sample from individuals with COVID-19 Sample collection C243 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C243_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C243_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C244 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 50 serum beyond Day 25 SAMD01814505 COVID-19_Lipid_C244 Serum sample from individuals with COVID-19 Sample collection C244 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C244_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C244_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C245 Homo sapiens 9606 2020 Japan 77 SARS-CoV-2 COVID-19 58 serum Days 10-12 SAMD01814506 COVID-19_Lipid_C245 Serum sample from individuals with COVID-19 Sample collection C245 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C245_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C245_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C246 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 59 serum Days 7-9 SAMD01814507 COVID-19_Lipid_C246 Serum sample from individuals with COVID-19 Sample collection C246 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C246_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C246_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C247 Homo sapiens 9606 2020 Japan 77 SARS-CoV-2 COVID-19 58 serum Days 13-15 SAMD01814508 COVID-19_Lipid_C247 Serum sample from individuals with COVID-19 Sample collection C247 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C247_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C247_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C248 Homo sapiens 9606 2020 Japan 92 SARS-CoV-2 COVID-19 54 serum Days 19-24 SAMD01814509 COVID-19_Lipid_C248 Serum sample from individuals with COVID-19 Sample collection C248 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C248_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C248_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C249 Homo sapiens 9606 2020 Japan 56 SARS-CoV-2 COVID-19 53 serum Days 19-24 SAMD01814510 COVID-19_Lipid_C249 Serum sample from individuals with COVID-19 Sample collection C249 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C249_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C249_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C25 Homo sapiens 9606 2020 Japan 36 SARS-CoV-2 COVID-19 9 serum Days 13-15 SAMD01814511 COVID-19_Lipid_C25 Serum sample from individuals with COVID-19 Sample collection C25 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C25_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C25_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C250 Homo sapiens 9606 2020 Japan 77 SARS-CoV-2 COVID-19 58 serum Days 16-18 SAMD01814512 COVID-19_Lipid_C250 Serum sample from individuals with COVID-19 Sample collection C250 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C250_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C250_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C251 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 59 serum Days 10-12 SAMD01814513 COVID-19_Lipid_C251 Serum sample from individuals with COVID-19 Sample collection C251 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C251_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C251_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C252 Homo sapiens 9606 2020 Japan 77 SARS-CoV-2 COVID-19 58 serum Days 19-24 SAMD01814514 COVID-19_Lipid_C252 Serum sample from individuals with COVID-19 Sample collection C252 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C252_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C252_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C253 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 59 serum Days 13-15 SAMD01814515 COVID-19_Lipid_C253 Serum sample from individuals with COVID-19 Sample collection C253 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C253_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C253_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C254 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 59 serum Days 16-18 SAMD01814516 COVID-19_Lipid_C254 Serum sample from individuals with COVID-19 Sample collection C254 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C254_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C254_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C255 Homo sapiens 9606 2020 Japan 81 SARS-CoV-2 COVID-19 47 serum beyond Day 25 SAMD01814517 COVID-19_Lipid_C255 Serum sample from individuals with COVID-19 Sample collection C255 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C255_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C255_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C256 Homo sapiens 9606 2020 Japan 45 SARS-CoV-2 COVID-19 63 serum Days 4-6 SAMD01814518 COVID-19_Lipid_C256 Serum sample from individuals with COVID-19 Sample collection C256 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C256_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C256_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C257 Homo sapiens 9606 2020 Japan 45 SARS-CoV-2 COVID-19 63 serum Days 7-9 SAMD01814519 COVID-19_Lipid_C257 Serum sample from individuals with COVID-19 Sample collection C257 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C257_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C257_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C258 Homo sapiens 9606 2020 Japan 45 SARS-CoV-2 COVID-19 63 serum Days 10-12 SAMD01814520 COVID-19_Lipid_C258 Serum sample from individuals with COVID-19 Sample collection C258 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C258_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C258_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C259 Homo sapiens 9606 2020 Japan 45 SARS-CoV-2 COVID-19 63 serum Days 13-15 SAMD01814521 COVID-19_Lipid_C259 Serum sample from individuals with COVID-19 Sample collection C259 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C259_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C259_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C26 Homo sapiens 9606 2020 Japan 36 SARS-CoV-2 COVID-19 9 serum Days 16-18 SAMD01814522 COVID-19_Lipid_C26 Serum sample from individuals with COVID-19 Sample collection C26 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C26_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C26_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C260 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 48 serum beyond Day 25 SAMD01814523 COVID-19_Lipid_C260 Serum sample from individuals with COVID-19 Sample collection C260 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C260_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C260_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C261 Homo sapiens 9606 2020 Japan 78 SARS-CoV-2 COVID-19 64 serum Days 7-9 SAMD01814524 COVID-19_Lipid_C261 Serum sample from individuals with COVID-19 Sample collection C261 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C261_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C261_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C262 Homo sapiens 9606 2020 Japan 78 SARS-CoV-2 COVID-19 64 serum Days 10-12 SAMD01814525 COVID-19_Lipid_C262 Serum sample from individuals with COVID-19 Sample collection C262 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C262_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C262_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C263 Homo sapiens 9606 2020 Japan 78 SARS-CoV-2 COVID-19 64 serum Days 13-15 SAMD01814526 COVID-19_Lipid_C263 Serum sample from individuals with COVID-19 Sample collection C263 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C263_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C263_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C264 Homo sapiens 9606 2020 Japan 45 SARS-CoV-2 COVID-19 63 serum Days 19-24 SAMD01814527 COVID-19_Lipid_C264 Serum sample from individuals with COVID-19 Sample collection C264 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C264_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C264_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C265 Homo sapiens 9606 2020 Japan 92 SARS-CoV-2 COVID-19 54 serum beyond Day 25 SAMD01814528 COVID-19_Lipid_C265 Serum sample from individuals with COVID-19 Sample collection C265 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C265_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C265_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C266 Homo sapiens 9606 2020 Japan 48 SARS-CoV-2 COVID-19 65 serum Days 4-6 SAMD01814529 COVID-19_Lipid_C266 Serum sample from individuals with COVID-19 Sample collection C266 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C266_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C266_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C267 Homo sapiens 9606 2020 Japan 48 SARS-CoV-2 COVID-19 65 serum Days 7-9 SAMD01814530 COVID-19_Lipid_C267 Serum sample from individuals with COVID-19 Sample collection C267 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C267_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C267_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C268 Homo sapiens 9606 2020 Japan 36 SARS-CoV-2 COVID-19 66 serum Days 4-6 SAMD01814531 COVID-19_Lipid_C268 Serum sample from individuals with COVID-19 Sample collection C268 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C268_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C268_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C269 Homo sapiens 9606 2020 Japan 36 SARS-CoV-2 COVID-19 66 serum Days 10-12 SAMD01814532 COVID-19_Lipid_C269 Serum sample from individuals with COVID-19 Sample collection C269 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C269_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C269_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C27 Homo sapiens 9606 2020 Japan 36 SARS-CoV-2 COVID-19 9 serum Days 19-24 SAMD01814533 COVID-19_Lipid_C27 Serum sample from individuals with COVID-19 Sample collection C27 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C27_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C27_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C270 Homo sapiens 9606 2020 Japan 36 SARS-CoV-2 COVID-19 66 serum Days 10-12 SAMD01814534 COVID-19_Lipid_C270 Serum sample from individuals with COVID-19 Sample collection C270 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C270_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C270_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C271 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 57 serum beyond Day 25 SAMD01814535 COVID-19_Lipid_C271 Serum sample from individuals with COVID-19 Sample collection C271 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C271_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C271_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C272 Homo sapiens 9606 2020 Japan 56 SARS-CoV-2 COVID-19 67 serum Days 4-6 SAMD01814536 COVID-19_Lipid_C272 Serum sample from individuals with COVID-19 Sample collection C272 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C272_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C272_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C273 Homo sapiens 9606 2020 Japan 56 SARS-CoV-2 COVID-19 67 serum Days 7-9 SAMD01814537 COVID-19_Lipid_C273 Serum sample from individuals with COVID-19 Sample collection C273 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C273_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C273_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C274 Homo sapiens 9606 2020 Japan 48 SARS-CoV-2 COVID-19 65 serum Days 7-9 SAMD01814538 COVID-19_Lipid_C274 Serum sample from individuals with COVID-19 Sample collection C274 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C274_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C274_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C275 Homo sapiens 9606 2020 Japan 36 SARS-CoV-2 COVID-19 66 serum Days 13-15 SAMD01814539 COVID-19_Lipid_C275 Serum sample from individuals with COVID-19 Sample collection C275 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C275_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C275_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C276 Homo sapiens 9606 2020 Japan 36 SARS-CoV-2 COVID-19 66 serum Days 16-18 SAMD01814540 COVID-19_Lipid_C276 Serum sample from individuals with COVID-19 Sample collection C276 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C276_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C276_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C277 Homo sapiens 9606 2020 Japan 56 SARS-CoV-2 COVID-19 67 serum Days 10-12 SAMD01814541 COVID-19_Lipid_C277 Serum sample from individuals with COVID-19 Sample collection C277 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C277_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C277_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C278 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 67 serum Days 13-15 SAMD01814542 COVID-19_Lipid_C278 Serum sample from individuals with COVID-19 Sample collection C278 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C278_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C278_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C279 Homo sapiens 9606 2020 Japan 45 SARS-CoV-2 COVID-19 81 serum Days 13-15 SAMD01814543 COVID-19_Lipid_C279 Serum sample from individuals with COVID-19 Sample collection C279 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C279_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C279_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C28 Homo sapiens 9606 2020 Japan 49 SARS-CoV-2 COVID-19 12 serum Days 13-15 SAMD01814544 COVID-19_Lipid_C28 Serum sample from individuals with COVID-19 Sample collection C28 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C28_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C28_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C280 Homo sapiens 9606 2020 Japan 78 SARS-CoV-2 COVID-19 74 serum Days 1-3 SAMD01814545 COVID-19_Lipid_C280 Serum sample from individuals with COVID-19 Sample collection C280 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C280_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C280_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 1-3 C281 Homo sapiens 9606 2020 Japan 78 SARS-CoV-2 COVID-19 74 serum Days 4-6 SAMD01814546 COVID-19_Lipid_C281 Serum sample from individuals with COVID-19 Sample collection C281 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C281_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C281_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C282 Homo sapiens 9606 2020 Japan 78 SARS-CoV-2 COVID-19 74 serum Days 7-9 SAMD01814547 COVID-19_Lipid_C282 Serum sample from individuals with COVID-19 Sample collection C282 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C282_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C282_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C283 Homo sapiens 9606 2020 Japan 45 SARS-CoV-2 COVID-19 63 serum beyond Day 25 SAMD01814548 COVID-19_Lipid_C283 Serum sample from individuals with COVID-19 Sample collection C283 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C283_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C283_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C284 Homo sapiens 9606 2020 Japan 45 SARS-CoV-2 COVID-19 81 serum Days 16-18 SAMD01814549 COVID-19_Lipid_C284 Serum sample from individuals with COVID-19 Sample collection C284 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C284_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C284_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C285 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 59 serum beyond Day 25 SAMD01814550 COVID-19_Lipid_C285 Serum sample from individuals with COVID-19 Sample collection C285 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C285_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C285_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C286 Homo sapiens 9606 2020 Japan 76 SARS-CoV-2 COVID-19 69 serum SAMD01814551 COVID-19_Lipid_C286 Serum sample from individuals with COVID-19 Sample collection C286 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C286_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C286_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 missing C287 Homo sapiens 9606 2020 Japan 45 SARS-CoV-2 COVID-19 79 serum Days 1-3 SAMD01814552 COVID-19_Lipid_C287 Serum sample from individuals with COVID-19 Sample collection C287 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C287_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C287_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 1-3 C288 Homo sapiens 9606 2020 Japan 45 SARS-CoV-2 COVID-19 79 serum Days 4-6 SAMD01814553 COVID-19_Lipid_C288 Serum sample from individuals with COVID-19 Sample collection C288 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C288_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C288_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C289 Homo sapiens 9606 2020 Japan 84 SARS-CoV-2 COVID-19 70 serum Days 7-9 SAMD01814554 COVID-19_Lipid_C289 Serum sample from individuals with COVID-19 Sample collection C289 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C289_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C289_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C29 Homo sapiens 9606 2020 Japan 49 SARS-CoV-2 COVID-19 12 serum Days 16-18 SAMD01814555 COVID-19_Lipid_C29 Serum sample from individuals with COVID-19 Sample collection C29 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C29_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C29_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C290 Homo sapiens 9606 2020 Japan 84 SARS-CoV-2 COVID-19 70 serum Days 10-12 SAMD01814556 COVID-19_Lipid_C290 Serum sample from individuals with COVID-19 Sample collection C290 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C290_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C290_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C291 Homo sapiens 9606 2020 Japan 72 SARS-CoV-2 COVID-19 71 serum Days 7-9 SAMD01814557 COVID-19_Lipid_C291 Serum sample from individuals with COVID-19 Sample collection C291 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C291_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C291_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C292 Homo sapiens 9606 2020 Japan 72 SARS-CoV-2 COVID-19 71 serum Days 10-12 SAMD01814558 COVID-19_Lipid_C292 Serum sample from individuals with COVID-19 Sample collection C292 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C292_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C292_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C293 Homo sapiens 9606 2020 Japan 48 SARS-CoV-2 COVID-19 72 serum Days 10-12 SAMD01814559 COVID-19_Lipid_C293 Serum sample from individuals with COVID-19 Sample collection C293 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C293_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C293_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C294 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 73 serum Days 7-9 SAMD01814560 COVID-19_Lipid_C294 Serum sample from individuals with COVID-19 Sample collection C294 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C294_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C294_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C295 Homo sapiens 9606 2020 Japan 54 SARS-CoV-2 COVID-19 55 serum beyond Day 25 SAMD01814561 COVID-19_Lipid_C295 Serum sample from individuals with COVID-19 Sample collection C295 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C295_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C295_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C296 Homo sapiens 9606 2020 Japan 78 SARS-CoV-2 COVID-19 74 serum Days 10-12 SAMD01814562 COVID-19_Lipid_C296 Serum sample from individuals with COVID-19 Sample collection C296 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C296_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C296_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C297 Homo sapiens 9606 2020 Japan 78 SARS-CoV-2 COVID-19 74 serum Days 13-15 SAMD01814563 COVID-19_Lipid_C297 Serum sample from individuals with COVID-19 Sample collection C297 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C297_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C297_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C298 Homo sapiens 9606 2020 Japan 50 SARS-CoV-2 COVID-19 76 serum Days 4-6 SAMD01814564 COVID-19_Lipid_C298 Serum sample from individuals with COVID-19 Sample collection C298 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C298_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C298_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C299 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 73 serum Days 10-12 SAMD01814565 COVID-19_Lipid_C299 Serum sample from individuals with COVID-19 Sample collection C299 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C299_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C299_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C3 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 13 serum Days 10-12 SAMD01814566 COVID-19_Lipid_C3 Serum sample from individuals with COVID-19 Sample collection C3 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C3_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C3_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C30 Homo sapiens 9606 2020 Japan 49 SARS-CoV-2 COVID-19 12 serum Days 19-24 SAMD01814567 COVID-19_Lipid_C30 Serum sample from individuals with COVID-19 Sample collection C30 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C30_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C30_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C300 Homo sapiens 9606 2020 Japan 53 SARS-CoV-2 COVID-19 77 serum Days 7-9 SAMD01814568 COVID-19_Lipid_C300 Serum sample from individuals with COVID-19 Sample collection C300 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C300_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C300_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C301 Homo sapiens 9606 2020 Japan 84 SARS-CoV-2 COVID-19 70 serum Days 10-12 SAMD01814569 COVID-19_Lipid_C301 Serum sample from individuals with COVID-19 Sample collection C301 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C301_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C301_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C302 Homo sapiens 9606 2020 Japan 48 SARS-CoV-2 COVID-19 78 serum Days 4-6 SAMD01814570 COVID-19_Lipid_C302 Serum sample from individuals with COVID-19 Sample collection C302 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C302_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C302_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C303 Homo sapiens 9606 2020 Japan 45 SARS-CoV-2 COVID-19 79 serum Days 7-9 SAMD01814571 COVID-19_Lipid_C303 Serum sample from individuals with COVID-19 Sample collection C303 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C303_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C303_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C304 Homo sapiens 9606 2020 Japan 76 SARS-CoV-2 COVID-19 69 serum SAMD01814572 COVID-19_Lipid_C304 Serum sample from individuals with COVID-19 Sample collection C304 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C304_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C304_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 missing C305 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 73 serum pre-onset SAMD01814573 COVID-19_Lipid_C305 Serum sample from individuals with COVID-19 Sample collection C305 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C305_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C305_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 pre-onset C306 Homo sapiens 9606 2020 Japan 45 SARS-CoV-2 COVID-19 81 serum Days 7-9 SAMD01814574 COVID-19_Lipid_C306 Serum sample from individuals with COVID-19 Sample collection C306 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C306_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C306_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C307 Homo sapiens 9606 2020 Japan 45 SARS-CoV-2 COVID-19 81 serum Days 10-12 SAMD01814575 COVID-19_Lipid_C307 Serum sample from individuals with COVID-19 Sample collection C307 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C307_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C307_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C308 Homo sapiens 9606 2020 Japan 84 SARS-CoV-2 COVID-19 70 serum Days 13-15 SAMD01814576 COVID-19_Lipid_C308 Serum sample from individuals with COVID-19 Sample collection C308 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C308_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C308_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C309 Homo sapiens 9606 2020 Japan 30 SARS-CoV-2 COVID-19 83 serum SAMD01814577 COVID-19_Lipid_C309 Serum sample from individuals with COVID-19 Sample collection C309 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C309_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C309_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 missing C31 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 10 serum Days 13-15 SAMD01814578 COVID-19_Lipid_C31 Serum sample from individuals with COVID-19 Sample collection C31 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C31_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C31_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C310 Homo sapiens 9606 2020 Japan 53 SARS-CoV-2 COVID-19 77 serum Days 10-12 SAMD01814579 COVID-19_Lipid_C310 Serum sample from individuals with COVID-19 Sample collection C310 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C310_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C310_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C311 Homo sapiens 9606 2020 Japan 45 SARS-CoV-2 COVID-19 79 serum Days 7-9 SAMD01814580 COVID-19_Lipid_C311 Serum sample from individuals with COVID-19 Sample collection C311 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C311_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C311_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C312 Homo sapiens 9606 2020 Japan 72 SARS-CoV-2 COVID-19 71 serum Days 13-15 SAMD01814581 COVID-19_Lipid_C312 Serum sample from individuals with COVID-19 Sample collection C312 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C312_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C312_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C313 Homo sapiens 9606 2020 Japan 51 SARS-CoV-2 COVID-19 76 serum Days 7-9 SAMD01814582 COVID-19_Lipid_C313 Serum sample from individuals with COVID-19 Sample collection C313 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C313_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C313_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C314 Homo sapiens 9606 2020 Japan 78 SARS-CoV-2 COVID-19 74 serum Days 16-18 SAMD01814583 COVID-19_Lipid_C314 Serum sample from individuals with COVID-19 Sample collection C314 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C314_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C314_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C315 Homo sapiens 9606 2020 Japan 76 SARS-CoV-2 COVID-19 69 serum SAMD01814584 COVID-19_Lipid_C315 Serum sample from individuals with COVID-19 Sample collection C315 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C315_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C315_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 missing C316 Homo sapiens 9606 2020 Japan 48 SARS-CoV-2 COVID-19 78 serum Days 7-9 SAMD01814585 COVID-19_Lipid_C316 Serum sample from individuals with COVID-19 Sample collection C316 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C316_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C316_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C317 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 73 serum Days 13-15 SAMD01814586 COVID-19_Lipid_C317 Serum sample from individuals with COVID-19 Sample collection C317 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C317_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C317_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C318 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 82 serum Days 4-6 SAMD01814587 COVID-19_Lipid_C318 Serum sample from individuals with COVID-19 Sample collection C318 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C318_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C318_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C319 Homo sapiens 9606 2020 Japan 48 SARS-CoV-2 COVID-19 78 serum Days 10-12 SAMD01814588 COVID-19_Lipid_C319 Serum sample from individuals with COVID-19 Sample collection C319 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C319_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C319_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C32 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 10 serum Days 16-18 SAMD01814589 COVID-19_Lipid_C32 Serum sample from individuals with COVID-19 Sample collection C32 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C32_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C32_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C320 Homo sapiens 9606 2020 Japan 84 SARS-CoV-2 COVID-19 70 serum Days 16-18 SAMD01814590 COVID-19_Lipid_C320 Serum sample from individuals with COVID-19 Sample collection C320 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C320_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C320_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C321 Homo sapiens 9606 2020 Japan 45 SARS-CoV-2 COVID-19 79 serum Days 10-12 SAMD01814591 COVID-19_Lipid_C321 Serum sample from individuals with COVID-19 Sample collection C321 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C321_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C321_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C322 Homo sapiens 9606 2020 Japan 53 SARS-CoV-2 COVID-19 77 serum Days 13-15 SAMD01814592 COVID-19_Lipid_C322 Serum sample from individuals with COVID-19 Sample collection C322 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C322_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C322_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C323 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 84 serum Days 7-9 SAMD01814593 COVID-19_Lipid_C323 Serum sample from individuals with COVID-19 Sample collection C323 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C323_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C323_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C324 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 84 serum Days 10-12 SAMD01814594 COVID-19_Lipid_C324 Serum sample from individuals with COVID-19 Sample collection C324 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C324_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C324_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C325 Homo sapiens 9606 2020 Japan 53 SARS-CoV-2 COVID-19 77 serum Days 16-18 SAMD01814595 COVID-19_Lipid_C325 Serum sample from individuals with COVID-19 Sample collection C325 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C325_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C325_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C326 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 85 serum Days 1-3 SAMD01814596 COVID-19_Lipid_C326 Serum sample from individuals with COVID-19 Sample collection C326 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C326_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C326_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 1-3 C327 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 85 serum Days 4-6 SAMD01814597 COVID-19_Lipid_C327 Serum sample from individuals with COVID-19 Sample collection C327 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C327_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C327_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C328 Homo sapiens 9606 2020 Japan 84 SARS-CoV-2 COVID-19 70 serum Days 19-24 SAMD01814598 COVID-19_Lipid_C328 Serum sample from individuals with COVID-19 Sample collection C328 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C328_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C328_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C329 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 82 serum Days 7-9 SAMD01814599 COVID-19_Lipid_C329 Serum sample from individuals with COVID-19 Sample collection C329 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C329_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C329_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C33 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 10 serum Days 19-24 SAMD01814600 COVID-19_Lipid_C33 Serum sample from individuals with COVID-19 Sample collection C33 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C33_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C33_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C330 Homo sapiens 9606 2020 Japan 48 SARS-CoV-2 COVID-19 78 serum Days 13-15 SAMD01814601 COVID-19_Lipid_C330 Serum sample from individuals with COVID-19 Sample collection C330 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C330_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C330_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C331 Homo sapiens 9606 2020 Japan 34 SARS-CoV-2 COVID-19 87 serum Days 1-3 SAMD01814602 COVID-19_Lipid_C331 Serum sample from individuals with COVID-19 Sample collection C331 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C331_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C331_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 1-3 C332 Homo sapiens 9606 2020 Japan 66 SARS-CoV-2 COVID-19 88 serum Days 7-9 SAMD01814603 COVID-19_Lipid_C332 Serum sample from individuals with COVID-19 Sample collection C332 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C332_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C332_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C333 Homo sapiens 9606 2020 Japan 73 SARS-CoV-2 COVID-19 89 serum Days 10-12 SAMD01814604 COVID-19_Lipid_C333 Serum sample from individuals with COVID-19 Sample collection C333 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C333_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C333_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C334 Homo sapiens 9606 2020 Japan 51 SARS-CoV-2 COVID-19 76 serum Days 13-15 SAMD01814605 COVID-19_Lipid_C334 Serum sample from individuals with COVID-19 Sample collection C334 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C334_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C334_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C335 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 67 serum beyond Day 25 SAMD01814606 COVID-19_Lipid_C335 Serum sample from individuals with COVID-19 Sample collection C335 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C335_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C335_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C336 Homo sapiens 9606 2020 Japan 76 SARS-CoV-2 COVID-19 69 serum SAMD01814607 COVID-19_Lipid_C336 Serum sample from individuals with COVID-19 Sample collection C336 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C336_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C336_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 missing C337 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 82 serum Days 10-12 SAMD01814608 COVID-19_Lipid_C337 Serum sample from individuals with COVID-19 Sample collection C337 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C337_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C337_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C338 Homo sapiens 9606 2020 Japan 28 SARS-CoV-2 COVID-19 90 serum Days 4-6 SAMD01814609 COVID-19_Lipid_C338 Serum sample from individuals with COVID-19 Sample collection C338 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C338_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C338_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C339 Homo sapiens 9606 2020 Japan 28 SARS-CoV-2 COVID-19 90 serum pre-onset SAMD01814610 COVID-19_Lipid_C339 Serum sample from individuals with COVID-19 Sample collection C339 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C339_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C339_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 pre-onset C34 Homo sapiens 9606 2020 Japan 47 SARS-CoV-2 COVID-19 2 serum Days 16-18 SAMD01814611 COVID-19_Lipid_C34 Serum sample from individuals with COVID-19 Sample collection C34 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C34_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C34_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C340 Homo sapiens 9606 2020 Japan 66 SARS-CoV-2 COVID-19 88 serum Days 10-12 SAMD01814612 COVID-19_Lipid_C340 Serum sample from individuals with COVID-19 Sample collection C340 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C340_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C340_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C341 Homo sapiens 9606 2020 Japan 48 SARS-CoV-2 COVID-19 72 serum beyond Day 25 SAMD01814613 COVID-19_Lipid_C341 Serum sample from individuals with COVID-19 Sample collection C341 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C341_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C341_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C342 Homo sapiens 9606 2020 Japan 53 SARS-CoV-2 COVID-19 77 serum Days 19-24 SAMD01814614 COVID-19_Lipid_C342 Serum sample from individuals with COVID-19 Sample collection C342 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C342_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C342_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C343 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 85 serum Days 7-9 SAMD01814615 COVID-19_Lipid_C343 Serum sample from individuals with COVID-19 Sample collection C343 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C343_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C343_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C344 Homo sapiens 9606 2020 Japan 78 SARS-CoV-2 COVID-19 64 serum beyond Day 25 SAMD01814616 COVID-19_Lipid_C344 Serum sample from individuals with COVID-19 Sample collection C344 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C344_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C344_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C345 Homo sapiens 9606 2020 Japan 71 SARS-CoV-2 COVID-19 97 serum Days 7-9 SAMD01814617 COVID-19_Lipid_C345 Serum sample from individuals with COVID-19 Sample collection C345 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C345_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C345_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C346 Homo sapiens 9606 2020 Japan 73 SARS-CoV-2 COVID-19 89 serum Days 13-15 SAMD01814618 COVID-19_Lipid_C346 Serum sample from individuals with COVID-19 Sample collection C346 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C346_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C346_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C347 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 85 serum Days 10-12 SAMD01814619 COVID-19_Lipid_C347 Serum sample from individuals with COVID-19 Sample collection C347 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C347_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C347_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C348 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 82 serum Days 13-15 SAMD01814620 COVID-19_Lipid_C348 Serum sample from individuals with COVID-19 Sample collection C348 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C348_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C348_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C349 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 82 serum Days 16-18 SAMD01814621 COVID-19_Lipid_C349 Serum sample from individuals with COVID-19 Sample collection C349 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C349_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C349_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C35 Homo sapiens 9606 2020 Japan 47 SARS-CoV-2 COVID-19 2 serum Days 19-24 SAMD01814622 COVID-19_Lipid_C35 Serum sample from individuals with COVID-19 Sample collection C35 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C35_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C35_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C350 Homo sapiens 9606 2020 Japan 66 SARS-CoV-2 COVID-19 88 serum Days 10-12 SAMD01814623 COVID-19_Lipid_C350 Serum sample from individuals with COVID-19 Sample collection C350 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C350_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C350_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C351 Homo sapiens 9606 2020 Japan 71 SARS-CoV-2 COVID-19 97 serum Days 10-12 SAMD01814624 COVID-19_Lipid_C351 Serum sample from individuals with COVID-19 Sample collection C351 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C351_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C351_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C352 Homo sapiens 9606 2020 Japan 73 SARS-CoV-2 COVID-19 89 serum Days 16-18 SAMD01814625 COVID-19_Lipid_C352 Serum sample from individuals with COVID-19 Sample collection C352 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C352_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C352_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C353 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 84 serum Days 13-15 SAMD01814626 COVID-19_Lipid_C353 Serum sample from individuals with COVID-19 Sample collection C353 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C353_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C353_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C354 Homo sapiens 9606 2020 Japan 73 SARS-CoV-2 COVID-19 96 serum Days 7-9 SAMD01814627 COVID-19_Lipid_C354 Serum sample from individuals with COVID-19 Sample collection C354 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C354_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C354_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C355 Homo sapiens 9606 2020 Japan 78 SARS-CoV-2 COVID-19 74 serum beyond Day 25 SAMD01814628 COVID-19_Lipid_C355 Serum sample from individuals with COVID-19 Sample collection C355 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C355_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C355_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C356 Homo sapiens 9606 2020 Japan 71 SARS-CoV-2 COVID-19 97 serum Days 10-12 SAMD01814629 COVID-19_Lipid_C356 Serum sample from individuals with COVID-19 Sample collection C356 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C356_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C356_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C357 Homo sapiens 9606 2020 Japan 79 SARS-CoV-2 COVID-19 98 serum Days 4-6 SAMD01814630 COVID-19_Lipid_C357 Serum sample from individuals with COVID-19 Sample collection C357 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C357_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C357_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C358 Homo sapiens 9606 2020 Japan 29 SARS-CoV-2 COVID-19 90 serum Days 10-12 SAMD01814631 COVID-19_Lipid_C358 Serum sample from individuals with COVID-19 Sample collection C358 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C358_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C358_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C359 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 85 serum Days 13-15 SAMD01814632 COVID-19_Lipid_C359 Serum sample from individuals with COVID-19 Sample collection C359 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C359_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C359_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C36 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 14 serum Days 13-15 SAMD01814633 COVID-19_Lipid_C36 Serum sample from individuals with COVID-19 Sample collection C36 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C36_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C36_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C360 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 73 serum beyond Day 25 SAMD01814634 COVID-19_Lipid_C360 Serum sample from individuals with COVID-19 Sample collection C360 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C360_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C360_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C361 Homo sapiens 9606 2020 Japan 73 SARS-CoV-2 COVID-19 96 serum Days 13-15 SAMD01814635 COVID-19_Lipid_C361 Serum sample from individuals with COVID-19 Sample collection C361 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C361_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C361_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C362 Homo sapiens 9606 2020 Japan 28 SARS-CoV-2 COVID-19 90 serum Days 13-15 SAMD01814636 COVID-19_Lipid_C362 Serum sample from individuals with COVID-19 Sample collection C362 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C362_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C362_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C363 Homo sapiens 9606 2020 Japan 48 SARS-CoV-2 COVID-19 65 serum beyond Day 25 SAMD01814637 COVID-19_Lipid_C363 Serum sample from individuals with COVID-19 Sample collection C363 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C363_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C363_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C364 Homo sapiens 9606 2020 Japan 73 SARS-CoV-2 COVID-19 89 serum Days 19-24 SAMD01814638 COVID-19_Lipid_C364 Serum sample from individuals with COVID-19 Sample collection C364 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C364_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C364_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C365 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 82 serum Days 19-24 SAMD01814639 COVID-19_Lipid_C365 Serum sample from individuals with COVID-19 Sample collection C365 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C365_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C365_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C366 Homo sapiens 9606 2020 Japan 71 SARS-CoV-2 COVID-19 97 serum Days 13-15 SAMD01814640 COVID-19_Lipid_C366 Serum sample from individuals with COVID-19 Sample collection C366 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C366_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C366_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C367 Homo sapiens 9606 2020 Japan 79 SARS-CoV-2 COVID-19 98 serum Days 7-9 SAMD01814641 COVID-19_Lipid_C367 Serum sample from individuals with COVID-19 Sample collection C367 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C367_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C367_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C368 Homo sapiens 9606 2020 Japan 66 SARS-CoV-2 COVID-19 95 serum Days 10-12 SAMD01814642 COVID-19_Lipid_C368 Serum sample from individuals with COVID-19 Sample collection C368 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C368_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C368_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C369 Homo sapiens 9606 2020 Japan 66 SARS-CoV-2 COVID-19 95 serum Days 13-15 SAMD01814643 COVID-19_Lipid_C369 Serum sample from individuals with COVID-19 Sample collection C369 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C369_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C369_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C37 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 14 serum Days 16-18 SAMD01814644 COVID-19_Lipid_C37 Serum sample from individuals with COVID-19 Sample collection C37 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C37_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C37_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C370 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 84 serum Days 19-24 SAMD01814645 COVID-19_Lipid_C370 Serum sample from individuals with COVID-19 Sample collection C370 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C370_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C370_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C371 Homo sapiens 9606 2020 Japan 73 SARS-CoV-2 COVID-19 89 serum Days 19-24 SAMD01814646 COVID-19_Lipid_C371 Serum sample from individuals with COVID-19 Sample collection C371 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C371_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C371_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C372 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 94 serum Days 10-12 SAMD01814647 COVID-19_Lipid_C372 Serum sample from individuals with COVID-19 Sample collection C372 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C372_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C372_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C373 Homo sapiens 9606 2020 Japan 79 SARS-CoV-2 COVID-19 98 serum Days 10-12 SAMD01814648 COVID-19_Lipid_C373 Serum sample from individuals with COVID-19 Sample collection C373 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C373_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C373_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C374 Homo sapiens 9606 2020 Japan 73 SARS-CoV-2 COVID-19 96 serum Days 16-18 SAMD01814649 COVID-19_Lipid_C374 Serum sample from individuals with COVID-19 Sample collection C374 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C374_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C374_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C375 Homo sapiens 9606 2020 Japan 79 SARS-CoV-2 COVID-19 92 serum Days 4-6 SAMD01814650 COVID-19_Lipid_C375 Serum sample from individuals with COVID-19 Sample collection C375 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C375_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C375_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C376 Homo sapiens 9606 2020 Japan 53 SARS-CoV-2 COVID-19 77 serum beyond Day 25 SAMD01814651 COVID-19_Lipid_C376 Serum sample from individuals with COVID-19 Sample collection C376 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C376_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C376_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C377 Homo sapiens 9606 2020 Japan 21 SARS-CoV-2 COVID-19 93 serum Days 1-3 SAMD01814652 COVID-19_Lipid_C377 Serum sample from individuals with COVID-19 Sample collection C377 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C377_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C377_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 1-3 C378 Homo sapiens 9606 2020 Japan 77 SARS-CoV-2 COVID-19 91 serum SAMD01814653 COVID-19_Lipid_C378 Serum sample from individuals with COVID-19 Sample collection C378 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C378_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C378_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 missing C379 Homo sapiens 9606 2020 Japan 77 SARS-CoV-2 COVID-19 91 serum SAMD01814654 COVID-19_Lipid_C379 Serum sample from individuals with COVID-19 Sample collection C379 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C379_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C379_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 missing C38 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 14 serum Days 19-24 SAMD01814655 COVID-19_Lipid_C38 Serum sample from individuals with COVID-19 Sample collection C38 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C38_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C38_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C380 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 85 serum Days 19-24 SAMD01814656 COVID-19_Lipid_C380 Serum sample from individuals with COVID-19 Sample collection C380 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C380_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C380_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C381 Homo sapiens 9606 2020 Japan 48 SARS-CoV-2 COVID-19 99 serum Days 1-3 SAMD01814657 COVID-19_Lipid_C381 Serum sample from individuals with COVID-19 Sample collection C381 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C381_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C381_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 1-3 C382 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 100 serum Days 4-6 SAMD01814658 COVID-19_Lipid_C382 Serum sample from individuals with COVID-19 Sample collection C382 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C382_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C382_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C383 Homo sapiens 9606 2020 Japan 79 SARS-CoV-2 COVID-19 92 serum Days 7-9 SAMD01814659 COVID-19_Lipid_C383 Serum sample from individuals with COVID-19 Sample collection C383 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C383_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C383_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C384 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 82 serum beyond Day 25 SAMD01814660 COVID-19_Lipid_C384 Serum sample from individuals with COVID-19 Sample collection C384 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C384_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C384_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C385 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 94 serum Days 13-15 SAMD01814661 COVID-19_Lipid_C385 Serum sample from individuals with COVID-19 Sample collection C385 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C385_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C385_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C386 Homo sapiens 9606 2020 Japan 77 SARS-CoV-2 COVID-19 91 serum SAMD01814662 COVID-19_Lipid_C386 Serum sample from individuals with COVID-19 Sample collection C386 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C386_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C386_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 missing C387 Homo sapiens 9606 2020 Japan 51 SARS-CoV-2 COVID-19 76 serum beyond Day 25 SAMD01814663 COVID-19_Lipid_C387 Serum sample from individuals with COVID-19 Sample collection C387 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C387_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C387_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C388 Homo sapiens 9606 2020 Japan 48 SARS-CoV-2 COVID-19 78 serum beyond Day 25 SAMD01814664 COVID-19_Lipid_C388 Serum sample from individuals with COVID-19 Sample collection C388 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C388_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C388_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C389 Homo sapiens 9606 2020 Japan 45 SARS-CoV-2 COVID-19 79 serum beyond Day 25 SAMD01814665 COVID-19_Lipid_C389 Serum sample from individuals with COVID-19 Sample collection C389 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C389_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C389_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C39 Homo sapiens 9606 2020 Japan 71 SARS-CoV-2 COVID-19 20 serum Days 10-12 SAMD01814666 COVID-19_Lipid_C39 Serum sample from individuals with COVID-19 Sample collection C39 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C39_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C39_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C390 Homo sapiens 9606 2020 Japan 71 SARS-CoV-2 COVID-19 101 serum Days 7-9 SAMD01814667 COVID-19_Lipid_C390 Serum sample from individuals with COVID-19 Sample collection C390 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C390_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C390_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C391 Homo sapiens 9606 2020 Japan 77 SARS-CoV-2 COVID-19 91 serum SAMD01814668 COVID-19_Lipid_C391 Serum sample from individuals with COVID-19 Sample collection C391 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C391_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C391_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 missing C392 Homo sapiens 9606 2020 Japan 48 SARS-CoV-2 COVID-19 99 serum Days 4-6 SAMD01814669 COVID-19_Lipid_C392 Serum sample from individuals with COVID-19 Sample collection C392 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C392_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C392_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C393 Homo sapiens 9606 2020 Japan 79 SARS-CoV-2 COVID-19 92 serum Days 10-12 SAMD01814670 COVID-19_Lipid_C393 Serum sample from individuals with COVID-19 Sample collection C393 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C393_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C393_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C394 Homo sapiens 9606 2020 Japan 66 SARS-CoV-2 COVID-19 95 serum Days 16-18 SAMD01814671 COVID-19_Lipid_C394 Serum sample from individuals with COVID-19 Sample collection C394 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C394_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C394_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C395 Homo sapiens 9606 2020 Japan 79 SARS-CoV-2 COVID-19 98 serum Days 13-15 SAMD01814672 COVID-19_Lipid_C395 Serum sample from individuals with COVID-19 Sample collection C395 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C395_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C395_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C396 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 100 serum Days 7-9 SAMD01814673 COVID-19_Lipid_C396 Serum sample from individuals with COVID-19 Sample collection C396 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C396_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C396_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C397 Homo sapiens 9606 2020 Japan 71 SARS-CoV-2 COVID-19 101 serum Days 10-12 SAMD01814674 COVID-19_Lipid_C397 Serum sample from individuals with COVID-19 Sample collection C397 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C397_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C397_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C398 Homo sapiens 9606 2020 Japan 86 SARS-CoV-2 COVID-19 102 serum SAMD01814675 COVID-19_Lipid_C398 Serum sample from individuals with COVID-19 Sample collection C398 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C398_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C398_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 missing C399 Homo sapiens 9606 2020 Japan 86 SARS-CoV-2 COVID-19 102 serum SAMD01814676 COVID-19_Lipid_C399 Serum sample from individuals with COVID-19 Sample collection C399 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C399_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C399_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 missing C4 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 13 serum Days 13-15 SAMD01814677 COVID-19_Lipid_C4 Serum sample from individuals with COVID-19 Sample collection C4 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C4_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C4_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C40 Homo sapiens 9606 2020 Japan 24 SARS-CoV-2 COVID-19 3 serum Days 4-6 SAMD01814678 COVID-19_Lipid_C40 Serum sample from individuals with COVID-19 Sample collection C40 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C40_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C40_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C400 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 103 serum Days 4-6 SAMD01814679 COVID-19_Lipid_C400 Serum sample from individuals with COVID-19 Sample collection C400 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C400_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C400_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C401 Homo sapiens 9606 2020 Japan 71 SARS-CoV-2 COVID-19 101 serum Days 13-15 SAMD01814680 COVID-19_Lipid_C401 Serum sample from individuals with COVID-19 Sample collection C401 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C401_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C401_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C402 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 100 serum Days 10-12 SAMD01814681 COVID-19_Lipid_C402 Serum sample from individuals with COVID-19 Sample collection C402 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C402_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C402_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C403 Homo sapiens 9606 2020 Japan 79 SARS-CoV-2 COVID-19 92 serum Days 10-12 SAMD01814682 COVID-19_Lipid_C403 Serum sample from individuals with COVID-19 Sample collection C403 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C403_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C403_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C404 Homo sapiens 9606 2020 Japan 46 SARS-CoV-2 COVID-19 104 serum Days 1-3 SAMD01814683 COVID-19_Lipid_C404 Serum sample from individuals with COVID-19 Sample collection C404 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C404_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C404_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 1-3 C405 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 105 serum Days 10-12 SAMD01814684 COVID-19_Lipid_C405 Serum sample from individuals with COVID-19 Sample collection C405 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C405_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C405_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C406 Homo sapiens 9606 2020 Japan 79 SARS-CoV-2 COVID-19 92 serum Days 13-15 SAMD01814685 COVID-19_Lipid_C406 Serum sample from individuals with COVID-19 Sample collection C406 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C406_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C406_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C407 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 103 serum Days 7-9 SAMD01814686 COVID-19_Lipid_C407 Serum sample from individuals with COVID-19 Sample collection C407 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C407_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C407_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C408 Homo sapiens 9606 2020 Japan 46 SARS-CoV-2 COVID-19 104 serum Days 4-6 SAMD01814687 COVID-19_Lipid_C408 Serum sample from individuals with COVID-19 Sample collection C408 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C408_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C408_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C409 Homo sapiens 9606 2020 Japan 48 SARS-CoV-2 COVID-19 99 serum Days 10-12 SAMD01814688 COVID-19_Lipid_C409 Serum sample from individuals with COVID-19 Sample collection C409 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C409_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C409_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C41 Homo sapiens 9606 2020 Japan 24 SARS-CoV-2 COVID-19 3 serum Days 7-9 SAMD01814689 COVID-19_Lipid_C41 Serum sample from individuals with COVID-19 Sample collection C41 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C41_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C41_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C410 Homo sapiens 9606 2020 Japan 34 SARS-CoV-2 COVID-19 106 serum Days 4-6 SAMD01814690 COVID-19_Lipid_C410 Serum sample from individuals with COVID-19 Sample collection C410 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C410_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C410_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C411 Homo sapiens 9606 2020 Japan 36 SARS-CoV-2 COVID-19 107 serum Days 4-6 SAMD01814691 COVID-19_Lipid_C411 Serum sample from individuals with COVID-19 Sample collection C411 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C411_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C411_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C412 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 103 serum Days 10-12 SAMD01814692 COVID-19_Lipid_C412 Serum sample from individuals with COVID-19 Sample collection C412 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C412_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C412_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C413 Homo sapiens 9606 2020 Japan 79 SARS-CoV-2 COVID-19 92 serum Days 16-18 SAMD01814693 COVID-19_Lipid_C413 Serum sample from individuals with COVID-19 Sample collection C413 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C413_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C413_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C414 Homo sapiens 9606 2020 Japan 86 SARS-CoV-2 COVID-19 102 serum SAMD01814694 COVID-19_Lipid_C414 Serum sample from individuals with COVID-19 Sample collection C414 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C414_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C414_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 missing C415 Homo sapiens 9606 2020 Japan 26 SARS-CoV-2 COVID-19 108 serum Days 7-9 SAMD01814695 COVID-19_Lipid_C415 Serum sample from individuals with COVID-19 Sample collection C415 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C415_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C415_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C416 Homo sapiens 9606 2020 Japan 45 SARS-CoV-2 COVID-19 81 serum beyond Day 25 SAMD01814696 COVID-19_Lipid_C416 Serum sample from individuals with COVID-19 Sample collection C416 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C416_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C416_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C417 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 100 serum Days 13-15 SAMD01814697 COVID-19_Lipid_C417 Serum sample from individuals with COVID-19 Sample collection C417 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C417_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C417_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C418 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 105 serum Days 13-15 SAMD01814698 COVID-19_Lipid_C418 Serum sample from individuals with COVID-19 Sample collection C418 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C418_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C418_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C419 Homo sapiens 9606 2020 Japan 71 SARS-CoV-2 COVID-19 101 serum Days 16-18 SAMD01814699 COVID-19_Lipid_C419 Serum sample from individuals with COVID-19 Sample collection C419 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C419_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C419_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C420 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 110 serum Days 10-12 SAMD01814700 COVID-19_Lipid_C420 Serum sample from individuals with COVID-19 Sample collection C420 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C420_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C420_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C421 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 105 serum Days 13-15 SAMD01814701 COVID-19_Lipid_C421 Serum sample from individuals with COVID-19 Sample collection C421 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C421_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C421_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C422 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 100 serum Days 13-15 SAMD01814702 COVID-19_Lipid_C422 Serum sample from individuals with COVID-19 Sample collection C422 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C422_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C422_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C423 Homo sapiens 9606 2020 Japan 34 SARS-CoV-2 COVID-19 106 serum Days 7-9 SAMD01814703 COVID-19_Lipid_C423 Serum sample from individuals with COVID-19 Sample collection C423 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C423_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C423_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C424 Homo sapiens 9606 2020 Japan 32 SARS-CoV-2 COVID-19 109 serum Days 7-9 SAMD01814704 COVID-19_Lipid_C424 Serum sample from individuals with COVID-19 Sample collection C424 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C424_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C424_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C425 Homo sapiens 9606 2020 Japan 46 SARS-CoV-2 COVID-19 104 serum Days 10-12 SAMD01814705 COVID-19_Lipid_C425 Serum sample from individuals with COVID-19 Sample collection C425 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C425_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C425_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C426 Homo sapiens 9606 2020 Japan 32 SARS-CoV-2 COVID-19 109 serum Days 10-12 SAMD01814706 COVID-19_Lipid_C426 Serum sample from individuals with COVID-19 Sample collection C426 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C426_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C426_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C427 Homo sapiens 9606 2020 Japan 76 SARS-CoV-2 COVID-19 69 serum SAMD01814707 COVID-19_Lipid_C427 Serum sample from individuals with COVID-19 Sample collection C427 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C427_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C427_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 missing C428 Homo sapiens 9606 2020 Japan 73 SARS-CoV-2 COVID-19 71 serum beyond Day 25 SAMD01814708 COVID-19_Lipid_C428 Serum sample from individuals with COVID-19 Sample collection C428 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C428_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C428_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C429 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 100 serum Days 19-24 SAMD01814709 COVID-19_Lipid_C429 Serum sample from individuals with COVID-19 Sample collection C429 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C429_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C429_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C43 Homo sapiens 9606 2020 Japan 68 SARS-CoV-2 COVID-19 8 serum Days 10-12 SAMD01814710 COVID-19_Lipid_C43 Serum sample from individuals with COVID-19 Sample collection C43 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C43_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C43_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C430 Homo sapiens 9606 2020 Japan 74 SARS-CoV-2 COVID-19 111 serum SAMD01814711 COVID-19_Lipid_C430 Serum sample from individuals with COVID-19 Sample collection C430 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C430_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C430_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 missing C431 Homo sapiens 9606 2020 Japan 32 SARS-CoV-2 COVID-19 109 serum Days 13-15 SAMD01814712 COVID-19_Lipid_C431 Serum sample from individuals with COVID-19 Sample collection C431 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C431_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C431_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C432 Homo sapiens 9606 2020 Japan 54 SARS-CoV-2 COVID-19 112 serum Days 7-9 SAMD01814713 COVID-19_Lipid_C432 Serum sample from individuals with COVID-19 Sample collection C432 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C432_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C432_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C433 Homo sapiens 9606 2020 Japan 36 SARS-CoV-2 COVID-19 113 serum SAMD01814714 COVID-19_Lipid_C433 Serum sample from individuals with COVID-19 Sample collection C433 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C433_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C433_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 missing C434 Homo sapiens 9606 2020 Japan 36 SARS-CoV-2 COVID-19 113 serum SAMD01814715 COVID-19_Lipid_C434 Serum sample from individuals with COVID-19 Sample collection C434 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C434_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C434_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 missing C435 Homo sapiens 9606 2020 Japan 46 SARS-CoV-2 COVID-19 116 serum Days 7-9 SAMD01814716 COVID-19_Lipid_C435 Serum sample from individuals with COVID-19 Sample collection C435 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C435_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C435_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C436 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 110 serum Days 19-24 SAMD01814717 COVID-19_Lipid_C436 Serum sample from individuals with COVID-19 Sample collection C436 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C436_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C436_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C437 Homo sapiens 9606 2020 Japan 36 SARS-CoV-2 COVID-19 113 serum SAMD01814718 COVID-19_Lipid_C437 Serum sample from individuals with COVID-19 Sample collection C437 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C437_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C437_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 missing C438 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 115 serum Days 13-15 SAMD01814719 COVID-19_Lipid_C438 Serum sample from individuals with COVID-19 Sample collection C438 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C438_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C438_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C439 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 115 serum Days 16-18 SAMD01814720 COVID-19_Lipid_C439 Serum sample from individuals with COVID-19 Sample collection C439 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C439_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C439_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C44 Homo sapiens 9606 2020 Japan 68 SARS-CoV-2 COVID-19 8 serum Days 13-15 SAMD01814721 COVID-19_Lipid_C44 Serum sample from individuals with COVID-19 Sample collection C44 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C44_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C44_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C440 Homo sapiens 9606 2020 Japan 53 SARS-CoV-2 COVID-19 120 serum Days 10-12 SAMD01814722 COVID-19_Lipid_C440 Serum sample from individuals with COVID-19 Sample collection C440 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C440_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C440_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C441 Homo sapiens 9606 2020 Japan 53 SARS-CoV-2 COVID-19 120 serum Days 13-15 SAMD01814723 COVID-19_Lipid_C441 Serum sample from individuals with COVID-19 Sample collection C441 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C441_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C441_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C442 Homo sapiens 9606 2020 Japan 53 SARS-CoV-2 COVID-19 120 serum Days 16-18 SAMD01814724 COVID-19_Lipid_C442 Serum sample from individuals with COVID-19 Sample collection C442 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C442_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C442_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C443 Homo sapiens 9606 2020 Japan 54 SARS-CoV-2 COVID-19 112 serum Days 10-12 SAMD01814725 COVID-19_Lipid_C443 Serum sample from individuals with COVID-19 Sample collection C443 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C443_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C443_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C444 Homo sapiens 9606 2020 Japan 54 SARS-CoV-2 COVID-19 112 serum Days 10-12 SAMD01814726 COVID-19_Lipid_C444 Serum sample from individuals with COVID-19 Sample collection C444 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C444_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C444_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C445 Homo sapiens 9606 2020 Japan 26 SARS-CoV-2 COVID-19 118 serum Days 4-6 SAMD01814727 COVID-19_Lipid_C445 Serum sample from individuals with COVID-19 Sample collection C445 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C445_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C445_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C446 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 119 serum Days 4-6 SAMD01814728 COVID-19_Lipid_C446 Serum sample from individuals with COVID-19 Sample collection C446 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C446_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C446_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C447 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 119 serum Days 7-9 SAMD01814729 COVID-19_Lipid_C447 Serum sample from individuals with COVID-19 Sample collection C447 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C447_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C447_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C448 Homo sapiens 9606 2020 Japan 65 SARS-CoV-2 COVID-19 117 serum Days 7-9 SAMD01814730 COVID-19_Lipid_C448 Serum sample from individuals with COVID-19 Sample collection C448 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C448_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C448_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C449 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 124 serum Days 7-9 SAMD01814731 COVID-19_Lipid_C449 Serum sample from individuals with COVID-19 Sample collection C449 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C449_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C449_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C45 Homo sapiens 9606 2020 Japan 68 SARS-CoV-2 COVID-19 8 serum Days 16-18 SAMD01814732 COVID-19_Lipid_C45 Serum sample from individuals with COVID-19 Sample collection C45 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C45_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C45_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C450 Homo sapiens 9606 2020 Japan 77 SARS-CoV-2 COVID-19 121 serum Days 7-9 SAMD01814733 COVID-19_Lipid_C450 Serum sample from individuals with COVID-19 Sample collection C450 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C450_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C450_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C451 Homo sapiens 9606 2020 Japan 77 SARS-CoV-2 COVID-19 121 serum Days 10-12 SAMD01814734 COVID-19_Lipid_C451 Serum sample from individuals with COVID-19 Sample collection C451 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C451_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C451_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C452 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 128 serum Days 7-9 SAMD01814735 COVID-19_Lipid_C452 Serum sample from individuals with COVID-19 Sample collection C452 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C452_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C452_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C453 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 128 serum Days 10-12 SAMD01814736 COVID-19_Lipid_C453 Serum sample from individuals with COVID-19 Sample collection C453 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C453_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C453_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C454 Homo sapiens 9606 2020 Japan 65 SARS-CoV-2 COVID-19 117 serum Days 13-15 SAMD01814737 COVID-19_Lipid_C454 Serum sample from individuals with COVID-19 Sample collection C454 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C454_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C454_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C455 Homo sapiens 9606 2020 Japan 65 SARS-CoV-2 COVID-19 117 serum Days 16-18 SAMD01814738 COVID-19_Lipid_C455 Serum sample from individuals with COVID-19 Sample collection C455 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C455_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C455_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C456 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 123 serum Days 7-9 SAMD01814739 COVID-19_Lipid_C456 Serum sample from individuals with COVID-19 Sample collection C456 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C456_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C456_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C457 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 123 serum Days 10-12 SAMD01814740 COVID-19_Lipid_C457 Serum sample from individuals with COVID-19 Sample collection C457 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C457_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C457_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C458 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 105 serum beyond Day 25 SAMD01814741 COVID-19_Lipid_C458 Serum sample from individuals with COVID-19 Sample collection C458 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C458_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C458_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C459 Homo sapiens 9606 2020 Japan 46 SARS-CoV-2 COVID-19 116 serum Days 13-15 SAMD01814742 COVID-19_Lipid_C459 Serum sample from individuals with COVID-19 Sample collection C459 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C459_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C459_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C46 Homo sapiens 9606 2020 Japan 68 SARS-CoV-2 COVID-19 8 serum Days 19-24 SAMD01814743 COVID-19_Lipid_C46 Serum sample from individuals with COVID-19 Sample collection C46 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C46_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C46_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C460 Homo sapiens 9606 2020 Japan 83 SARS-CoV-2 COVID-19 122 serum Days 4-6 SAMD01814744 COVID-19_Lipid_C460 Serum sample from individuals with COVID-19 Sample collection C460 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C460_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C460_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C461 Homo sapiens 9606 2020 Japan 83 SARS-CoV-2 COVID-19 122 serum Days 7-9 SAMD01814745 COVID-19_Lipid_C461 Serum sample from individuals with COVID-19 Sample collection C461 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C461_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C461_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C462 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 125 serum Days 13-15 SAMD01814746 COVID-19_Lipid_C462 Serum sample from individuals with COVID-19 Sample collection C462 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C462_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C462_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C463 Homo sapiens 9606 2020 Japan 64 SARS-CoV-2 COVID-19 125 serum Days 16-18 SAMD01814747 COVID-19_Lipid_C463 Serum sample from individuals with COVID-19 Sample collection C463 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C463_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C463_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C464 Homo sapiens 9606 2020 Japan 70 SARS-CoV-2 COVID-19 127 serum Days 16-18 SAMD01814748 COVID-19_Lipid_C464 Serum sample from individuals with COVID-19 Sample collection C464 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C464_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C464_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C465 Homo sapiens 9606 2020 Japan 70 SARS-CoV-2 COVID-19 127 serum Days 16-18 SAMD01814749 COVID-19_Lipid_C465 Serum sample from individuals with COVID-19 Sample collection C465 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C465_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C465_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C466 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 126 serum Days 7-9 SAMD01814750 COVID-19_Lipid_C466 Serum sample from individuals with COVID-19 Sample collection C466 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C466_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C466_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C467 Homo sapiens 9606 2020 Japan 55 SARS-CoV-2 COVID-19 129 serum Days 10-12 SAMD01814751 COVID-19_Lipid_C467 Serum sample from individuals with COVID-19 Sample collection C467 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C467_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C467_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C468 Homo sapiens 9606 2020 Japan 55 SARS-CoV-2 COVID-19 129 serum Days 13-15 SAMD01814752 COVID-19_Lipid_C468 Serum sample from individuals with COVID-19 Sample collection C468 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C468_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C468_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C469 Homo sapiens 9606 2020 Japan 77 SARS-CoV-2 COVID-19 121 serum pre-onset SAMD01814753 COVID-19_Lipid_C469 Serum sample from individuals with COVID-19 Sample collection C469 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C469_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C469_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 pre-onset C47 Homo sapiens 9606 2020 Japan 68 SARS-CoV-2 COVID-19 1 serum Days 10-12 SAMD01814754 COVID-19_Lipid_C47 Serum sample from individuals with COVID-19 Sample collection C47 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C47_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C47_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C470 Homo sapiens 9606 2020 Japan 77 SARS-CoV-2 COVID-19 121 serum Days 4-6 SAMD01814755 COVID-19_Lipid_C470 Serum sample from individuals with COVID-19 Sample collection C470 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C470_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C470_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C471 Homo sapiens 9606 2020 Japan 83 SARS-CoV-2 COVID-19 122 serum Days 1-3 SAMD01814756 COVID-19_Lipid_C471 Serum sample from individuals with COVID-19 Sample collection C471 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C471_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C471_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 1-3 C472 Homo sapiens 9606 2020 Japan 65 SARS-CoV-2 COVID-19 117 serum Days 10-12 SAMD01814757 COVID-19_Lipid_C472 Serum sample from individuals with COVID-19 Sample collection C472 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C472_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C472_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C473 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 123 serum pre-onset SAMD01814758 COVID-19_Lipid_C473 Serum sample from individuals with COVID-19 Sample collection C473 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C473_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C473_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 pre-onset C474 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 123 serum Days 4-6 SAMD01814759 COVID-19_Lipid_C474 Serum sample from individuals with COVID-19 Sample collection C474 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C474_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C474_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C475 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 100 serum beyond Day 25 SAMD01814760 COVID-19_Lipid_C475 Serum sample from individuals with COVID-19 Sample collection C475 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C475_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C475_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C476 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 124 serum Days 4-6 SAMD01814761 COVID-19_Lipid_C476 Serum sample from individuals with COVID-19 Sample collection C476 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C476_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C476_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C477 Homo sapiens 9606 2020 Japan 46 SARS-CoV-2 COVID-19 116 serum Days 10-12 SAMD01814762 COVID-19_Lipid_C477 Serum sample from individuals with COVID-19 Sample collection C477 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C477_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C477_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C478 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 115 serum Days 16-18 SAMD01814763 COVID-19_Lipid_C478 Serum sample from individuals with COVID-19 Sample collection C478 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C478_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C478_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C479 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 125 serum Days 10-12 SAMD01814764 COVID-19_Lipid_C479 Serum sample from individuals with COVID-19 Sample collection C479 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C479_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C479_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C48 Homo sapiens 9606 2020 Japan 77 SARS-CoV-2 COVID-19 6 serum Days 19-24 SAMD01814765 COVID-19_Lipid_C48 Serum sample from individuals with COVID-19 Sample collection C48 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C48_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C48_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C480 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 119 serum Days 10-12 SAMD01814766 COVID-19_Lipid_C480 Serum sample from individuals with COVID-19 Sample collection C480 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C480_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C480_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C481 Homo sapiens 9606 2020 Japan 70 SARS-CoV-2 COVID-19 127 serum Days 13-15 SAMD01814767 COVID-19_Lipid_C481 Serum sample from individuals with COVID-19 Sample collection C481 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C481_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C481_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C482 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 126 serum Days 4-6 SAMD01814768 COVID-19_Lipid_C482 Serum sample from individuals with COVID-19 Sample collection C482 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C482_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C482_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C483 Homo sapiens 9606 2020 Japan 86 SARS-CoV-2 COVID-19 130 serum Days 7-9 SAMD01814769 COVID-19_Lipid_C483 Serum sample from individuals with COVID-19 Sample collection C483 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C483_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C483_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C484 Homo sapiens 9606 2020 Japan 73 SARS-CoV-2 COVID-19 131 serum Days 4-6 SAMD01814770 COVID-19_Lipid_C484 Serum sample from individuals with COVID-19 Sample collection C484 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C484_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C484_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C485 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 123 serum Days 10-12 SAMD01814771 COVID-19_Lipid_C485 Serum sample from individuals with COVID-19 Sample collection C485 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C485_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C485_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C486 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 126 serum Days 7-9 SAMD01814772 COVID-19_Lipid_C486 Serum sample from individuals with COVID-19 Sample collection C486 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C486_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C486_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C487 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 124 serum Days 10-12 SAMD01814773 COVID-19_Lipid_C487 Serum sample from individuals with COVID-19 Sample collection C487 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C487_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C487_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C488 Homo sapiens 9606 2021 Japan 38 SARS-CoV-2 COVID-19 149 serum Days 10-12 SAMD01814774 COVID-19_Lipid_C488 Serum sample from individuals with COVID-19 Sample collection C488 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C488_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C488_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C489 Homo sapiens 9606 2021 Japan 15 SARS-CoV-2 COVID-19 132 serum Days 1-3 SAMD01814775 COVID-19_Lipid_C489 Serum sample from individuals with COVID-19 Sample collection C489 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C489_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C489_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 1-3 C49 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 17 serum Days 19-24 SAMD01814776 COVID-19_Lipid_C49 Serum sample from individuals with COVID-19 Sample collection C49 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C49_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C49_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C490 Homo sapiens 9606 2021 Japan 15 SARS-CoV-2 COVID-19 132 serum Days 4-6 SAMD01814777 COVID-19_Lipid_C490 Serum sample from individuals with COVID-19 Sample collection C490 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C490_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C490_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C491 Homo sapiens 9606 2021 Japan 20 SARS-CoV-2 COVID-19 148 serum Days 1-3 SAMD01814778 COVID-19_Lipid_C491 Serum sample from individuals with COVID-19 Sample collection C491 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C491_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C491_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 1-3 C492 Homo sapiens 9606 2021 Japan 67 SARS-CoV-2 COVID-19 133 serum Days 4-6 SAMD01814779 COVID-19_Lipid_C492 Serum sample from individuals with COVID-19 Sample collection C492 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C492_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C492_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C493 Homo sapiens 9606 2020 Japan 77 SARS-CoV-2 COVID-19 121 serum Days 13-15 SAMD01814780 COVID-19_Lipid_C493 Serum sample from individuals with COVID-19 Sample collection C493 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C493_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C493_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C494 Homo sapiens 9606 2020 Japan 83 SARS-CoV-2 COVID-19 122 serum Days 10-12 SAMD01814781 COVID-19_Lipid_C494 Serum sample from individuals with COVID-19 Sample collection C494 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C494_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C494_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C495 Homo sapiens 9606 2020 Japan 55 SARS-CoV-2 COVID-19 129 serum Days 16-18 SAMD01814782 COVID-19_Lipid_C495 Serum sample from individuals with COVID-19 Sample collection C495 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C495_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C495_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C496 Homo sapiens 9606 2020 Japan 73 SARS-CoV-2 COVID-19 131 serum Days 7-9 SAMD01814783 COVID-19_Lipid_C496 Serum sample from individuals with COVID-19 Sample collection C496 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C496_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C496_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C497 Homo sapiens 9606 2020 Japan 64 SARS-CoV-2 COVID-19 125 serum Days 19-24 SAMD01814784 COVID-19_Lipid_C497 Serum sample from individuals with COVID-19 Sample collection C497 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C497_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C497_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C498 Homo sapiens 9606 2020 Japan 66 SARS-CoV-2 COVID-19 95 serum beyond Day 25 SAMD01814785 COVID-19_Lipid_C498 Serum sample from individuals with COVID-19 Sample collection C498 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C498_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C498_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C499 Homo sapiens 9606 2020 Japan 60 SARS-CoV-2 COVID-19 147 serum Days 7-9 SAMD01814786 COVID-19_Lipid_C499 Serum sample from individuals with COVID-19 Sample collection C499 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C499_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C499_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C5 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 13 serum Days 16-18 SAMD01814787 COVID-19_Lipid_C5 Serum sample from individuals with COVID-19 Sample collection C5 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C5_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C5_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C50 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 19 serum Days 16-18 SAMD01814788 COVID-19_Lipid_C50 Serum sample from individuals with COVID-19 Sample collection C50 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C50_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C50_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C500 Homo sapiens 9606 2020 Japan 73 SARS-CoV-2 COVID-19 131 serum Days 10-12 SAMD01814789 COVID-19_Lipid_C500 Serum sample from individuals with COVID-19 Sample collection C500 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C500_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C500_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C501 Homo sapiens 9606 2021 Japan 15 SARS-CoV-2 COVID-19 132 serum Days 7-9 SAMD01814790 COVID-19_Lipid_C501 Serum sample from individuals with COVID-19 Sample collection C501 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C501_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C501_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C502 Homo sapiens 9606 2021 Japan 20 SARS-CoV-2 COVID-19 148 serum Days 4-6 SAMD01814791 COVID-19_Lipid_C502 Serum sample from individuals with COVID-19 Sample collection C502 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C502_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C502_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C503 Homo sapiens 9606 2020 Japan 54 SARS-CoV-2 COVID-19 135 serum Days 10-12 SAMD01814792 COVID-19_Lipid_C503 Serum sample from individuals with COVID-19 Sample collection C503 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C503_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C503_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C504 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 134 serum Days 7-9 SAMD01814793 COVID-19_Lipid_C504 Serum sample from individuals with COVID-19 Sample collection C504 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C504_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C504_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C505 Homo sapiens 9606 2020 Japan 38 SARS-CoV-2 COVID-19 149 serum Days 13-15 SAMD01814794 COVID-19_Lipid_C505 Serum sample from individuals with COVID-19 Sample collection C505 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C505_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C505_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C506 Homo sapiens 9606 2020 Japan 47 SARS-CoV-2 COVID-19 141 serum Days 10-12 SAMD01814795 COVID-19_Lipid_C506 Serum sample from individuals with COVID-19 Sample collection C506 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C506_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C506_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C507 Homo sapiens 9606 2020 Japan 47 SARS-CoV-2 COVID-19 141 serum Days 13-15 SAMD01814796 COVID-19_Lipid_C507 Serum sample from individuals with COVID-19 Sample collection C507 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C507_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C507_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C508 Homo sapiens 9606 2020 Japan 83 SARS-CoV-2 COVID-19 122 serum Days 13-15 SAMD01814797 COVID-19_Lipid_C508 Serum sample from individuals with COVID-19 Sample collection C508 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C508_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C508_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C509 Homo sapiens 9606 2020 Japan 83 SARS-CoV-2 COVID-19 122 serum Days 16-18 SAMD01814798 COVID-19_Lipid_C509 Serum sample from individuals with COVID-19 Sample collection C509 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C509_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C509_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C51 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 21 serum Days 4-6 SAMD01814799 COVID-19_Lipid_C51 Serum sample from individuals with COVID-19 Sample collection C51 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C51_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C51_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C510 Homo sapiens 9606 2021 Japan 67 SARS-CoV-2 COVID-19 133 serum Days 7-9 SAMD01814800 COVID-19_Lipid_C510 Serum sample from individuals with COVID-19 Sample collection C510 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C510_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C510_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C511 Homo sapiens 9606 2021 Japan 67 SARS-CoV-2 COVID-19 133 serum Days 10-12 SAMD01814801 COVID-19_Lipid_C511 Serum sample from individuals with COVID-19 Sample collection C511 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C511_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C511_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C512 Homo sapiens 9606 2020 Japan 55 SARS-CoV-2 COVID-19 129 serum Days 19-24 SAMD01814802 COVID-19_Lipid_C512 Serum sample from individuals with COVID-19 Sample collection C512 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C512_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C512_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C513 Homo sapiens 9606 2020 Japan 60 SARS-CoV-2 COVID-19 147 serum Days 10-12 SAMD01814803 COVID-19_Lipid_C513 Serum sample from individuals with COVID-19 Sample collection C513 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C513_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C513_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C514 Homo sapiens 9606 2021 Japan 15 SARS-CoV-2 COVID-19 132 serum Days 7-9 SAMD01814804 COVID-19_Lipid_C514 Serum sample from individuals with COVID-19 Sample collection C514 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C514_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C514_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C515 Homo sapiens 9606 2021 Japan 20 SARS-CoV-2 COVID-19 148 serum Days 7-9 SAMD01814805 COVID-19_Lipid_C515 Serum sample from individuals with COVID-19 Sample collection C515 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C515_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C515_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C516 Homo sapiens 9606 2020 Japan 73 SARS-CoV-2 COVID-19 131 serum Days 13-15 SAMD01814806 COVID-19_Lipid_C516 Serum sample from individuals with COVID-19 Sample collection C516 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C516_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C516_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C517 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 134 serum Days 10-12 SAMD01814807 COVID-19_Lipid_C517 Serum sample from individuals with COVID-19 Sample collection C517 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C517_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C517_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C518 Homo sapiens 9606 2020 Japan 70 SARS-CoV-2 COVID-19 138 serum Days 10-12 SAMD01814808 COVID-19_Lipid_C518 Serum sample from individuals with COVID-19 Sample collection C518 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C518_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C518_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C519 Homo sapiens 9606 2020 Japan 54 SARS-CoV-2 COVID-19 135 serum Days 13-15 SAMD01814809 COVID-19_Lipid_C519 Serum sample from individuals with COVID-19 Sample collection C519 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C519_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C519_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C52 Homo sapiens 9606 2020 Japan 68 SARS-CoV-2 COVID-19 1 serum Days 13-15 SAMD01814810 COVID-19_Lipid_C52 Serum sample from individuals with COVID-19 Sample collection C52 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C52_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C52_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C520 Homo sapiens 9606 2021 Japan 72 SARS-CoV-2 COVID-19 136 serum Days 4-6 SAMD01814811 COVID-19_Lipid_C520 Serum sample from individuals with COVID-19 Sample collection C520 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C520_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C520_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C521 Homo sapiens 9606 2021 Japan 72 SARS-CoV-2 COVID-19 136 serum Days 7-9 SAMD01814812 COVID-19_Lipid_C521 Serum sample from individuals with COVID-19 Sample collection C521 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C521_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C521_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C522 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 139 serum Days 10-12 SAMD01814813 COVID-19_Lipid_C522 Serum sample from individuals with COVID-19 Sample collection C522 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C522_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C522_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C523 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 139 serum Days 13-15 SAMD01814814 COVID-19_Lipid_C523 Serum sample from individuals with COVID-19 Sample collection C523 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C523_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C523_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C524 Homo sapiens 9606 2021 Japan 60 SARS-CoV-2 COVID-19 140 serum Days 7-9 SAMD01814815 COVID-19_Lipid_C524 Serum sample from individuals with COVID-19 Sample collection C524 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C524_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C524_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C525 Homo sapiens 9606 2021 Japan 57 SARS-CoV-2 COVID-19 137 serum Days 7-9 SAMD01814816 COVID-19_Lipid_C525 Serum sample from individuals with COVID-19 Sample collection C525 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C525_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C525_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C526 Homo sapiens 9606 2020 Japan 26 SARS-CoV-2 COVID-19 108 serum beyond Day 25 SAMD01814817 COVID-19_Lipid_C526 Serum sample from individuals with COVID-19 Sample collection C526 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C526_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C526_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C527 Homo sapiens 9606 2021 Japan 47 SARS-CoV-2 COVID-19 144 serum Days 10-12 SAMD01814818 COVID-19_Lipid_C527 Serum sample from individuals with COVID-19 Sample collection C527 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C527_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C527_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C528 Homo sapiens 9606 2021 Japan 58 SARS-CoV-2 COVID-19 142 serum Days 7-9 SAMD01814819 COVID-19_Lipid_C528 Serum sample from individuals with COVID-19 Sample collection C528 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C528_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C528_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C529 Homo sapiens 9606 2021 Japan 60 SARS-CoV-2 COVID-19 143 serum Days 4-6 SAMD01814820 COVID-19_Lipid_C529 Serum sample from individuals with COVID-19 Sample collection C529 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C529_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C529_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C53 Homo sapiens 9606 2020 Japan 36 SARS-CoV-2 COVID-19 9 serum beyond Day 25 SAMD01814821 COVID-19_Lipid_C53 Serum sample from individuals with COVID-19 Sample collection C53 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C53_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C53_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C530 Homo sapiens 9606 2020 Japan 47 SARS-CoV-2 COVID-19 141 serum Days 16-18 SAMD01814822 COVID-19_Lipid_C530 Serum sample from individuals with COVID-19 Sample collection C530 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C530_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C530_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C531 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 134 serum Days 13-15 SAMD01814823 COVID-19_Lipid_C531 Serum sample from individuals with COVID-19 Sample collection C531 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C531_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C531_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C532 Homo sapiens 9606 2020 Japan 60 SARS-CoV-2 COVID-19 147 serum Days 13-15 SAMD01814824 COVID-19_Lipid_C532 Serum sample from individuals with COVID-19 Sample collection C532 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C532_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C532_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C533 Homo sapiens 9606 2020 Japan 70 SARS-CoV-2 COVID-19 138 serum Days 13-15 SAMD01814825 COVID-19_Lipid_C533 Serum sample from individuals with COVID-19 Sample collection C533 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C533_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C533_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C534 Homo sapiens 9606 2021 Japan 68 SARS-CoV-2 COVID-19 146 serum Days 13-15 SAMD01814826 COVID-19_Lipid_C534 Serum sample from individuals with COVID-19 Sample collection C534 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C534_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C534_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C535 Homo sapiens 9606 2021 Japan 54 SARS-CoV-2 COVID-19 145 serum Days 4-6 SAMD01814827 COVID-19_Lipid_C535 Serum sample from individuals with COVID-19 Sample collection C535 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C535_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C535_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C536 Homo sapiens 9606 2021 Japan 54 SARS-CoV-2 COVID-19 145 serum Days 7-9 SAMD01814828 COVID-19_Lipid_C536 Serum sample from individuals with COVID-19 Sample collection C536 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C536_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C536_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C537 Homo sapiens 9606 2021 Japan 72 SARS-CoV-2 COVID-19 136 serum Days 7-9 SAMD01814829 COVID-19_Lipid_C537 Serum sample from individuals with COVID-19 Sample collection C537 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C537_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C537_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C538 Homo sapiens 9606 2020 Japan 79 SARS-CoV-2 COVID-19 98 serum beyond Day 25 SAMD01814830 COVID-19_Lipid_C538 Serum sample from individuals with COVID-19 Sample collection C538 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C538_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C538_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C539 Homo sapiens 9606 2020 Japan 66 SARS-CoV-2 COVID-19 88 serum beyond Day 25 SAMD01814831 COVID-19_Lipid_C539 Serum sample from individuals with COVID-19 Sample collection C539 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C539_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C539_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C54 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 16 serum Days 16-18 SAMD01814832 COVID-19_Lipid_C54 Serum sample from individuals with COVID-19 Sample collection C54 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C54_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C54_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C540 Homo sapiens 9606 2020 Japan 46 SARS-CoV-2 COVID-19 104 serum beyond Day 25 SAMD01814833 COVID-19_Lipid_C540 Serum sample from individuals with COVID-19 Sample collection C540 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C540_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C540_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C541 Homo sapiens 9606 2021 Japan 47 SARS-CoV-2 COVID-19 144 serum Days 13-15 SAMD01814834 COVID-19_Lipid_C541 Serum sample from individuals with COVID-19 Sample collection C541 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C541_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C541_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C542 Homo sapiens 9606 2020 Japan 60 SARS-CoV-2 COVID-19 147 serum Days 16-18 SAMD01814835 COVID-19_Lipid_C542 Serum sample from individuals with COVID-19 Sample collection C542 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C542_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C542_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C543 Homo sapiens 9606 2021 Japan 67 SARS-CoV-2 COVID-19 133 serum Days 13-15 SAMD01814836 COVID-19_Lipid_C543 Serum sample from individuals with COVID-19 Sample collection C543 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C543_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C543_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C544 Homo sapiens 9606 2021 Japan 60 SARS-CoV-2 COVID-19 143 serum Days 7-9 SAMD01814837 COVID-19_Lipid_C544 Serum sample from individuals with COVID-19 Sample collection C544 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C544_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C544_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C545 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 134 serum Days 13-15 SAMD01814838 COVID-19_Lipid_C545 Serum sample from individuals with COVID-19 Sample collection C545 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C545_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C545_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C546 Homo sapiens 9606 2020 Japan 73 SARS-CoV-2 COVID-19 96 serum beyond Day 25 SAMD01814839 COVID-19_Lipid_C546 Serum sample from individuals with COVID-19 Sample collection C546 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C546_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C546_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C547 Homo sapiens 9606 2021 Japan 60 SARS-CoV-2 COVID-19 140 serum Days 10-12 SAMD01814840 COVID-19_Lipid_C547 Serum sample from individuals with COVID-19 Sample collection C547 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C547_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C547_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C548 Homo sapiens 9606 2020 Japan 70 SARS-CoV-2 COVID-19 138 serum Days 16-18 SAMD01814841 COVID-19_Lipid_C548 Serum sample from individuals with COVID-19 Sample collection C548 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C548_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C548_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C549 Homo sapiens 9606 2020 Japan 47 SARS-CoV-2 COVID-19 141 serum Days 19-24 SAMD01814842 COVID-19_Lipid_C549 Serum sample from individuals with COVID-19 Sample collection C549 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C549_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C549_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C55 Homo sapiens 9606 2020 Japan 71 SARS-CoV-2 COVID-19 20 serum Days 13-15 SAMD01814843 COVID-19_Lipid_C55 Serum sample from individuals with COVID-19 Sample collection C55 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C55_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C55_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C550 Homo sapiens 9606 2021 Japan 60 SARS-CoV-2 COVID-19 140 serum Days 13-15 SAMD01814844 COVID-19_Lipid_C550 Serum sample from individuals with COVID-19 Sample collection C550 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C550_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C550_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C551 Homo sapiens 9606 2021 Japan 47 SARS-CoV-2 COVID-19 144 serum Days 16-18 SAMD01814845 COVID-19_Lipid_C551 Serum sample from individuals with COVID-19 Sample collection C551 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C551_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C551_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C552 Homo sapiens 9606 2021 Japan 60 SARS-CoV-2 COVID-19 143 serum Days 10-12 SAMD01814846 COVID-19_Lipid_C552 Serum sample from individuals with COVID-19 Sample collection C552 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C552_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C552_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C553 Homo sapiens 9606 2021 Japan 68 SARS-CoV-2 COVID-19 146 serum Days 16-18 SAMD01814847 COVID-19_Lipid_C553 Serum sample from individuals with COVID-19 Sample collection C553 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C553_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C553_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C554 Homo sapiens 9606 2021 Japan 58 SARS-CoV-2 COVID-19 152 serum Days 10-12 SAMD01814848 COVID-19_Lipid_C554 Serum sample from individuals with COVID-19 Sample collection C554 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C554_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C554_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C555 Homo sapiens 9606 2021 Japan 78 SARS-CoV-2 COVID-19 153 serum Days 7-9 SAMD01814849 COVID-19_Lipid_C555 Serum sample from individuals with COVID-19 Sample collection C555 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C555_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C555_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C556 Homo sapiens 9606 2021 Japan 40 SARS-CoV-2 COVID-19 154 serum Days 7-9 SAMD01814850 COVID-19_Lipid_C556 Serum sample from individuals with COVID-19 Sample collection C556 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C556_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C556_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C557 Homo sapiens 9606 2021 Japan 97 SARS-CoV-2 COVID-19 155 serum Days 4-6 SAMD01814851 COVID-19_Lipid_C557 Serum sample from individuals with COVID-19 Sample collection C557 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C557_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C557_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C558 Homo sapiens 9606 2021 Japan 15 SARS-CoV-2 COVID-19 156 serum pre-onset SAMD01814852 COVID-19_Lipid_C558 Serum sample from individuals with COVID-19 Sample collection C558 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C558_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C558_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 pre-onset C559 Homo sapiens 9606 2021 Japan 15 SARS-CoV-2 COVID-19 156 serum Days 1-3 SAMD01814853 COVID-19_Lipid_C559 Serum sample from individuals with COVID-19 Sample collection C559 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C559_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C559_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 1-3 C56 Homo sapiens 9606 2020 Japan 76 SARS-CoV-2 COVID-19 18 serum Days 19-24 SAMD01814854 COVID-19_Lipid_C56 Serum sample from individuals with COVID-19 Sample collection C56 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C56_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C56_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C560 Homo sapiens 9606 2021 Japan 88 SARS-CoV-2 COVID-19 151 serum Days 4-6 SAMD01814855 COVID-19_Lipid_C560 Serum sample from individuals with COVID-19 Sample collection C560 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C560_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C560_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C561 Homo sapiens 9606 2021 Japan 88 SARS-CoV-2 COVID-19 151 serum Days 7-9 SAMD01814856 COVID-19_Lipid_C561 Serum sample from individuals with COVID-19 Sample collection C561 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C561_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C561_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C562 Homo sapiens 9606 2021 Japan 58 SARS-CoV-2 COVID-19 142 serum Days 13-15 SAMD01814857 COVID-19_Lipid_C562 Serum sample from individuals with COVID-19 Sample collection C562 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C562_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C562_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C563 Homo sapiens 9606 2021 Japan 71 SARS-CoV-2 COVID-19 158 serum Days 4-6 SAMD01814858 COVID-19_Lipid_C563 Serum sample from individuals with COVID-19 Sample collection C563 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C563_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C563_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C564 Homo sapiens 9606 2021 Japan 67 SARS-CoV-2 COVID-19 133 serum Days 16-18 SAMD01814859 COVID-19_Lipid_C564 Serum sample from individuals with COVID-19 Sample collection C564 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C564_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C564_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C565 Homo sapiens 9606 2021 Japan 65 SARS-CoV-2 COVID-19 159 serum Days 10-12 SAMD01814860 COVID-19_Lipid_C565 Serum sample from individuals with COVID-19 Sample collection C565 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C565_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C565_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C566 Homo sapiens 9606 2021 Japan 78 SARS-CoV-2 COVID-19 153 serum Days 10-12 SAMD01814861 COVID-19_Lipid_C566 Serum sample from individuals with COVID-19 Sample collection C566 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C566_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C566_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C567 Homo sapiens 9606 2021 Japan 40 SARS-CoV-2 COVID-19 154 serum Days 10-12 SAMD01814862 COVID-19_Lipid_C567 Serum sample from individuals with COVID-19 Sample collection C567 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C567_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C567_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C568 Homo sapiens 9606 2021 Japan 58 SARS-CoV-2 COVID-19 152 serum Days 13-15 SAMD01814863 COVID-19_Lipid_C568 Serum sample from individuals with COVID-19 Sample collection C568 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C568_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C568_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C569 Homo sapiens 9606 2021 Japan 97 SARS-CoV-2 COVID-19 155 serum Days 7-9 SAMD01814864 COVID-19_Lipid_C569 Serum sample from individuals with COVID-19 Sample collection C569 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C569_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C569_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C57 Homo sapiens 9606 2020 Japan 24 SARS-CoV-2 COVID-19 3 serum Days 13-15 SAMD01814865 COVID-19_Lipid_C57 Serum sample from individuals with COVID-19 Sample collection C57 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C57_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C57_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C570 Homo sapiens 9606 2021 Japan 71 SARS-CoV-2 COVID-19 157 serum Days 13-15 SAMD01814866 COVID-19_Lipid_C570 Serum sample from individuals with COVID-19 Sample collection C570 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C570_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C570_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C571 Homo sapiens 9606 2021 Japan 15 SARS-CoV-2 COVID-19 156 serum Days 4-6 SAMD01814867 COVID-19_Lipid_C571 Serum sample from individuals with COVID-19 Sample collection C571 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C571_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C571_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C572 Homo sapiens 9606 2021 Japan 47 SARS-CoV-2 COVID-19 144 serum Days 19-24 SAMD01814868 COVID-19_Lipid_C572 Serum sample from individuals with COVID-19 Sample collection C572 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C572_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C572_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C573 Homo sapiens 9606 2021 Japan 60 SARS-CoV-2 COVID-19 140 serum Days 16-18 SAMD01814869 COVID-19_Lipid_C573 Serum sample from individuals with COVID-19 Sample collection C573 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C573_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C573_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C574 Homo sapiens 9606 2021 Japan 67 SARS-CoV-2 COVID-19 133 serum Days 19-24 SAMD01814870 COVID-19_Lipid_C574 Serum sample from individuals with COVID-19 Sample collection C574 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C574_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C574_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C575 Homo sapiens 9606 2021 Japan 75 SARS-CoV-2 COVID-19 168 serum SAMD01814871 COVID-19_Lipid_C575 Serum sample from individuals with COVID-19 Sample collection C575 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C575_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C575_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 missing C576 Homo sapiens 9606 2021 Japan 71 SARS-CoV-2 COVID-19 158 serum Days 7-9 SAMD01814872 COVID-19_Lipid_C576 Serum sample from individuals with COVID-19 Sample collection C576 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C576_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C576_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C577 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 123 serum beyond Day 25 SAMD01814873 COVID-19_Lipid_C577 Serum sample from individuals with COVID-19 Sample collection C577 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C577_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C577_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C578 Homo sapiens 9606 2021 Japan 46 SARS-CoV-2 COVID-19 160 serum Days 4-6 SAMD01814874 COVID-19_Lipid_C578 Serum sample from individuals with COVID-19 Sample collection C578 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C578_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C578_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C579 Homo sapiens 9606 2021 Japan 73 SARS-CoV-2 COVID-19 161 serum Days 10-12 SAMD01814875 COVID-19_Lipid_C579 Serum sample from individuals with COVID-19 Sample collection C579 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C579_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C579_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C58 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 19 serum Days 19-24 SAMD01814876 COVID-19_Lipid_C58 Serum sample from individuals with COVID-19 Sample collection C58 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C58_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C58_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C580 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 94 serum beyond Day 25 SAMD01814877 COVID-19_Lipid_C580 Serum sample from individuals with COVID-19 Sample collection C580 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C580_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C580_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C581 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 103 serum beyond Day 25 SAMD01814878 COVID-19_Lipid_C581 Serum sample from individuals with COVID-19 Sample collection C581 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C581_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C581_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C582 Homo sapiens 9606 2021 Japan 40 SARS-CoV-2 COVID-19 154 serum Days 13-15 SAMD01814879 COVID-19_Lipid_C582 Serum sample from individuals with COVID-19 Sample collection C582 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C582_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C582_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C583 Homo sapiens 9606 2021 Japan 88 SARS-CoV-2 COVID-19 151 serum Days 10-12 SAMD01814880 COVID-19_Lipid_C583 Serum sample from individuals with COVID-19 Sample collection C583 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C583_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C583_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C584 Homo sapiens 9606 2021 Japan 65 SARS-CoV-2 COVID-19 159 serum Days 13-15 SAMD01814881 COVID-19_Lipid_C584 Serum sample from individuals with COVID-19 Sample collection C584 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C584_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C584_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C585 Homo sapiens 9606 2021 Japan 68 SARS-CoV-2 COVID-19 146 serum Days 19-24 SAMD01814882 COVID-19_Lipid_C585 Serum sample from individuals with COVID-19 Sample collection C585 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C585_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C585_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C586 Homo sapiens 9606 2020 Japan 64 SARS-CoV-2 COVID-19 125 serum beyond Day 25 SAMD01814883 COVID-19_Lipid_C586 Serum sample from individuals with COVID-19 Sample collection C586 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C586_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C586_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C587 Homo sapiens 9606 2021 Japan 46 SARS-CoV-2 COVID-19 160 serum Days 7-9 SAMD01814884 COVID-19_Lipid_C587 Serum sample from individuals with COVID-19 Sample collection C587 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C587_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C587_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C588 Homo sapiens 9606 2021 Japan 15 SARS-CoV-2 COVID-19 156 serum Days 7-9 SAMD01814885 COVID-19_Lipid_C588 Serum sample from individuals with COVID-19 Sample collection C588 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C588_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C588_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C589 Homo sapiens 9606 2021 Japan 75 SARS-CoV-2 COVID-19 168 serum SAMD01814886 COVID-19_Lipid_C589 Serum sample from individuals with COVID-19 Sample collection C589 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C589_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C589_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 missing C59 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 21 serum Days 7-9 SAMD01814887 COVID-19_Lipid_C59 Serum sample from individuals with COVID-19 Sample collection C59 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C59_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C59_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C590 Homo sapiens 9606 2020 Japan 79 SARS-CoV-2 COVID-19 92 serum beyond Day 25 SAMD01814888 COVID-19_Lipid_C590 Serum sample from individuals with COVID-19 Sample collection C590 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C590_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C590_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C591 Homo sapiens 9606 2021 Japan 71 SARS-CoV-2 COVID-19 158 serum Days 10-12 SAMD01814889 COVID-19_Lipid_C591 Serum sample from individuals with COVID-19 Sample collection C591 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C591_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C591_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C592 Homo sapiens 9606 2021 Japan 61 SARS-CoV-2 COVID-19 163 serum Days 10-12 SAMD01814890 COVID-19_Lipid_C592 Serum sample from individuals with COVID-19 Sample collection C592 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C592_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C592_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C593 Homo sapiens 9606 2021 Japan 47 SARS-CoV-2 COVID-19 162 serum pre-onset SAMD01814891 COVID-19_Lipid_C593 Serum sample from individuals with COVID-19 Sample collection C593 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C593_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C593_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 pre-onset C594 Homo sapiens 9606 2021 Japan 47 SARS-CoV-2 COVID-19 162 serum Days 4-6 SAMD01814892 COVID-19_Lipid_C594 Serum sample from individuals with COVID-19 Sample collection C594 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C594_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C594_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C595 Homo sapiens 9606 2021 Japan 47 SARS-CoV-2 COVID-19 162 serum Days 7-9 SAMD01814893 COVID-19_Lipid_C595 Serum sample from individuals with COVID-19 Sample collection C595 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C595_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C595_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C596 Homo sapiens 9606 2021 Japan 47 SARS-CoV-2 COVID-19 162 serum Days 10-12 SAMD01814894 COVID-19_Lipid_C596 Serum sample from individuals with COVID-19 Sample collection C596 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C596_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C596_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C597 Homo sapiens 9606 2021 Japan 73 SARS-CoV-2 COVID-19 161 serum Days 13-15 SAMD01814895 COVID-19_Lipid_C597 Serum sample from individuals with COVID-19 Sample collection C597 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C597_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C597_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C598 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 164 serum Days 4-6 SAMD01814896 COVID-19_Lipid_C598 Serum sample from individuals with COVID-19 Sample collection C598 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C598_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C598_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C599 Homo sapiens 9606 2021 Japan 78 SARS-CoV-2 COVID-19 166 serum Days 7-9 SAMD01814897 COVID-19_Lipid_C599 Serum sample from individuals with COVID-19 Sample collection C599 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C599_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C599_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C6 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 16 serum Days 7-9 SAMD01814898 COVID-19_Lipid_C6 Serum sample from individuals with COVID-19 Sample collection C6 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C6_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C6_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C60 Homo sapiens 9606 2020 Japan 68 SARS-CoV-2 COVID-19 1 serum Days 16-18 SAMD01814899 COVID-19_Lipid_C60 Serum sample from individuals with COVID-19 Sample collection C60 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C60_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C60_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C600 Homo sapiens 9606 2021 Japan 78 SARS-CoV-2 COVID-19 166 serum Days 10-12 SAMD01814900 COVID-19_Lipid_C600 Serum sample from individuals with COVID-19 Sample collection C600 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C600_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C600_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C601 Homo sapiens 9606 2021 Japan 88 SARS-CoV-2 COVID-19 151 serum Days 13-15 SAMD01814901 COVID-19_Lipid_C601 Serum sample from individuals with COVID-19 Sample collection C601 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C601_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C601_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C602 Homo sapiens 9606 2021 Japan 65 SARS-CoV-2 COVID-19 159 serum Days 16-18 SAMD01814902 COVID-19_Lipid_C602 Serum sample from individuals with COVID-19 Sample collection C602 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C602_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C602_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C603 Homo sapiens 9606 2021 Japan 40 SARS-CoV-2 COVID-19 154 serum Days 16-18 SAMD01814903 COVID-19_Lipid_C603 Serum sample from individuals with COVID-19 Sample collection C603 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C603_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C603_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C604 Homo sapiens 9606 2021 Japan 83 SARS-CoV-2 COVID-19 167 serum Days 10-12 SAMD01814904 COVID-19_Lipid_C604 Serum sample from individuals with COVID-19 Sample collection C604 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C604_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C604_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C605 Homo sapiens 9606 2021 Japan 15 SARS-CoV-2 COVID-19 156 serum Days 10-12 SAMD01814905 COVID-19_Lipid_C605 Serum sample from individuals with COVID-19 Sample collection C605 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C605_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C605_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C606 Homo sapiens 9606 2020 Japan 48 SARS-CoV-2 COVID-19 99 serum beyond Day 25 SAMD01814906 COVID-19_Lipid_C606 Serum sample from individuals with COVID-19 Sample collection C606 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C606_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C606_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C607 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 110 serum beyond Day 25 SAMD01814907 COVID-19_Lipid_C607 Serum sample from individuals with COVID-19 Sample collection C607 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C607_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C607_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C608 Homo sapiens 9606 2021 Japan 46 SARS-CoV-2 COVID-19 160 serum Days 10-12 SAMD01814908 COVID-19_Lipid_C608 Serum sample from individuals with COVID-19 Sample collection C608 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C608_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C608_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C609 Homo sapiens 9606 2021 Japan 61 SARS-CoV-2 COVID-19 163 serum Days 13-15 SAMD01814909 COVID-19_Lipid_C609 Serum sample from individuals with COVID-19 Sample collection C609 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C609_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C609_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C61 Homo sapiens 9606 2020 Japan 68 SARS-CoV-2 COVID-19 8 serum beyond Day 25 SAMD01814910 COVID-19_Lipid_C61 Serum sample from individuals with COVID-19 Sample collection C61 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C61_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C61_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C610 Homo sapiens 9606 2021 Japan 73 SARS-CoV-2 COVID-19 169 serum Days 7-9 SAMD01814911 COVID-19_Lipid_C610 Serum sample from individuals with COVID-19 Sample collection C610 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C610_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C610_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C611 Homo sapiens 9606 2021 Japan 61 SARS-CoV-2 COVID-19 163 serum Days 16-18 SAMD01814912 COVID-19_Lipid_C611 Serum sample from individuals with COVID-19 Sample collection C611 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C611_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C611_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C612 Homo sapiens 9606 2021 Japan 71 SARS-CoV-2 COVID-19 158 serum Days 13-15 SAMD01814913 COVID-19_Lipid_C612 Serum sample from individuals with COVID-19 Sample collection C612 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C612_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C612_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C613 Homo sapiens 9606 2021 Japan 47 SARS-CoV-2 COVID-19 162 serum Days 10-12 SAMD01814914 COVID-19_Lipid_C613 Serum sample from individuals with COVID-19 Sample collection C613 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C613_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C613_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C614 Homo sapiens 9606 2021 Japan 97 SARS-CoV-2 COVID-19 155 serum Days 13-15 SAMD01814915 COVID-19_Lipid_C614 Serum sample from individuals with COVID-19 Sample collection C614 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C614_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C614_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C615 Homo sapiens 9606 2021 Japan 75 SARS-CoV-2 COVID-19 168 serum SAMD01814916 COVID-19_Lipid_C615 Serum sample from individuals with COVID-19 Sample collection C615 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C615_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C615_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 missing C616 Homo sapiens 9606 2020 Japan 60 SARS-CoV-2 COVID-19 147 serum beyond Day 25 SAMD01814917 COVID-19_Lipid_C616 Serum sample from individuals with COVID-19 Sample collection C616 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C616_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C616_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C617 Homo sapiens 9606 2021 Japan 78 SARS-CoV-2 COVID-19 170 serum Days 10-12 SAMD01814918 COVID-19_Lipid_C617 Serum sample from individuals with COVID-19 Sample collection C617 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C617_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C617_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C618 Homo sapiens 9606 2021 Japan 40 SARS-CoV-2 COVID-19 154 serum Days 19-24 SAMD01814919 COVID-19_Lipid_C618 Serum sample from individuals with COVID-19 Sample collection C618 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C618_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C618_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C619 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 164 serum Days 7-9 SAMD01814920 COVID-19_Lipid_C619 Serum sample from individuals with COVID-19 Sample collection C619 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C619_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C619_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C62 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 16 serum Days 19-24 SAMD01814921 COVID-19_Lipid_C62 Serum sample from individuals with COVID-19 Sample collection C62 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C62_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C62_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C620 Homo sapiens 9606 2021 Japan 88 SARS-CoV-2 COVID-19 151 serum Days 16-18 SAMD01814922 COVID-19_Lipid_C620 Serum sample from individuals with COVID-19 Sample collection C620 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C620_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C620_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C621 Homo sapiens 9606 2021 Japan 65 SARS-CoV-2 COVID-19 159 serum Days 19-24 SAMD01814923 COVID-19_Lipid_C621 Serum sample from individuals with COVID-19 Sample collection C621 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C621_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C621_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C622 Homo sapiens 9606 2021 Japan 83 SARS-CoV-2 COVID-19 167 serum Days 13-15 SAMD01814924 COVID-19_Lipid_C622 Serum sample from individuals with COVID-19 Sample collection C622 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C622_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C622_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C623 Homo sapiens 9606 2021 Japan 78 SARS-CoV-2 COVID-19 170 serum Days 13-15 SAMD01814925 COVID-19_Lipid_C623 Serum sample from individuals with COVID-19 Sample collection C623 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C623_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C623_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C624 Homo sapiens 9606 2021 Japan 47 SARS-CoV-2 COVID-19 162 serum Days 13-15 SAMD01814926 COVID-19_Lipid_C624 Serum sample from individuals with COVID-19 Sample collection C624 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C624_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C624_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C625 Homo sapiens 9606 2020 Japan 32 SARS-CoV-2 COVID-19 109 serum beyond Day 25 SAMD01814927 COVID-19_Lipid_C625 Serum sample from individuals with COVID-19 Sample collection C625 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C625_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C625_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C626 Homo sapiens 9606 2021 Japan 53 SARS-CoV-2 COVID-19 171 serum pre-onset SAMD01814928 COVID-19_Lipid_C626 Serum sample from individuals with COVID-19 Sample collection C626 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C626_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C626_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 pre-onset C627 Homo sapiens 9606 2021 Japan 53 SARS-CoV-2 COVID-19 171 serum Days 1-3 SAMD01814929 COVID-19_Lipid_C627 Serum sample from individuals with COVID-19 Sample collection C627 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C627_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C627_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 1-3 C628 Homo sapiens 9606 2021 Japan 73 SARS-CoV-2 COVID-19 169 serum Days 10-12 SAMD01814930 COVID-19_Lipid_C628 Serum sample from individuals with COVID-19 Sample collection C628 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C628_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C628_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C629 Homo sapiens 9606 2021 Japan 78 SARS-CoV-2 COVID-19 166 serum Days 13-15 SAMD01814931 COVID-19_Lipid_C629 Serum sample from individuals with COVID-19 Sample collection C629 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C629_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C629_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C63 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 21 serum Days 4-6 SAMD01814932 COVID-19_Lipid_C63 Serum sample from individuals with COVID-19 Sample collection C63 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C63_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C63_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C630 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 128 serum beyond Day 25 SAMD01814933 COVID-19_Lipid_C630 Serum sample from individuals with COVID-19 Sample collection C630 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C630_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C630_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C631 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 126 serum beyond Day 25 SAMD01814934 COVID-19_Lipid_C631 Serum sample from individuals with COVID-19 Sample collection C631 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C631_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C631_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C632 Homo sapiens 9606 2021 Japan 46 SARS-CoV-2 COVID-19 160 serum Days 13-15 SAMD01814935 COVID-19_Lipid_C632 Serum sample from individuals with COVID-19 Sample collection C632 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C632_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C632_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C633 Homo sapiens 9606 2021 Japan 19 SARS-CoV-2 COVID-19 173 serum SAMD01814936 COVID-19_Lipid_C633 Serum sample from individuals with COVID-19 Sample collection C633 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C633_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C633_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 missing C634 Homo sapiens 9606 2021 Japan 32 SARS-CoV-2 COVID-19 174 serum Days 4-6 SAMD01814937 COVID-19_Lipid_C634 Serum sample from individuals with COVID-19 Sample collection C634 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C634_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C634_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C635 Homo sapiens 9606 2021 Japan 53 SARS-CoV-2 COVID-19 171 serum Days 4-6 SAMD01814938 COVID-19_Lipid_C635 Serum sample from individuals with COVID-19 Sample collection C635 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C635_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C635_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C636 Homo sapiens 9606 2021 Japan 71 SARS-CoV-2 COVID-19 158 serum Days 16-18 SAMD01814939 COVID-19_Lipid_C636 Serum sample from individuals with COVID-19 Sample collection C636 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C636_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C636_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C637 Homo sapiens 9606 2021 Japan 65 SARS-CoV-2 COVID-19 175 serum Days 1-3 SAMD01814940 COVID-19_Lipid_C637 Serum sample from individuals with COVID-19 Sample collection C637 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C637_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C637_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 1-3 C638 Homo sapiens 9606 2021 Japan 65 SARS-CoV-2 COVID-19 175 serum Days 4-6 SAMD01814941 COVID-19_Lipid_C638 Serum sample from individuals with COVID-19 Sample collection C638 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C638_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C638_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C639 Homo sapiens 9606 2021 Japan 31 SARS-CoV-2 COVID-19 173 serum SAMD01814942 COVID-19_Lipid_C639 Serum sample from individuals with COVID-19 Sample collection C639 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C639_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C639_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 missing C64 Homo sapiens 9606 2020 Japan 68 SARS-CoV-2 COVID-19 1 serum Days 16-18 SAMD01814943 COVID-19_Lipid_C64 Serum sample from individuals with COVID-19 Sample collection C64 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C64_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C64_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C640 Homo sapiens 9606 2021 Japan 73 SARS-CoV-2 COVID-19 169 serum Days 13-15 SAMD01814944 COVID-19_Lipid_C640 Serum sample from individuals with COVID-19 Sample collection C640 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C640_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C640_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C641 Homo sapiens 9606 2021 Japan 78 SARS-CoV-2 COVID-19 170 serum Days 16-18 SAMD01814945 COVID-19_Lipid_C641 Serum sample from individuals with COVID-19 Sample collection C641 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C641_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C641_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C642 Homo sapiens 9606 2021 Japan 71 SARS-CoV-2 COVID-19 158 serum Days 19-24 SAMD01814946 COVID-19_Lipid_C642 Serum sample from individuals with COVID-19 Sample collection C642 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C642_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C642_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C643 Homo sapiens 9606 2021 Japan 83 SARS-CoV-2 COVID-19 167 serum Days 16-18 SAMD01814947 COVID-19_Lipid_C643 Serum sample from individuals with COVID-19 Sample collection C643 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C643_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C643_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C644 Homo sapiens 9606 2021 Japan 53 SARS-CoV-2 COVID-19 171 serum Days 7-9 SAMD01814948 COVID-19_Lipid_C644 Serum sample from individuals with COVID-19 Sample collection C644 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C644_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C644_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C645 Homo sapiens 9606 2021 Japan 78 SARS-CoV-2 COVID-19 166 serum Days 16-18 SAMD01814949 COVID-19_Lipid_C645 Serum sample from individuals with COVID-19 Sample collection C645 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C645_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C645_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C646 Homo sapiens 9606 2021 Japan 86 SARS-CoV-2 COVID-19 186 serum Days 10-12 SAMD01814950 COVID-19_Lipid_C646 Serum sample from individuals with COVID-19 Sample collection C646 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C646_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C646_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C647 Homo sapiens 9606 2021 Japan 97 SARS-CoV-2 COVID-19 155 serum Days 19-24 SAMD01814951 COVID-19_Lipid_C647 Serum sample from individuals with COVID-19 Sample collection C647 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C647_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C647_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C648 Homo sapiens 9606 2021 Japan 83 SARS-CoV-2 COVID-19 167 serum Days 19-24 SAMD01814952 COVID-19_Lipid_C648 Serum sample from individuals with COVID-19 Sample collection C648 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C648_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C648_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C649 Homo sapiens 9606 2021 Japan 78 SARS-CoV-2 COVID-19 166 serum Days 19-24 SAMD01814953 COVID-19_Lipid_C649 Serum sample from individuals with COVID-19 Sample collection C649 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C649_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C649_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C65 Homo sapiens 9606 2020 Japan 71 SARS-CoV-2 COVID-19 20 serum Days 16-18 SAMD01814954 COVID-19_Lipid_C65 Serum sample from individuals with COVID-19 Sample collection C65 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C65_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C65_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C650 Homo sapiens 9606 2021 Japan 73 SARS-CoV-2 COVID-19 169 serum Days 16-18 SAMD01814955 COVID-19_Lipid_C650 Serum sample from individuals with COVID-19 Sample collection C650 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C650_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C650_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C651 Homo sapiens 9606 2021 Japan 78 SARS-CoV-2 COVID-19 170 serum Days 19-24 SAMD01814956 COVID-19_Lipid_C651 Serum sample from individuals with COVID-19 Sample collection C651 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C651_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C651_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C652 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 115 serum beyond Day 25 SAMD01814957 COVID-19_Lipid_C652 Serum sample from individuals with COVID-19 Sample collection C652 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C652_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C652_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C653 Homo sapiens 9606 2020 Japan 46 SARS-CoV-2 COVID-19 116 serum beyond Day 25 SAMD01814958 COVID-19_Lipid_C653 Serum sample from individuals with COVID-19 Sample collection C653 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C653_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C653_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C654 Homo sapiens 9606 2020 Japan 54 SARS-CoV-2 COVID-19 112 serum beyond Day 25 SAMD01814959 COVID-19_Lipid_C654 Serum sample from individuals with COVID-19 Sample collection C654 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C654_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C654_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C655 Homo sapiens 9606 2021 Japan 47 SARS-CoV-2 COVID-19 162 serum Days 19-24 SAMD01814960 COVID-19_Lipid_C655 Serum sample from individuals with COVID-19 Sample collection C655 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C655_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C655_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C656 Homo sapiens 9606 2021 Japan 46 SARS-CoV-2 COVID-19 160 serum Days 19-24 SAMD01814961 COVID-19_Lipid_C656 Serum sample from individuals with COVID-19 Sample collection C656 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C656_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C656_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C657 Homo sapiens 9606 2021 Japan 65 SARS-CoV-2 COVID-19 175 serum Days 7-9 SAMD01814962 COVID-19_Lipid_C657 Serum sample from individuals with COVID-19 Sample collection C657 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C657_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C657_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C658 Homo sapiens 9606 2021 Japan 91 SARS-CoV-2 COVID-19 179 serum Days 10-12 SAMD01814963 COVID-19_Lipid_C658 Serum sample from individuals with COVID-19 Sample collection C658 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C658_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C658_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C659 Homo sapiens 9606 2021 Japan 67 SARS-CoV-2 COVID-19 133 serum beyond Day 25 SAMD01814964 COVID-19_Lipid_C659 Serum sample from individuals with COVID-19 Sample collection C659 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C659_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C659_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C66 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 21 serum Days 10-12 SAMD01814965 COVID-19_Lipid_C66 Serum sample from individuals with COVID-19 Sample collection C66 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C66_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C66_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C660 Homo sapiens 9606 2021 Japan 44 SARS-CoV-2 COVID-19 178 serum Days 7-9 SAMD01814966 COVID-19_Lipid_C660 Serum sample from individuals with COVID-19 Sample collection C660 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C660_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C660_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C661 Homo sapiens 9606 2021 Japan 48 SARS-CoV-2 COVID-19 176 serum Days 10-12 SAMD01814967 COVID-19_Lipid_C661 Serum sample from individuals with COVID-19 Sample collection C661 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C661_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C661_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C662 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 119 serum beyond Day 25 SAMD01814968 COVID-19_Lipid_C662 Serum sample from individuals with COVID-19 Sample collection C662 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C662_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C662_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C663 Homo sapiens 9606 2020 Japan 47 SARS-CoV-2 COVID-19 141 serum beyond Day 25 SAMD01814969 COVID-19_Lipid_C663 Serum sample from individuals with COVID-19 Sample collection C663 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C663_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C663_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C664 Homo sapiens 9606 2021 Japan 72 SARS-CoV-2 COVID-19 177 serum Days 13-15 SAMD01814970 COVID-19_Lipid_C664 Serum sample from individuals with COVID-19 Sample collection C664 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C664_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C664_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C665 Homo sapiens 9606 2021 Japan 80 SARS-CoV-2 COVID-19 180 serum Days 4-6 SAMD01814971 COVID-19_Lipid_C665 Serum sample from individuals with COVID-19 Sample collection C665 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C665_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C665_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C666 Homo sapiens 9606 2021 Japan 86 SARS-CoV-2 COVID-19 186 serum Days 13-15 SAMD01814972 COVID-19_Lipid_C666 Serum sample from individuals with COVID-19 Sample collection C666 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C666_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C666_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C667 Homo sapiens 9606 2021 Japan 47 SARS-CoV-2 COVID-19 144 serum beyond Day 25 SAMD01814973 COVID-19_Lipid_C667 Serum sample from individuals with COVID-19 Sample collection C667 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C667_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C667_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C668 Homo sapiens 9606 2021 Japan 73 SARS-CoV-2 COVID-19 169 serum Days 19-24 SAMD01814974 COVID-19_Lipid_C668 Serum sample from individuals with COVID-19 Sample collection C668 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C668_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C668_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C669 Homo sapiens 9606 2021 Japan 65 SARS-CoV-2 COVID-19 159 serum beyond Day 25 SAMD01814975 COVID-19_Lipid_C669 Serum sample from individuals with COVID-19 Sample collection C669 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C669_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C669_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C67 Homo sapiens 9606 2020 Japan 24 SARS-CoV-2 COVID-19 3 serum Days 16-18 SAMD01814976 COVID-19_Lipid_C67 Serum sample from individuals with COVID-19 Sample collection C67 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C67_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C67_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C670 Homo sapiens 9606 2021 Japan 72 SARS-CoV-2 COVID-19 177 serum Days 16-18 SAMD01814977 COVID-19_Lipid_C670 Serum sample from individuals with COVID-19 Sample collection C670 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C670_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C670_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C671 Homo sapiens 9606 2021 Japan 44 SARS-CoV-2 COVID-19 178 serum Days 10-12 SAMD01814978 COVID-19_Lipid_C671 Serum sample from individuals with COVID-19 Sample collection C671 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C671_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C671_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C672 Homo sapiens 9606 2021 Japan 91 SARS-CoV-2 COVID-19 179 serum Days 13-15 SAMD01814979 COVID-19_Lipid_C672 Serum sample from individuals with COVID-19 Sample collection C672 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C672_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C672_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C673 Homo sapiens 9606 2021 Japan 80 SARS-CoV-2 COVID-19 180 serum Days 7-9 SAMD01814980 COVID-19_Lipid_C673 Serum sample from individuals with COVID-19 Sample collection C673 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C673_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C673_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C674 Homo sapiens 9606 2021 Japan 48 SARS-CoV-2 COVID-19 176 serum Days 13-15 SAMD01814981 COVID-19_Lipid_C674 Serum sample from individuals with COVID-19 Sample collection C674 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C674_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C674_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C675 Homo sapiens 9606 2021 Japan 83 SARS-CoV-2 COVID-19 181 serum Days 1-3 SAMD01814982 COVID-19_Lipid_C675 Serum sample from individuals with COVID-19 Sample collection C675 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C675_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C675_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 1-3 C676 Homo sapiens 9606 2021 Japan 42 SARS-CoV-2 COVID-19 182 serum Days 7-9 SAMD01814983 COVID-19_Lipid_C676 Serum sample from individuals with COVID-19 Sample collection C676 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C676_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C676_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C677 Homo sapiens 9606 2021 Japan 91 SARS-CoV-2 COVID-19 179 serum Days 16-18 SAMD01814984 COVID-19_Lipid_C677 Serum sample from individuals with COVID-19 Sample collection C677 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C677_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C677_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C678 Homo sapiens 9606 2021 Japan 42 SARS-CoV-2 COVID-19 182 serum Days 10-12 SAMD01814985 COVID-19_Lipid_C678 Serum sample from individuals with COVID-19 Sample collection C678 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C678_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C678_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C679 Homo sapiens 9606 2021 Japan 15 SARS-CoV-2 COVID-19 132 serum beyond Day 25 SAMD01814986 COVID-19_Lipid_C679 Serum sample from individuals with COVID-19 Sample collection C679 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C679_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C679_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C68 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 10 serum beyond Day 25 SAMD01814987 COVID-19_Lipid_C68 Serum sample from individuals with COVID-19 Sample collection C68 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C68_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C68_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C680 Homo sapiens 9606 2021 Japan 83 SARS-CoV-2 COVID-19 181 serum Days 4-6 SAMD01814988 COVID-19_Lipid_C680 Serum sample from individuals with COVID-19 Sample collection C680 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C680_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C680_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C681 Homo sapiens 9606 2021 Japan 72 SARS-CoV-2 COVID-19 177 serum Days 19-24 SAMD01814989 COVID-19_Lipid_C681 Serum sample from individuals with COVID-19 Sample collection C681 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C681_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C681_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C682 Homo sapiens 9606 2021 Japan 27 SARS-CoV-2 COVID-19 183 serum Days 1-3 SAMD01814990 COVID-19_Lipid_C682 Serum sample from individuals with COVID-19 Sample collection C682 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C682_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C682_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 1-3 C683 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 284 serum Days 7-9 SAMD01814991 COVID-19_Lipid_C683 Serum sample from individuals with COVID-19 Sample collection C683 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C683_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C683_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C684 Homo sapiens 9606 2021 Japan 80 SARS-CoV-2 COVID-19 180 serum Days 10-12 SAMD01814992 COVID-19_Lipid_C684 Serum sample from individuals with COVID-19 Sample collection C684 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C684_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C684_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C685 Homo sapiens 9606 2021 Japan 27 SARS-CoV-2 COVID-19 183 serum Days 4-6 SAMD01814993 COVID-19_Lipid_C685 Serum sample from individuals with COVID-19 Sample collection C685 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C685_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C685_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C686 Homo sapiens 9606 2021 Japan 83 SARS-CoV-2 COVID-19 167 serum beyond Day 25 SAMD01814994 COVID-19_Lipid_C686 Serum sample from individuals with COVID-19 Sample collection C686 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C686_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C686_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C687 Homo sapiens 9606 2021 Japan 64 SARS-CoV-2 COVID-19 185 serum Days 10-12 SAMD01814995 COVID-19_Lipid_C687 Serum sample from individuals with COVID-19 Sample collection C687 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C687_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C687_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C688 Homo sapiens 9606 2021 Japan 75 SARS-CoV-2 COVID-19 187 serum Days 4-6 SAMD01814996 COVID-19_Lipid_C688 Serum sample from individuals with COVID-19 Sample collection C688 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C688_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C688_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C689 Homo sapiens 9606 2021 Japan 75 SARS-CoV-2 COVID-19 187 serum Days 7-9 SAMD01814997 COVID-19_Lipid_C689 Serum sample from individuals with COVID-19 Sample collection C689 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C689_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C689_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C69 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 15 serum beyond Day 25 SAMD01814998 COVID-19_Lipid_C69 Serum sample from individuals with COVID-19 Sample collection C69 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C69_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C69_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C690 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 284 serum Days 10-12 SAMD01814999 COVID-19_Lipid_C690 Serum sample from individuals with COVID-19 Sample collection C690 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C690_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C690_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C691 Homo sapiens 9606 2021 Japan 64 SARS-CoV-2 COVID-19 185 serum Days 13-15 SAMD01815000 COVID-19_Lipid_C691 Serum sample from individuals with COVID-19 Sample collection C691 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C691_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C691_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C692 Homo sapiens 9606 2021 Japan 91 SARS-CoV-2 COVID-19 179 serum Days 19-24 SAMD01815001 COVID-19_Lipid_C692 Serum sample from individuals with COVID-19 Sample collection C692 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C692_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C692_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C693 Homo sapiens 9606 2021 Japan 78 SARS-CoV-2 COVID-19 170 serum beyond Day 25 SAMD01815002 COVID-19_Lipid_C693 Serum sample from individuals with COVID-19 Sample collection C693 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C693_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C693_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C694 Homo sapiens 9606 2021 Japan 20 SARS-CoV-2 COVID-19 148 serum beyond Day 25 SAMD01815003 COVID-19_Lipid_C694 Serum sample from individuals with COVID-19 Sample collection C694 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C694_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C694_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C695 Homo sapiens 9606 2021 Japan 80 SARS-CoV-2 COVID-19 180 serum Days 16-18 SAMD01815004 COVID-19_Lipid_C695 Serum sample from individuals with COVID-19 Sample collection C695 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C695_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C695_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C696 Homo sapiens 9606 2021 Japan 15 SARS-CoV-2 COVID-19 156 serum beyond Day 25 SAMD01815005 COVID-19_Lipid_C696 Serum sample from individuals with COVID-19 Sample collection C696 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C696_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C696_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C697 Homo sapiens 9606 2021 Japan 46 SARS-CoV-2 COVID-19 160 serum beyond Day 25 SAMD01815006 COVID-19_Lipid_C697 Serum sample from individuals with COVID-19 Sample collection C697 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C697_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C697_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C698 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 284 serum Days 13-15 SAMD01815007 COVID-19_Lipid_C698 Serum sample from individuals with COVID-19 Sample collection C698 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C698_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C698_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C699 Homo sapiens 9606 2021 Japan 80 SARS-CoV-2 COVID-19 180 serum Days 19-24 SAMD01815008 COVID-19_Lipid_C699 Serum sample from individuals with COVID-19 Sample collection C699 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C699_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C699_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C7 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 16 serum Days 10-12 SAMD01815009 COVID-19_Lipid_C7 Serum sample from individuals with COVID-19 Sample collection C7 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C7_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C7_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C70 Homo sapiens 9606 2020 Japan 76 SARS-CoV-2 COVID-19 22 serum Days 4-6 SAMD01815010 COVID-19_Lipid_C70 Serum sample from individuals with COVID-19 Sample collection C70 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C70_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C70_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C700 Homo sapiens 9606 2021 Japan 69 SARS-CoV-2 COVID-19 124 serum beyond Day 25 SAMD01815011 COVID-19_Lipid_C700 Serum sample from individuals with COVID-19 Sample collection C700 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C700_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C700_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C701 Homo sapiens 9606 2021 Japan 44 SARS-CoV-2 COVID-19 188 serum Days 4-6 SAMD01815012 COVID-19_Lipid_C701 Serum sample from individuals with COVID-19 Sample collection C701 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C701_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C701_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C702 Homo sapiens 9606 2021 Japan 88 SARS-CoV-2 COVID-19 151 serum beyond Day 25 SAMD01815013 COVID-19_Lipid_C702 Serum sample from individuals with COVID-19 Sample collection C702 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C702_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C702_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C703 Homo sapiens 9606 2021 Japan 47 SARS-CoV-2 COVID-19 162 serum beyond Day 25 SAMD01815014 COVID-19_Lipid_C703 Serum sample from individuals with COVID-19 Sample collection C703 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C703_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C703_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C704 Homo sapiens 9606 2021 Japan 56 SARS-CoV-2 COVID-19 189 serum Days 1-3 SAMD01815015 COVID-19_Lipid_C704 Serum sample from individuals with COVID-19 Sample collection C704 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C704_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C704_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 1-3 C705 Homo sapiens 9606 2021 Japan 56 SARS-CoV-2 COVID-19 189 serum Days 4-6 SAMD01815016 COVID-19_Lipid_C705 Serum sample from individuals with COVID-19 Sample collection C705 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C705_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C705_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C706 Homo sapiens 9606 2021 Japan 54 SARS-CoV-2 COVID-19 190 serum Days 7-9 SAMD01815017 COVID-19_Lipid_C706 Serum sample from individuals with COVID-19 Sample collection C706 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C706_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C706_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C707 Homo sapiens 9606 2021 Japan 56 SARS-CoV-2 COVID-19 189 serum Days 7-9 SAMD01815018 COVID-19_Lipid_C707 Serum sample from individuals with COVID-19 Sample collection C707 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C707_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C707_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C708 Homo sapiens 9606 2021 Japan 54 SARS-CoV-2 COVID-19 145 serum beyond Day 25 SAMD01815019 COVID-19_Lipid_C708 Serum sample from individuals with COVID-19 Sample collection C708 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C708_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C708_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C709 Homo sapiens 9606 2021 Japan 44 SARS-CoV-2 COVID-19 188 serum Days 7-9 SAMD01815020 COVID-19_Lipid_C709 Serum sample from individuals with COVID-19 Sample collection C709 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C709_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C709_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C71 Homo sapiens 9606 2020 Japan 76 SARS-CoV-2 COVID-19 22 serum pre-onset SAMD01815021 COVID-19_Lipid_C71 Serum sample from individuals with COVID-19 Sample collection C71 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C71_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C71_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 pre-onset C710 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 191 serum Days 1-3 SAMD01815022 COVID-19_Lipid_C710 Serum sample from individuals with COVID-19 Sample collection C710 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C710_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C710_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 1-3 C711 Homo sapiens 9606 2021 Japan 32 SARS-CoV-2 COVID-19 192 serum Days 1-3 SAMD01815023 COVID-19_Lipid_C711 Serum sample from individuals with COVID-19 Sample collection C711 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C711_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C711_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 1-3 C712 Homo sapiens 9606 2020 Japan 70 SARS-CoV-2 COVID-19 138 serum beyond Day 25 SAMD01815024 COVID-19_Lipid_C712 Serum sample from individuals with COVID-19 Sample collection C712 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C712_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C712_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C713 Homo sapiens 9606 2021 Japan 88 SARS-CoV-2 COVID-19 202 serum Days 4-6 SAMD01815025 COVID-19_Lipid_C713 Serum sample from individuals with COVID-19 Sample collection C713 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C713_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C713_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C714 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 191 serum Days 4-6 SAMD01815026 COVID-19_Lipid_C714 Serum sample from individuals with COVID-19 Sample collection C714 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C714_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C714_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C715 Homo sapiens 9606 2021 Japan 54 SARS-CoV-2 COVID-19 190 serum Days 10-12 SAMD01815027 COVID-19_Lipid_C715 Serum sample from individuals with COVID-19 Sample collection C715 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C715_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C715_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C716 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 134 serum beyond Day 25 SAMD01815028 COVID-19_Lipid_C716 Serum sample from individuals with COVID-19 Sample collection C716 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C716_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C716_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C717 Homo sapiens 9606 2021 Japan 44 SARS-CoV-2 COVID-19 188 serum Days 10-12 SAMD01815029 COVID-19_Lipid_C717 Serum sample from individuals with COVID-19 Sample collection C717 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C717_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C717_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C718 Homo sapiens 9606 2020 Japan 55 SARS-CoV-2 COVID-19 129 serum beyond Day 25 SAMD01815030 COVID-19_Lipid_C718 Serum sample from individuals with COVID-19 Sample collection C718 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C718_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C718_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C719 Homo sapiens 9606 2021 Japan 58 SARS-CoV-2 COVID-19 152 serum beyond Day 25 SAMD01815031 COVID-19_Lipid_C719 Serum sample from individuals with COVID-19 Sample collection C719 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C719_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C719_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C72 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 23 serum pre-onset SAMD01815032 COVID-19_Lipid_C72 Serum sample from individuals with COVID-19 Sample collection C72 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C72_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C72_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 pre-onset C720 Homo sapiens 9606 2021 Japan 88 SARS-CoV-2 COVID-19 202 serum Days 7-9 SAMD01815033 COVID-19_Lipid_C720 Serum sample from individuals with COVID-19 Sample collection C720 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C720_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C720_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C721 Homo sapiens 9606 2021 Japan 65 SARS-CoV-2 COVID-19 175 serum beyond Day 25 SAMD01815034 COVID-19_Lipid_C721 Serum sample from individuals with COVID-19 Sample collection C721 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C721_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C721_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C722 Homo sapiens 9606 2021 Japan 32 SARS-CoV-2 COVID-19 192 serum Days 4-6 SAMD01815035 COVID-19_Lipid_C722 Serum sample from individuals with COVID-19 Sample collection C722 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C722_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C722_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C723 Homo sapiens 9606 2021 Japan 54 SARS-CoV-2 COVID-19 190 serum Days 13-15 SAMD01815036 COVID-19_Lipid_C723 Serum sample from individuals with COVID-19 Sample collection C723 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C723_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C723_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C724 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 191 serum Days 7-9 SAMD01815037 COVID-19_Lipid_C724 Serum sample from individuals with COVID-19 Sample collection C724 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C724_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C724_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C725 Homo sapiens 9606 2021 Japan 88 SARS-CoV-2 COVID-19 202 serum Days 10-12 SAMD01815038 COVID-19_Lipid_C725 Serum sample from individuals with COVID-19 Sample collection C725 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C725_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C725_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C726 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 191 serum Days 10-12 SAMD01815039 COVID-19_Lipid_C726 Serum sample from individuals with COVID-19 Sample collection C726 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C726_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C726_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C727 Homo sapiens 9606 2021 Japan 32 SARS-CoV-2 COVID-19 192 serum Days 7-9 SAMD01815040 COVID-19_Lipid_C727 Serum sample from individuals with COVID-19 Sample collection C727 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C727_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C727_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C728 Homo sapiens 9606 2021 Japan 44 SARS-CoV-2 COVID-19 194 serum pre-onset SAMD01815041 COVID-19_Lipid_C728 Serum sample from individuals with COVID-19 Sample collection C728 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C728_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C728_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 pre-onset C729 Homo sapiens 9606 2021 Japan 44 SARS-CoV-2 COVID-19 194 serum Days 1-3 SAMD01815042 COVID-19_Lipid_C729 Serum sample from individuals with COVID-19 Sample collection C729 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C729_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C729_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 1-3 C73 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 23 serum Days 1-3 SAMD01815043 COVID-19_Lipid_C73 Serum sample from individuals with COVID-19 Sample collection C73 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C73_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C73_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 1-3 C730 Homo sapiens 9606 2021 Japan 44 SARS-CoV-2 COVID-19 194 serum Days 4-6 SAMD01815044 COVID-19_Lipid_C730 Serum sample from individuals with COVID-19 Sample collection C730 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C730_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C730_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C731 Homo sapiens 9606 2021 Japan 61 SARS-CoV-2 COVID-19 195 serum pre-onset SAMD01815045 COVID-19_Lipid_C731 Serum sample from individuals with COVID-19 Sample collection C731 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C731_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C731_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 pre-onset C732 Homo sapiens 9606 2021 Japan 61 SARS-CoV-2 COVID-19 195 serum Days 1-3 SAMD01815046 COVID-19_Lipid_C732 Serum sample from individuals with COVID-19 Sample collection C732 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C732_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C732_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 1-3 C733 Homo sapiens 9606 2021 Japan 61 SARS-CoV-2 COVID-19 195 serum Days 4-6 SAMD01815047 COVID-19_Lipid_C733 Serum sample from individuals with COVID-19 Sample collection C733 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C733_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C733_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C734 Homo sapiens 9606 2021 Japan 44 SARS-CoV-2 COVID-19 194 serum Days 10-12 SAMD01815048 COVID-19_Lipid_C734 Serum sample from individuals with COVID-19 Sample collection C734 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C734_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C734_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C735 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 139 serum beyond Day 25 SAMD01815049 COVID-19_Lipid_C735 Serum sample from individuals with COVID-19 Sample collection C735 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C735_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C735_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C736 Homo sapiens 9606 2021 Japan 32 SARS-CoV-2 COVID-19 192 serum Days 10-12 SAMD01815050 COVID-19_Lipid_C736 Serum sample from individuals with COVID-19 Sample collection C736 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C736_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C736_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C737 Homo sapiens 9606 2021 Japan 71 SARS-CoV-2 COVID-19 157 serum beyond Day 25 SAMD01815051 COVID-19_Lipid_C737 Serum sample from individuals with COVID-19 Sample collection C737 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C737_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C737_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C738 Homo sapiens 9606 2021 Japan 58 SARS-CoV-2 COVID-19 142 serum beyond Day 25 SAMD01815052 COVID-19_Lipid_C738 Serum sample from individuals with COVID-19 Sample collection C738 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C738_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C738_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C739 Homo sapiens 9606 2021 Japan 61 SARS-CoV-2 COVID-19 143 serum beyond Day 25 SAMD01815053 COVID-19_Lipid_C739 Serum sample from individuals with COVID-19 Sample collection C739 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C739_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C739_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C74 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 23 serum Days 4-6 SAMD01815054 COVID-19_Lipid_C74 Serum sample from individuals with COVID-19 Sample collection C74 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C74_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C74_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C740 Homo sapiens 9606 2020 Japan 39 SARS-CoV-2 COVID-19 149 serum beyond Day 25 SAMD01815055 COVID-19_Lipid_C740 Serum sample from individuals with COVID-19 Sample collection C740 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C740_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C740_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C741 Homo sapiens 9606 2021 Japan 61 SARS-CoV-2 COVID-19 195 serum Days 7-9 SAMD01815056 COVID-19_Lipid_C741 Serum sample from individuals with COVID-19 Sample collection C741 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C741_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C741_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C742 Homo sapiens 9606 2021 Japan 73 SARS-CoV-2 COVID-19 161 serum beyond Day 25 SAMD01815057 COVID-19_Lipid_C742 Serum sample from individuals with COVID-19 Sample collection C742 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C742_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C742_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C743 Homo sapiens 9606 2021 Japan 61 SARS-CoV-2 COVID-19 163 serum beyond Day 25 SAMD01815058 COVID-19_Lipid_C743 Serum sample from individuals with COVID-19 Sample collection C743 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C743_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C743_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C744 Homo sapiens 9606 2021 Japan 77 SARS-CoV-2 COVID-19 197 serum SAMD01815059 COVID-19_Lipid_C744 Serum sample from individuals with COVID-19 Sample collection C744 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C744_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C744_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 missing C745 Homo sapiens 9606 2021 Japan 77 SARS-CoV-2 COVID-19 197 serum SAMD01815060 COVID-19_Lipid_C745 Serum sample from individuals with COVID-19 Sample collection C745 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C745_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C745_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 missing C746 Homo sapiens 9606 2021 Japan 61 SARS-CoV-2 COVID-19 195 serum Days 13-15 SAMD01815061 COVID-19_Lipid_C746 Serum sample from individuals with COVID-19 Sample collection C746 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C746_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C746_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C747 Homo sapiens 9606 2021 Japan 77 SARS-CoV-2 COVID-19 197 serum SAMD01815062 COVID-19_Lipid_C747 Serum sample from individuals with COVID-19 Sample collection C747 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C747_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C747_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 missing C748 Homo sapiens 9606 2021 Japan 40 SARS-CoV-2 COVID-19 154 serum beyond Day 25 SAMD01815063 COVID-19_Lipid_C748 Serum sample from individuals with COVID-19 Sample collection C748 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C748_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C748_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C749 Homo sapiens 9606 2021 Japan 71 SARS-CoV-2 COVID-19 158 serum beyond Day 25 SAMD01815064 COVID-19_Lipid_C749 Serum sample from individuals with COVID-19 Sample collection C749 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C749_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C749_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C75 Homo sapiens 9606 2020 Japan 68 SARS-CoV-2 COVID-19 1 serum Days 19-24 SAMD01815065 COVID-19_Lipid_C75 Serum sample from individuals with COVID-19 Sample collection C75 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C75_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C75_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C750 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 164 serum beyond Day 25 SAMD01815066 COVID-19_Lipid_C750 Serum sample from individuals with COVID-19 Sample collection C750 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C750_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C750_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C751 Homo sapiens 9606 2021 Japan 74 SARS-CoV-2 COVID-19 201 serum Days 10-12 SAMD01815067 COVID-19_Lipid_C751 Serum sample from individuals with COVID-19 Sample collection C751 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C751_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C751_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C752 Homo sapiens 9606 2021 Japan 73 SARS-CoV-2 COVID-19 199 serum SAMD01815068 COVID-19_Lipid_C752 Serum sample from individuals with COVID-19 Sample collection C752 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C752_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C752_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 missing C753 Homo sapiens 9606 2021 Japan 72 SARS-CoV-2 COVID-19 200 serum Days 4-6 SAMD01815069 COVID-19_Lipid_C753 Serum sample from individuals with COVID-19 Sample collection C753 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C753_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C753_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C754 Homo sapiens 9606 2021 Japan 72 SARS-CoV-2 COVID-19 200 serum Days 7-9 SAMD01815070 COVID-19_Lipid_C754 Serum sample from individuals with COVID-19 Sample collection C754 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C754_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C754_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C755 Homo sapiens 9606 2021 Japan 44 SARS-CoV-2 COVID-19 178 serum beyond Day 25 SAMD01815071 COVID-19_Lipid_C755 Serum sample from individuals with COVID-19 Sample collection C755 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C755_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C755_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C756 Homo sapiens 9606 2021 Japan 48 SARS-CoV-2 COVID-19 176 serum beyond Day 25 SAMD01815072 COVID-19_Lipid_C756 Serum sample from individuals with COVID-19 Sample collection C756 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C756_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C756_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C757 Homo sapiens 9606 2021 Japan 83 SARS-CoV-2 COVID-19 203 serum Days 7-9 SAMD01815073 COVID-19_Lipid_C757 Serum sample from individuals with COVID-19 Sample collection C757 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C757_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C757_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C758 Homo sapiens 9606 2021 Japan 83 SARS-CoV-2 COVID-19 203 serum Days 10-12 SAMD01815074 COVID-19_Lipid_C758 Serum sample from individuals with COVID-19 Sample collection C758 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C758_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C758_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C759 Homo sapiens 9606 2021 Japan 57 SARS-CoV-2 COVID-19 204 serum Days 4-6 SAMD01815075 COVID-19_Lipid_C759 Serum sample from individuals with COVID-19 Sample collection C759 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C759_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C759_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C76 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 23 serum Days 7-9 SAMD01815076 COVID-19_Lipid_C76 Serum sample from individuals with COVID-19 Sample collection C76 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C76_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C76_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C760 Homo sapiens 9606 2021 Japan 83 SARS-CoV-2 COVID-19 203 serum Days 13-15 SAMD01815077 COVID-19_Lipid_C760 Serum sample from individuals with COVID-19 Sample collection C760 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C760_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C760_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C761 Homo sapiens 9606 2021 Japan 69 SARS-CoV-2 COVID-19 205 serum pre-onset SAMD01815078 COVID-19_Lipid_C761 Serum sample from individuals with COVID-19 Sample collection C761 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C761_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C761_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 pre-onset C762 Homo sapiens 9606 2021 Japan 69 SARS-CoV-2 COVID-19 205 serum Days 4-6 SAMD01815079 COVID-19_Lipid_C762 Serum sample from individuals with COVID-19 Sample collection C762 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C762_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C762_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C763 Homo sapiens 9606 2021 Japan 69 SARS-CoV-2 COVID-19 205 serum Days 7-9 SAMD01815080 COVID-19_Lipid_C763 Serum sample from individuals with COVID-19 Sample collection C763 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C763_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C763_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C764 Homo sapiens 9606 2021 Japan 71 SARS-CoV-2 COVID-19 206 serum Days 1-3 SAMD01815081 COVID-19_Lipid_C764 Serum sample from individuals with COVID-19 Sample collection C764 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C764_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C764_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 1-3 C765 Homo sapiens 9606 2021 Japan 71 SARS-CoV-2 COVID-19 206 serum pre-onset SAMD01815082 COVID-19_Lipid_C765 Serum sample from individuals with COVID-19 Sample collection C765 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C765_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C765_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 pre-onset C766 Homo sapiens 9606 2021 Japan 75 SARS-CoV-2 COVID-19 208 serum Days 4-6 SAMD01815083 COVID-19_Lipid_C766 Serum sample from individuals with COVID-19 Sample collection C766 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C766_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C766_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C767 Homo sapiens 9606 2021 Japan 72 SARS-CoV-2 COVID-19 207 serum Days 4-6 SAMD01815084 COVID-19_Lipid_C767 Serum sample from individuals with COVID-19 Sample collection C767 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C767_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C767_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C768 Homo sapiens 9606 2021 Japan 75 SARS-CoV-2 COVID-19 187 serum beyond Day 25 SAMD01815085 COVID-19_Lipid_C768 Serum sample from individuals with COVID-19 Sample collection C768 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C768_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C768_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C769 Homo sapiens 9606 2021 Japan 56 SARS-CoV-2 COVID-19 189 serum beyond Day 25 SAMD01815086 COVID-19_Lipid_C769 Serum sample from individuals with COVID-19 Sample collection C769 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C769_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C769_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C77 Homo sapiens 9606 2020 Japan 76 SARS-CoV-2 COVID-19 22 serum Days 7-9 SAMD01815087 COVID-19_Lipid_C77 Serum sample from individuals with COVID-19 Sample collection C77 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C77_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C77_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C770 Homo sapiens 9606 2021 Japan 64 SARS-CoV-2 COVID-19 185 serum beyond Day 25 SAMD01815088 COVID-19_Lipid_C770 Serum sample from individuals with COVID-19 Sample collection C770 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C770_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C770_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C771 Homo sapiens 9606 2021 Japan 57 SARS-CoV-2 COVID-19 204 serum Days 7-9 SAMD01815089 COVID-19_Lipid_C771 Serum sample from individuals with COVID-19 Sample collection C771 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C771_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C771_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C772 Homo sapiens 9606 2021 Japan 71 SARS-CoV-2 COVID-19 206 serum Days 4-6 SAMD01815090 COVID-19_Lipid_C772 Serum sample from individuals with COVID-19 Sample collection C772 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C772_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C772_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C773 Homo sapiens 9606 2021 Japan 75 SARS-CoV-2 COVID-19 208 serum Days 7-9 SAMD01815091 COVID-19_Lipid_C773 Serum sample from individuals with COVID-19 Sample collection C773 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C773_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C773_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C774 Homo sapiens 9606 2021 Japan 75 SARS-CoV-2 COVID-19 208 serum Days 10-12 SAMD01815092 COVID-19_Lipid_C774 Serum sample from individuals with COVID-19 Sample collection C774 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C774_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C774_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C775 Homo sapiens 9606 2021 Japan 83 SARS-CoV-2 COVID-19 203 serum Days 16-18 SAMD01815093 COVID-19_Lipid_C775 Serum sample from individuals with COVID-19 Sample collection C775 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C775_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C775_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C776 Homo sapiens 9606 2021 Japan 57 SARS-CoV-2 COVID-19 204 serum Days 10-12 SAMD01815094 COVID-19_Lipid_C776 Serum sample from individuals with COVID-19 Sample collection C776 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C776_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C776_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C777 Homo sapiens 9606 2021 Japan 69 SARS-CoV-2 COVID-19 205 serum Days 10-12 SAMD01815095 COVID-19_Lipid_C777 Serum sample from individuals with COVID-19 Sample collection C777 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C777_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C777_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C778 Homo sapiens 9606 2021 Japan 68 SARS-CoV-2 COVID-19 209 serum Days 7-9 SAMD01815096 COVID-19_Lipid_C778 Serum sample from individuals with COVID-19 Sample collection C778 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C778_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C778_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C779 Homo sapiens 9606 2021 Japan 68 SARS-CoV-2 COVID-19 209 serum Days 10-12 SAMD01815097 COVID-19_Lipid_C779 Serum sample from individuals with COVID-19 Sample collection C779 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C779_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C779_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C78 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 7 serum beyond Day 25 SAMD01815098 COVID-19_Lipid_C78 Serum sample from individuals with COVID-19 Sample collection C78 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C78_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C78_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C780 Homo sapiens 9606 2021 Japan 83 SARS-CoV-2 COVID-19 203 serum Days 19-24 SAMD01815099 COVID-19_Lipid_C780 Serum sample from individuals with COVID-19 Sample collection C780 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C780_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C780_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C781 Homo sapiens 9606 2021 Japan 71 SARS-CoV-2 COVID-19 206 serum Days 7-9 SAMD01815100 COVID-19_Lipid_C781 Serum sample from individuals with COVID-19 Sample collection C781 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C781_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C781_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C782 Homo sapiens 9606 2021 Japan 75 SARS-CoV-2 COVID-19 208 serum Days 13-15 SAMD01815101 COVID-19_Lipid_C782 Serum sample from individuals with COVID-19 Sample collection C782 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C782_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C782_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C783 Homo sapiens 9606 2021 Japan 68 SARS-CoV-2 COVID-19 209 serum Days 13-15 SAMD01815102 COVID-19_Lipid_C783 Serum sample from individuals with COVID-19 Sample collection C783 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C783_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C783_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C784 Homo sapiens 9606 2021 Japan 54 SARS-CoV-2 COVID-19 190 serum beyond Day 25 SAMD01815103 COVID-19_Lipid_C784 Serum sample from individuals with COVID-19 Sample collection C784 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C784_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C784_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C785 Homo sapiens 9606 2021 Japan 41 SARS-CoV-2 COVID-19 211 serum Days 1-3 SAMD01815104 COVID-19_Lipid_C785 Serum sample from individuals with COVID-19 Sample collection C785 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C785_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C785_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 1-3 C786 Homo sapiens 9606 2021 Japan 86 SARS-CoV-2 COVID-19 220 serum Days 7-9 SAMD01815105 COVID-19_Lipid_C786 Serum sample from individuals with COVID-19 Sample collection C786 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C786_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C786_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C787 Homo sapiens 9606 2021 Japan 83 SARS-CoV-2 COVID-19 210 serum pre-onset SAMD01815106 COVID-19_Lipid_C787 Serum sample from individuals with COVID-19 Sample collection C787 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C787_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C787_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 pre-onset C788 Homo sapiens 9606 2021 Japan 65 SARS-CoV-2 COVID-19 212 serum Days 10-12 SAMD01815107 COVID-19_Lipid_C788 Serum sample from individuals with COVID-19 Sample collection C788 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C788_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C788_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C789 Homo sapiens 9606 2021 Japan 68 SARS-CoV-2 COVID-19 209 serum Days 16-18 SAMD01815108 COVID-19_Lipid_C789 Serum sample from individuals with COVID-19 Sample collection C789 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C789_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C789_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C79 Homo sapiens 9606 2020 Japan 49 SARS-CoV-2 COVID-19 12 serum beyond Day 25 SAMD01815109 COVID-19_Lipid_C79 Serum sample from individuals with COVID-19 Sample collection C79 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C79_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C79_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C790 Homo sapiens 9606 2021 Japan 78 SARS-CoV-2 COVID-19 213 serum Days 4-6 SAMD01815110 COVID-19_Lipid_C790 Serum sample from individuals with COVID-19 Sample collection C790 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C790_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C790_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C791 Homo sapiens 9606 2021 Japan 78 SARS-CoV-2 COVID-19 213 serum Days 7-9 SAMD01815111 COVID-19_Lipid_C791 Serum sample from individuals with COVID-19 Sample collection C791 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C791_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C791_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C792 Homo sapiens 9606 2021 Japan 58 SARS-CoV-2 COVID-19 214 serum Days 1-3 SAMD01815112 COVID-19_Lipid_C792 Serum sample from individuals with COVID-19 Sample collection C792 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C792_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C792_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 1-3 C793 Homo sapiens 9606 2021 Japan 61 SARS-CoV-2 COVID-19 195 serum beyond Day 25 SAMD01815113 COVID-19_Lipid_C793 Serum sample from individuals with COVID-19 Sample collection C793 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C793_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C793_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C794 Homo sapiens 9606 2021 Japan 58 SARS-CoV-2 COVID-19 214 serum Days 4-6 SAMD01815114 COVID-19_Lipid_C794 Serum sample from individuals with COVID-19 Sample collection C794 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C794_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C794_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C795 Homo sapiens 9606 2021 Japan 65 SARS-CoV-2 COVID-19 212 serum Days 13-15 SAMD01815115 COVID-19_Lipid_C795 Serum sample from individuals with COVID-19 Sample collection C795 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C795_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C795_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C796 Homo sapiens 9606 2021 Japan 68 SARS-CoV-2 COVID-19 209 serum Days 19-24 SAMD01815116 COVID-19_Lipid_C796 Serum sample from individuals with COVID-19 Sample collection C796 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C796_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C796_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C797 Homo sapiens 9606 2021 Japan 44 SARS-CoV-2 COVID-19 194 serum beyond Day 25 SAMD01815117 COVID-19_Lipid_C797 Serum sample from individuals with COVID-19 Sample collection C797 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C797_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C797_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C798 Homo sapiens 9606 2021 Japan 83 SARS-CoV-2 COVID-19 210 serum Days 1-3 SAMD01815118 COVID-19_Lipid_C798 Serum sample from individuals with COVID-19 Sample collection C798 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C798_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C798_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 1-3 C799 Homo sapiens 9606 2021 Japan 73 SARS-CoV-2 COVID-19 215 serum Days 4-6 SAMD01815119 COVID-19_Lipid_C799 Serum sample from individuals with COVID-19 Sample collection C799 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C799_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C799_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C8 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 16 serum Days 13-15 SAMD01815120 COVID-19_Lipid_C8 Serum sample from individuals with COVID-19 Sample collection C8 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C8_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C8_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C80 Homo sapiens 9606 2020 Japan 71 SARS-CoV-2 COVID-19 20 serum Days 19-24 SAMD01815121 COVID-19_Lipid_C80 Serum sample from individuals with COVID-19 Sample collection C80 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C80_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C80_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C800 Homo sapiens 9606 2021 Japan 83 SARS-CoV-2 COVID-19 203 serum beyond Day 25 SAMD01815122 COVID-19_Lipid_C800 Serum sample from individuals with COVID-19 Sample collection C800 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C800_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C800_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C801 Homo sapiens 9606 2021 Japan 78 SARS-CoV-2 COVID-19 213 serum Days 10-12 SAMD01815123 COVID-19_Lipid_C801 Serum sample from individuals with COVID-19 Sample collection C801 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C801_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C801_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C802 Homo sapiens 9606 2021 Japan 58 SARS-CoV-2 COVID-19 214 serum Days 7-9 SAMD01815124 COVID-19_Lipid_C802 Serum sample from individuals with COVID-19 Sample collection C802 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C802_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C802_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C803 Homo sapiens 9606 2021 Japan 65 SARS-CoV-2 COVID-19 212 serum Days 16-18 SAMD01815125 COVID-19_Lipid_C803 Serum sample from individuals with COVID-19 Sample collection C803 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C803_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C803_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C804 Homo sapiens 9606 2021 Japan 73 SARS-CoV-2 COVID-19 215 serum Days 7-9 SAMD01815126 COVID-19_Lipid_C804 Serum sample from individuals with COVID-19 Sample collection C804 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C804_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C804_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C805 Homo sapiens 9606 2021 Japan 65 SARS-CoV-2 COVID-19 212 serum Days 19-24 SAMD01815127 COVID-19_Lipid_C805 Serum sample from individuals with COVID-19 Sample collection C805 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C805_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C805_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C806 Homo sapiens 9606 2021 Japan 48 SARS-CoV-2 COVID-19 218 serum Days 4-6 SAMD01815128 COVID-19_Lipid_C806 Serum sample from individuals with COVID-19 Sample collection C806 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C806_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C806_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C807 Homo sapiens 9606 2021 Japan 58 SARS-CoV-2 COVID-19 214 serum Days 10-12 SAMD01815129 COVID-19_Lipid_C807 Serum sample from individuals with COVID-19 Sample collection C807 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C807_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C807_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C808 Homo sapiens 9606 2021 Japan 73 SARS-CoV-2 COVID-19 215 serum Days 10-12 SAMD01815130 COVID-19_Lipid_C808 Serum sample from individuals with COVID-19 Sample collection C808 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C808_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C808_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C809 Homo sapiens 9606 2021 Japan 69 SARS-CoV-2 COVID-19 205 serum beyond Day 25 SAMD01815131 COVID-19_Lipid_C809 Serum sample from individuals with COVID-19 Sample collection C809 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C809_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C809_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C81 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 21 serum Days 13-15 SAMD01815132 COVID-19_Lipid_C81 Serum sample from individuals with COVID-19 Sample collection C81 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C81_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C81_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C810 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 219 serum Days 4-6 SAMD01916071 COVID-19_Lipid_C810 Serum sample from individuals with COVID-19 Sample collection C810 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C810_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C810_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C811 Homo sapiens 9606 2021 Japan 57 SARS-CoV-2 COVID-19 204 serum beyond Day 25 SAMD01815133 COVID-19_Lipid_C811 Serum sample from individuals with COVID-19 Sample collection C811 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C811_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C811_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C812 Homo sapiens 9606 2021 Japan 58 SARS-CoV-2 COVID-19 214 serum Days 13-15 SAMD01815134 COVID-19_Lipid_C812 Serum sample from individuals with COVID-19 Sample collection C812 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C812_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C812_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C813 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 219 serum Days 7-9 SAMD01815135 COVID-19_Lipid_C813 Serum sample from individuals with COVID-19 Sample collection C813 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C813_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C813_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C814 Homo sapiens 9606 2021 Japan 73 SARS-CoV-2 COVID-19 215 serum Days 13-15 SAMD01815136 COVID-19_Lipid_C814 Serum sample from individuals with COVID-19 Sample collection C814 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C814_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C814_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C815 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 219 serum Days 10-12 SAMD01815137 COVID-19_Lipid_C815 Serum sample from individuals with COVID-19 Sample collection C815 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C815_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C815_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C816 Homo sapiens 9606 2021 Japan 65 SARS-CoV-2 COVID-19 212 serum beyond Day 25 SAMD01815138 COVID-19_Lipid_C816 Serum sample from individuals with COVID-19 Sample collection C816 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C816_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C816_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C817 Homo sapiens 9606 2021 Japan 75 SARS-CoV-2 COVID-19 208 serum beyond Day 25 SAMD01815139 COVID-19_Lipid_C817 Serum sample from individuals with COVID-19 Sample collection C817 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C817_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C817_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C818 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 219 serum Days 13-15 SAMD01815140 COVID-19_Lipid_C818 Serum sample from individuals with COVID-19 Sample collection C818 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C818_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C818_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C819 Homo sapiens 9606 2021 Japan 72 SARS-CoV-2 COVID-19 200 serum beyond Day 25 SAMD01815141 COVID-19_Lipid_C819 Serum sample from individuals with COVID-19 Sample collection C819 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C819_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C819_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C82 Homo sapiens 9606 2020 Japan 65 SARS-CoV-2 COVID-19 25 serum Days 4-6 SAMD01815142 COVID-19_Lipid_C82 Serum sample from individuals with COVID-19 Sample collection C82 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C82_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C82_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C820 Homo sapiens 9606 2021 Japan 31 SARS-CoV-2 COVID-19 226 serum Days 7-9 SAMD01815143 COVID-19_Lipid_C820 Serum sample from individuals with COVID-19 Sample collection C820 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C820_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C820_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C821 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 227 serum pre-onset SAMD01815144 COVID-19_Lipid_C821 Serum sample from individuals with COVID-19 Sample collection C821 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C821_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C821_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 pre-onset C822 Homo sapiens 9606 2021 Japan 24 SARS-CoV-2 COVID-19 229 serum pre-onset SAMD01815145 COVID-19_Lipid_C822 Serum sample from individuals with COVID-19 Sample collection C822 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C822_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C822_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 pre-onset C823 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 227 serum Days 1-3 SAMD01815146 COVID-19_Lipid_C823 Serum sample from individuals with COVID-19 Sample collection C823 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C823_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C823_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 1-3 C824 Homo sapiens 9606 2021 Japan 24 SARS-CoV-2 COVID-19 229 serum Days 1-3 SAMD01815147 COVID-19_Lipid_C824 Serum sample from individuals with COVID-19 Sample collection C824 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C824_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C824_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 1-3 C825 Homo sapiens 9606 2021 Japan 37 SARS-CoV-2 COVID-19 228 serum Days 4-6 SAMD01815148 COVID-19_Lipid_C825 Serum sample from individuals with COVID-19 Sample collection C825 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C825_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C825_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C826 Homo sapiens 9606 2021 Japan 77 SARS-CoV-2 COVID-19 225 serum Days 4-6 SAMD01815149 COVID-19_Lipid_C826 Serum sample from individuals with COVID-19 Sample collection C826 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C826_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C826_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C827 Homo sapiens 9606 2021 Japan 64 SARS-CoV-2 COVID-19 234 serum Days 13-15 SAMD01815150 COVID-19_Lipid_C827 Serum sample from individuals with COVID-19 Sample collection C827 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C827_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C827_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C828 Homo sapiens 9606 2021 Japan 64 SARS-CoV-2 COVID-19 234 serum Days 16-18 SAMD01815151 COVID-19_Lipid_C828 Serum sample from individuals with COVID-19 Sample collection C828 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C828_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C828_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C829 Homo sapiens 9606 2021 Japan 67 SARS-CoV-2 COVID-19 223 serum Days 10-12 SAMD01815152 COVID-19_Lipid_C829 Serum sample from individuals with COVID-19 Sample collection C829 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C829_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C829_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C83 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 21 serum Days 16-18 SAMD01815153 COVID-19_Lipid_C83 Serum sample from individuals with COVID-19 Sample collection C83 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C83_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C83_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C830 Homo sapiens 9606 2021 Japan 56 SARS-CoV-2 COVID-19 230 serum Days 1-3 SAMD01815154 COVID-19_Lipid_C830 Serum sample from individuals with COVID-19 Sample collection C830 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C830_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C830_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 1-3 C831 Homo sapiens 9606 2021 Japan 56 SARS-CoV-2 COVID-19 230 serum Days 4-6 SAMD01815155 COVID-19_Lipid_C831 Serum sample from individuals with COVID-19 Sample collection C831 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C831_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C831_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C832 Homo sapiens 9606 2021 Japan 77 SARS-CoV-2 COVID-19 225 serum Days 7-9 SAMD01815156 COVID-19_Lipid_C832 Serum sample from individuals with COVID-19 Sample collection C832 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C832_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C832_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C833 Homo sapiens 9606 2021 Japan 69 SARS-CoV-2 COVID-19 224 serum Days 13-15 SAMD01815157 COVID-19_Lipid_C833 Serum sample from individuals with COVID-19 Sample collection C833 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C833_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C833_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C834 Homo sapiens 9606 2021 Japan 56 SARS-CoV-2 COVID-19 231 serum Days 7-9 SAMD01815158 COVID-19_Lipid_C834 Serum sample from individuals with COVID-19 Sample collection C834 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C834_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C834_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C835 Homo sapiens 9606 2021 Japan 59 SARS-CoV-2 COVID-19 232 serum Days 7-9 SAMD01815159 COVID-19_Lipid_C835 Serum sample from individuals with COVID-19 Sample collection C835 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C835_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C835_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C836 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 227 serum Days 4-6 SAMD01815160 COVID-19_Lipid_C836 Serum sample from individuals with COVID-19 Sample collection C836 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C836_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C836_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C837 Homo sapiens 9606 2021 Japan 48 SARS-CoV-2 COVID-19 235 serum Days 4-6 SAMD01815161 COVID-19_Lipid_C837 Serum sample from individuals with COVID-19 Sample collection C837 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C837_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C837_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C838 Homo sapiens 9606 2021 Japan 21 SARS-CoV-2 COVID-19 233 serum Days 4-6 SAMD01815162 COVID-19_Lipid_C838 Serum sample from individuals with COVID-19 Sample collection C838 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C838_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C838_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C839 Homo sapiens 9606 2021 Japan 24 SARS-CoV-2 COVID-19 229 serum Days 1-3 SAMD01815163 COVID-19_Lipid_C839 Serum sample from individuals with COVID-19 Sample collection C839 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C839_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C839_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 1-3 C84 Homo sapiens 9606 2020 Japan 76 SARS-CoV-2 COVID-19 18 serum beyond Day 25 SAMD01815164 COVID-19_Lipid_C84 Serum sample from individuals with COVID-19 Sample collection C84 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C84_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C84_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C840 Homo sapiens 9606 2021 Japan 67 SARS-CoV-2 COVID-19 223 serum Days 13-15 SAMD01815165 COVID-19_Lipid_C840 Serum sample from individuals with COVID-19 Sample collection C840 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C840_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C840_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C841 Homo sapiens 9606 2021 Japan 69 SARS-CoV-2 COVID-19 224 serum Days 16-18 SAMD01815166 COVID-19_Lipid_C841 Serum sample from individuals with COVID-19 Sample collection C841 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C841_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C841_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C842 Homo sapiens 9606 2021 Japan 56 SARS-CoV-2 COVID-19 231 serum Days 10-12 SAMD01815167 COVID-19_Lipid_C842 Serum sample from individuals with COVID-19 Sample collection C842 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C842_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C842_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C843 Homo sapiens 9606 2021 Japan 24 SARS-CoV-2 COVID-19 229 serum Days 4-6 SAMD01815168 COVID-19_Lipid_C843 Serum sample from individuals with COVID-19 Sample collection C843 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C843_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C843_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C844 Homo sapiens 9606 2021 Japan 69 SARS-CoV-2 COVID-19 234 serum Days 19-24 SAMD01815169 COVID-19_Lipid_C844 Serum sample from individuals with COVID-19 Sample collection C844 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C844_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C844_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C845 Homo sapiens 9606 2021 Japan 48 SARS-CoV-2 COVID-19 235 serum Days 7-9 SAMD01815170 COVID-19_Lipid_C845 Serum sample from individuals with COVID-19 Sample collection C845 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C845_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C845_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C846 Homo sapiens 9606 2021 Japan 59 SARS-CoV-2 COVID-19 232 serum Days 10-12 SAMD01815171 COVID-19_Lipid_C846 Serum sample from individuals with COVID-19 Sample collection C846 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C846_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C846_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C847 Homo sapiens 9606 2021 Japan 56 SARS-CoV-2 COVID-19 230 serum Days 7-9 SAMD01815172 COVID-19_Lipid_C847 Serum sample from individuals with COVID-19 Sample collection C847 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C847_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C847_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C848 Homo sapiens 9606 2021 Japan 24 SARS-CoV-2 COVID-19 229 serum Days 7-9 SAMD01815173 COVID-19_Lipid_C848 Serum sample from individuals with COVID-19 Sample collection C848 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C848_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C848_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C849 Homo sapiens 9606 2021 Japan 69 SARS-CoV-2 COVID-19 224 serum Days 19-24 SAMD01815174 COVID-19_Lipid_C849 Serum sample from individuals with COVID-19 Sample collection C849 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C849_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C849_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C850 Homo sapiens 9606 2021 Japan 21 SARS-CoV-2 COVID-19 233 serum Days 7-9 SAMD01815175 COVID-19_Lipid_C850 Serum sample from individuals with COVID-19 Sample collection C850 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C850_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C850_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C851 Homo sapiens 9606 2021 Japan 48 SARS-CoV-2 COVID-19 235 serum Days 10-12 SAMD01815176 COVID-19_Lipid_C851 Serum sample from individuals with COVID-19 Sample collection C851 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C851_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C851_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C852 Homo sapiens 9606 2021 Japan 67 SARS-CoV-2 COVID-19 223 serum Days 16-18 SAMD01815177 COVID-19_Lipid_C852 Serum sample from individuals with COVID-19 Sample collection C852 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C852_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C852_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C853 Homo sapiens 9606 2021 Japan 77 SARS-CoV-2 COVID-19 225 serum Days 10-12 SAMD01815178 COVID-19_Lipid_C853 Serum sample from individuals with COVID-19 Sample collection C853 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C853_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C853_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C854 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 227 serum Days 7-9 SAMD01815179 COVID-19_Lipid_C854 Serum sample from individuals with COVID-19 Sample collection C854 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C854_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C854_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C855 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 227 serum Days 10-12 SAMD01815180 COVID-19_Lipid_C855 Serum sample from individuals with COVID-19 Sample collection C855 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C855_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C855_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C856 Homo sapiens 9606 2021 Japan 56 SARS-CoV-2 COVID-19 230 serum Days 10-12 SAMD01815181 COVID-19_Lipid_C856 Serum sample from individuals with COVID-19 Sample collection C856 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C856_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C856_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C857 Homo sapiens 9606 2021 Japan 21 SARS-CoV-2 COVID-19 233 serum Days 10-12 SAMD01815182 COVID-19_Lipid_C857 Serum sample from individuals with COVID-19 Sample collection C857 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C857_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C857_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C858 Homo sapiens 9606 2021 Japan 77 SARS-CoV-2 COVID-19 225 serum Days 13-15 SAMD01815183 COVID-19_Lipid_C858 Serum sample from individuals with COVID-19 Sample collection C858 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C858_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C858_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C859 Homo sapiens 9606 2021 Japan 77 SARS-CoV-2 COVID-19 225 serum Days 16-18 SAMD01815184 COVID-19_Lipid_C859 Serum sample from individuals with COVID-19 Sample collection C859 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C859_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C859_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C86 Homo sapiens 9606 2020 Japan 65 SARS-CoV-2 COVID-19 25 serum Days 7-9 SAMD01815185 COVID-19_Lipid_C86 Serum sample from individuals with COVID-19 Sample collection C86 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C86_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C86_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C860 Homo sapiens 9606 2021 Japan 56 SARS-CoV-2 COVID-19 231 serum Days 13-15 SAMD01815186 COVID-19_Lipid_C860 Serum sample from individuals with COVID-19 Sample collection C860 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C860_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C860_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C861 Homo sapiens 9606 2021 Japan 56 SARS-CoV-2 COVID-19 231 serum Days 16-18 SAMD01815187 COVID-19_Lipid_C861 Serum sample from individuals with COVID-19 Sample collection C861 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C861_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C861_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C862 Homo sapiens 9606 2021 Japan 67 SARS-CoV-2 COVID-19 223 serum Days 19-24 SAMD01815188 COVID-19_Lipid_C862 Serum sample from individuals with COVID-19 Sample collection C862 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C862_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C862_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C863 Homo sapiens 9606 2021 Japan 48 SARS-CoV-2 COVID-19 235 serum Days 13-15 SAMD01815189 COVID-19_Lipid_C863 Serum sample from individuals with COVID-19 Sample collection C863 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C863_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C863_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C864 Homo sapiens 9606 2021 Japan 56 SARS-CoV-2 COVID-19 230 serum Days 13-15 SAMD01815190 COVID-19_Lipid_C864 Serum sample from individuals with COVID-19 Sample collection C864 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C864_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C864_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C865 Homo sapiens 9606 2021 Japan 69 SARS-CoV-2 COVID-19 234 serum beyond Day 25 SAMD01815191 COVID-19_Lipid_C865 Serum sample from individuals with COVID-19 Sample collection C865 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C865_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C865_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C866 Homo sapiens 9606 2021 Japan 56 SARS-CoV-2 COVID-19 231 serum Days 19-24 SAMD01815192 COVID-19_Lipid_C866 Serum sample from individuals with COVID-19 Sample collection C866 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C866_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C866_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C867 Homo sapiens 9606 2021 Japan 77 SARS-CoV-2 COVID-19 225 serum Days 19-24 SAMD01815193 COVID-19_Lipid_C867 Serum sample from individuals with COVID-19 Sample collection C867 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C867_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C867_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C868 Homo sapiens 9606 2021 Japan 56 SARS-CoV-2 COVID-19 231 serum beyond Day 25 SAMD01815194 COVID-19_Lipid_C868 Serum sample from individuals with COVID-19 Sample collection C868 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C868_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C868_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C869 Homo sapiens 9606 2021 Japan 67 SARS-CoV-2 COVID-19 223 serum beyond Day 25 SAMD01815195 COVID-19_Lipid_C869 Serum sample from individuals with COVID-19 Sample collection C869 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C869_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C869_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C87 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 23 serum Days 10-12 SAMD01815196 COVID-19_Lipid_C87 Serum sample from individuals with COVID-19 Sample collection C87 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C87_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C87_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C870 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 227 serum Days 19-24 SAMD01815197 COVID-19_Lipid_C870 Serum sample from individuals with COVID-19 Sample collection C870 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C870_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C870_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C871 Homo sapiens 9606 2021 Japan 77 SARS-CoV-2 COVID-19 225 serum beyond Day 25 SAMD01815198 COVID-19_Lipid_C871 Serum sample from individuals with COVID-19 Sample collection C871 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C871_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C871_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C872 Homo sapiens 9606 2021 Japan 57 SARS-CoV-2 COVID-19 230 serum beyond Day 25 SAMD01815199 COVID-19_Lipid_C872 Serum sample from individuals with COVID-19 Sample collection C872 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C872_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C872_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C88 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 26 serum Days 7-9 SAMD01815200 COVID-19_Lipid_C88 Serum sample from individuals with COVID-19 Sample collection C88 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C88_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C88_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C89 Homo sapiens 9606 2020 Japan 89 SARS-CoV-2 COVID-19 27 serum Days 10-12 SAMD01815201 COVID-19_Lipid_C89 Serum sample from individuals with COVID-19 Sample collection C89 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C89_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C89_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C9 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 19 serum Days 10-12 SAMD01815202 COVID-19_Lipid_C9 Serum sample from individuals with COVID-19 Sample collection C9 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C9_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C9_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C91 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 23 serum Days 13-15 SAMD01815203 COVID-19_Lipid_C91 Serum sample from individuals with COVID-19 Sample collection C91 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C91_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C91_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C92 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 19 serum beyond Day 25 SAMD01815204 COVID-19_Lipid_C92 Serum sample from individuals with COVID-19 Sample collection C92 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C92_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C92_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 beyond Day 25 C93 Homo sapiens 9606 2020 Japan 40 SARS-CoV-2 COVID-19 28 serum Days 4-6 SAMD01815205 COVID-19_Lipid_C93 Serum sample from individuals with COVID-19 Sample collection C93 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C93_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C93_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 4-6 C94 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 23 serum Days 16-18 SAMD01815206 COVID-19_Lipid_C94 Serum sample from individuals with COVID-19 Sample collection C94 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C94_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C94_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 16-18 C95 Homo sapiens 9606 2020 Japan 65 SARS-CoV-2 COVID-19 25 serum Days 10-12 SAMD01815207 COVID-19_Lipid_C95 Serum sample from individuals with COVID-19 Sample collection C95 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C95_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C95_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 10-12 C96 Homo sapiens 9606 2020 Japan 65 SARS-CoV-2 COVID-19 25 serum Days 13-15 SAMD01815208 COVID-19_Lipid_C96 Serum sample from individuals with COVID-19 Sample collection C96 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C96_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C96_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C97 Homo sapiens 9606 2020 Japan 40 SARS-CoV-2 COVID-19 28 serum Days 7-9 SAMD01815209 COVID-19_Lipid_C97 Serum sample from individuals with COVID-19 Sample collection C97 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C97_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C97_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 7-9 C98 Homo sapiens 9606 2020 Japan 89 SARS-CoV-2 COVID-19 27 serum Days 13-15 SAMD01815210 COVID-19_Lipid_C98 Serum sample from individuals with COVID-19 Sample collection C98 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C98_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C98_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 13-15 C99 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 21 serum Days 19-24 SAMD01815211 COVID-19_Lipid_C99 Serum sample from individuals with COVID-19 Sample collection C99 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C99_ext Chromatography 1 LC8060 system (Shimadzu) missing missing missing missing Mass spectrometry 1 missing MRM mode missing missing triple quadrupole C99_ext_LCMS_Pos_Glycerophospholipid Data processing 1 processed/MTBKS279_Glycerophospholipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 1 Days 19-24 C1 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 11 serum Days 16-18 SAMD01814353 COVID-19_Lipid_C1 Serum sample from individuals with COVID-19 Sample collection C1 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C1_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C1_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C10 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 19 serum Days 13-15 SAMD01814354 COVID-19_Lipid_C10 Serum sample from individuals with COVID-19 Sample collection C10 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C10_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C10_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C100 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 26 serum Days 13-15 SAMD01814355 COVID-19_Lipid_C100 Serum sample from individuals with COVID-19 Sample collection C100 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C100_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C100_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C101 Homo sapiens 9606 2020 Japan 40 SARS-CoV-2 COVID-19 28 serum Days 10-12 SAMD01814356 COVID-19_Lipid_C101 Serum sample from individuals with COVID-19 Sample collection C101 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C101_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C101_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C102 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 16 serum beyond Day 25 SAMD01814357 COVID-19_Lipid_C102 Serum sample from individuals with COVID-19 Sample collection C102 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C102_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C102_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C103 Homo sapiens 9606 2020 Japan 71 SARS-CoV-2 COVID-19 20 serum beyond Day 25 SAMD01814358 COVID-19_Lipid_C103 Serum sample from individuals with COVID-19 Sample collection C103 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C103_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C103_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C104 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 26 serum Days 16-18 SAMD01814359 COVID-19_Lipid_C104 Serum sample from individuals with COVID-19 Sample collection C104 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C104_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C104_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C105 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 23 serum Days 19-24 SAMD01814360 COVID-19_Lipid_C105 Serum sample from individuals with COVID-19 Sample collection C105 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C105_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C105_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C106 Homo sapiens 9606 2020 Japan 89 SARS-CoV-2 COVID-19 27 serum Days 16-18 SAMD01814361 COVID-19_Lipid_C106 Serum sample from individuals with COVID-19 Sample collection C106 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C106_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C106_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C107 Homo sapiens 9606 2020 Japan 76 SARS-CoV-2 COVID-19 22 serum Days 19-24 SAMD01814362 COVID-19_Lipid_C107 Serum sample from individuals with COVID-19 Sample collection C107 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C107_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C107_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C108 Homo sapiens 9606 2020 Japan 65 SARS-CoV-2 COVID-19 25 serum Days 16-18 SAMD01814363 COVID-19_Lipid_C108 Serum sample from individuals with COVID-19 Sample collection C108 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C108_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C108_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C109 Homo sapiens 9606 2020 Japan 65 SARS-CoV-2 COVID-19 25 serum Days 19-24 SAMD01814364 COVID-19_Lipid_C109 Serum sample from individuals with COVID-19 Sample collection C109 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C109_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C109_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C11 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 15 serum Days 16-18 SAMD01814365 COVID-19_Lipid_C11 Serum sample from individuals with COVID-19 Sample collection C11 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C11_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C11_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C110 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 21 serum beyond Day 25 SAMD01814366 COVID-19_Lipid_C110 Serum sample from individuals with COVID-19 Sample collection C110 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C110_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C110_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C111 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 26 serum Days 19-24 SAMD01814367 COVID-19_Lipid_C111 Serum sample from individuals with COVID-19 Sample collection C111 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C111_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C111_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C113 Homo sapiens 9606 2020 Japan 40 SARS-CoV-2 COVID-19 28 serum Days 16-18 SAMD01814368 COVID-19_Lipid_C113 Serum sample from individuals with COVID-19 Sample collection C113 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C113_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C113_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C114 Homo sapiens 9606 2020 Japan 89 SARS-CoV-2 COVID-19 27 serum Days 19-24 SAMD01814369 COVID-19_Lipid_C114 Serum sample from individuals with COVID-19 Sample collection C114 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C114_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C114_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C115 Homo sapiens 9606 2020 Japan 40 SARS-CoV-2 COVID-19 28 serum Days 19-24 SAMD01814370 COVID-19_Lipid_C115 Serum sample from individuals with COVID-19 Sample collection C115 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C115_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C115_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C116 Homo sapiens 9606 2020 Japan 68 SARS-CoV-2 COVID-19 1 serum beyond Day 25 SAMD01814371 COVID-19_Lipid_C116 Serum sample from individuals with COVID-19 Sample collection C116 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C116_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C116_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C117 Homo sapiens 9606 2020 Japan 76 SARS-CoV-2 COVID-19 22 serum beyond Day 25 SAMD01814372 COVID-19_Lipid_C117 Serum sample from individuals with COVID-19 Sample collection C117 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C117_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C117_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C118 Homo sapiens 9606 2020 Japan 89 SARS-CoV-2 COVID-19 27 serum beyond Day 25 SAMD01814373 COVID-19_Lipid_C118 Serum sample from individuals with COVID-19 Sample collection C118 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C118_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C118_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C119 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 26 serum beyond Day 25 SAMD01814374 COVID-19_Lipid_C119 Serum sample from individuals with COVID-19 Sample collection C119 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C119_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C119_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C12 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 15 serum Days 19-24 SAMD01814375 COVID-19_Lipid_C12 Serum sample from individuals with COVID-19 Sample collection C12 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C12_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C12_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C120 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 29 serum pre-onset SAMD01814376 COVID-19_Lipid_C120 Serum sample from individuals with COVID-19 Sample collection C120 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C120_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C120_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 pre-onset C121 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 29 serum Days 1-3 SAMD01814377 COVID-19_Lipid_C121 Serum sample from individuals with COVID-19 Sample collection C121 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C121_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C121_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 1-3 C122 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 29 serum Days 4-6 SAMD01814378 COVID-19_Lipid_C122 Serum sample from individuals with COVID-19 Sample collection C122 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C122_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C122_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C123 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 29 serum Days 7-9 SAMD01814379 COVID-19_Lipid_C123 Serum sample from individuals with COVID-19 Sample collection C123 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C123_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C123_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C124 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 29 serum Days 10-12 SAMD01814380 COVID-19_Lipid_C124 Serum sample from individuals with COVID-19 Sample collection C124 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C124_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C124_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C125 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 29 serum Days 13-15 SAMD01814381 COVID-19_Lipid_C125 Serum sample from individuals with COVID-19 Sample collection C125 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C125_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C125_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C126 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 29 serum Days 16-18 SAMD01814382 COVID-19_Lipid_C126 Serum sample from individuals with COVID-19 Sample collection C126 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C126_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C126_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C127 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 29 serum Days 19-24 SAMD01814383 COVID-19_Lipid_C127 Serum sample from individuals with COVID-19 Sample collection C127 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C127_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C127_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C128 Homo sapiens 9606 2020 Japan 24 SARS-CoV-2 COVID-19 3 serum beyond Day 25 SAMD01814384 COVID-19_Lipid_C128 Serum sample from individuals with COVID-19 Sample collection C128 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C128_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C128_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C129 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 17 serum beyond Day 25 SAMD01814385 COVID-19_Lipid_C129 Serum sample from individuals with COVID-19 Sample collection C129 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C129_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C129_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C13 Homo sapiens 9606 2020 Japan 76 SARS-CoV-2 COVID-19 18 serum Days 10-12 SAMD01814386 COVID-19_Lipid_C13 Serum sample from individuals with COVID-19 Sample collection C13 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C13_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C13_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C130 Homo sapiens 9606 2020 Japan 40 SARS-CoV-2 COVID-19 28 serum beyond Day 25 SAMD01814387 COVID-19_Lipid_C130 Serum sample from individuals with COVID-19 Sample collection C130 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C130_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C130_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C131 Homo sapiens 9606 2020 Japan 65 SARS-CoV-2 COVID-19 25 serum beyond Day 25 SAMD01814388 COVID-19_Lipid_C131 Serum sample from individuals with COVID-19 Sample collection C131 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C131_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C131_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C132 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 23 serum beyond Day 25 SAMD01814389 COVID-19_Lipid_C132 Serum sample from individuals with COVID-19 Sample collection C132 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C132_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C132_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C133 Homo sapiens 9606 2020 Japan 77 SARS-CoV-2 COVID-19 6 serum beyond Day 25 SAMD01814390 COVID-19_Lipid_C133 Serum sample from individuals with COVID-19 Sample collection C133 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C133_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C133_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C137 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 31 serum Days 4-6 SAMD01814391 COVID-19_Lipid_C137 Serum sample from individuals with COVID-19 Sample collection C137 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C137_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C137_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C138 Homo sapiens 9606 2020 Japan 92 SARS-CoV-2 COVID-19 32 serum Days 4-6 SAMD01814392 COVID-19_Lipid_C138 Serum sample from individuals with COVID-19 Sample collection C138 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C138_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C138_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C139 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 33 serum pre-onset SAMD01814393 COVID-19_Lipid_C139 Serum sample from individuals with COVID-19 Sample collection C139 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C139_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C139_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 pre-onset C14 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 serum SAMD01814394 COVID-19_Lipid_C14 Serum sample from individuals with COVID-19 Sample collection C14 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C14_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C14_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 missing C140 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 33 serum Days 4-6 SAMD01814395 COVID-19_Lipid_C140 Serum sample from individuals with COVID-19 Sample collection C140 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C140_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C140_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C141 Homo sapiens 9606 2020 Japan 92 SARS-CoV-2 COVID-19 31 serum Days 7-9 SAMD01814396 COVID-19_Lipid_C141 Serum sample from individuals with COVID-19 Sample collection C141 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C141_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C141_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C142 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 32 serum Days 7-9 SAMD01814397 COVID-19_Lipid_C142 Serum sample from individuals with COVID-19 Sample collection C142 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C142_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C142_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C145 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 30 serum Days 16-18 SAMD01814398 COVID-19_Lipid_C145 Serum sample from individuals with COVID-19 Sample collection C145 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C145_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C145_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C146 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 33 serum Days 10-12 SAMD01814399 COVID-19_Lipid_C146 Serum sample from individuals with COVID-19 Sample collection C146 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C146_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C146_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C148 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 30 serum Days 19-24 SAMD01814400 COVID-19_Lipid_C148 Serum sample from individuals with COVID-19 Sample collection C148 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C148_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C148_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C149 Homo sapiens 9606 2020 Japan 76 SARS-CoV-2 COVID-19 31 serum Days 10-12 SAMD01814401 COVID-19_Lipid_C149 Serum sample from individuals with COVID-19 Sample collection C149 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C149_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C149_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C15 Homo sapiens 9606 2020 Japan 76 SARS-CoV-2 COVID-19 18 serum Days 16-18 SAMD01916070 COVID-19_Lipid_C15 Serum sample from individuals with COVID-19 Sample collection C15 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C15_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C15_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C150 Homo sapiens 9606 2020 Japan 92 SARS-CoV-2 COVID-19 32 serum Days 13-15 SAMD01814402 COVID-19_Lipid_C150 Serum sample from individuals with COVID-19 Sample collection C150 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C150_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C150_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C151 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 33 serum Days 13-15 SAMD01814403 COVID-19_Lipid_C151 Serum sample from individuals with COVID-19 Sample collection C151 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C151_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C151_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C152 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 33 serum Days 16-18 SAMD01814404 COVID-19_Lipid_C152 Serum sample from individuals with COVID-19 Sample collection C152 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C152_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C152_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C153 Homo sapiens 9606 2020 Japan 92 SARS-CoV-2 COVID-19 32 serum Days 16-18 SAMD01814405 COVID-19_Lipid_C153 Serum sample from individuals with COVID-19 Sample collection C153 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C153_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C153_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C154 Homo sapiens 9606 2020 Japan 74 SARS-CoV-2 COVID-19 34 serum Days 10-12 SAMD01814406 COVID-19_Lipid_C154 Serum sample from individuals with COVID-19 Sample collection C154 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C154_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C154_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C155 Homo sapiens 9606 2020 Japan 74 SARS-CoV-2 COVID-19 34 serum Days 13-15 SAMD01814407 COVID-19_Lipid_C155 Serum sample from individuals with COVID-19 Sample collection C155 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C155_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C155_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C156 Homo sapiens 9606 2020 Japan 92 SARS-CoV-2 COVID-19 32 serum Days 19-24 SAMD01814408 COVID-19_Lipid_C156 Serum sample from individuals with COVID-19 Sample collection C156 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C156_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C156_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C157 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 33 serum Days 19-24 SAMD01814409 COVID-19_Lipid_C157 Serum sample from individuals with COVID-19 Sample collection C157 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C157_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C157_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C158 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 29 serum beyond Day 25 SAMD01814410 COVID-19_Lipid_C158 Serum sample from individuals with COVID-19 Sample collection C158 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C158_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C158_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C159 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 35 serum Days 10-12 SAMD01814411 COVID-19_Lipid_C159 Serum sample from individuals with COVID-19 Sample collection C159 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C159_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C159_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C16 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 17 serum Days 10-12 SAMD01814412 COVID-19_Lipid_C16 Serum sample from individuals with COVID-19 Sample collection C16 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C16_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C16_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C160 Homo sapiens 9606 2020 Japan 74 SARS-CoV-2 COVID-19 34 serum Days 16-18 SAMD01814413 COVID-19_Lipid_C160 Serum sample from individuals with COVID-19 Sample collection C160 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C160_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C160_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C161 Homo sapiens 9606 2020 Japan 87 SARS-CoV-2 COVID-19 36 serum Days 7-9 SAMD01814414 COVID-19_Lipid_C161 Serum sample from individuals with COVID-19 Sample collection C161 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C161_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C161_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C162 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 30 serum beyond Day 25 SAMD01814415 COVID-19_Lipid_C162 Serum sample from individuals with COVID-19 Sample collection C162 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C162_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C162_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C163 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 35 serum Days 13-15 SAMD01814416 COVID-19_Lipid_C163 Serum sample from individuals with COVID-19 Sample collection C163 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C163_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C163_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C164 Homo sapiens 9606 2020 Japan 66 SARS-CoV-2 COVID-19 37 serum Days 13-15 SAMD01814417 COVID-19_Lipid_C164 Serum sample from individuals with COVID-19 Sample collection C164 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C164_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C164_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C165 Homo sapiens 9606 2020 Japan 74 SARS-CoV-2 COVID-19 34 serum Days 19-24 SAMD01814418 COVID-19_Lipid_C165 Serum sample from individuals with COVID-19 Sample collection C165 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C165_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C165_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C166 Homo sapiens 9606 2020 Japan 66 SARS-CoV-2 COVID-19 37 serum Days 16-18 SAMD01814419 COVID-19_Lipid_C166 Serum sample from individuals with COVID-19 Sample collection C166 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C166_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C166_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C167 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 35 serum Days 16-18 SAMD01814420 COVID-19_Lipid_C167 Serum sample from individuals with COVID-19 Sample collection C167 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C167_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C167_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C168 Homo sapiens 9606 2020 Japan 92 SARS-CoV-2 COVID-19 32 serum beyond Day 25 SAMD01814421 COVID-19_Lipid_C168 Serum sample from individuals with COVID-19 Sample collection C168 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C168_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C168_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C169 Homo sapiens 9606 2020 Japan 38 SARS-CoV-2 COVID-19 38 serum Days 10-12 SAMD01814422 COVID-19_Lipid_C169 Serum sample from individuals with COVID-19 Sample collection C169 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C169_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C169_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C17 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 17 serum Days 13-15 SAMD01814423 COVID-19_Lipid_C17 Serum sample from individuals with COVID-19 Sample collection C17 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C17_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C17_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C170 Homo sapiens 9606 2020 Japan 34 SARS-CoV-2 COVID-19 39 serum Days 7-9 SAMD01814424 COVID-19_Lipid_C170 Serum sample from individuals with COVID-19 Sample collection C170 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C170_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C170_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C171 Homo sapiens 9606 2020 Japan 66 SARS-CoV-2 COVID-19 37 serum Days 19-24 SAMD01814425 COVID-19_Lipid_C171 Serum sample from individuals with COVID-19 Sample collection C171 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C171_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C171_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C172 Homo sapiens 9606 2020 Japan 87 SARS-CoV-2 COVID-19 36 serum Days 10-12 SAMD01814426 COVID-19_Lipid_C172 Serum sample from individuals with COVID-19 Sample collection C172 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C172_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C172_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C173 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 33 serum beyond Day 25 SAMD01814427 COVID-19_Lipid_C173 Serum sample from individuals with COVID-19 Sample collection C173 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C173_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C173_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C174 Homo sapiens 9606 2020 Japan 87 SARS-CoV-2 COVID-19 36 serum Days 16-18 SAMD01814428 COVID-19_Lipid_C174 Serum sample from individuals with COVID-19 Sample collection C174 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C174_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C174_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C175 Homo sapiens 9606 2020 Japan 51 SARS-CoV-2 COVID-19 40 serum Days 4-6 SAMD01814429 COVID-19_Lipid_C175 Serum sample from individuals with COVID-19 Sample collection C175 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C175_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C175_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C176 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 35 serum Days 19-24 SAMD01814430 COVID-19_Lipid_C176 Serum sample from individuals with COVID-19 Sample collection C176 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C176_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C176_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C177 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 40 serum Days 1-3 SAMD01814431 COVID-19_Lipid_C177 Serum sample from individuals with COVID-19 Sample collection C177 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C177_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C177_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 1-3 C178 Homo sapiens 9606 2020 Japan 87 SARS-CoV-2 COVID-19 36 serum Days 13-15 SAMD01814432 COVID-19_Lipid_C178 Serum sample from individuals with COVID-19 Sample collection C178 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C178_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C178_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C179 Homo sapiens 9606 2020 Japan 61 SARS-CoV-2 COVID-19 41 serum Days 4-6 SAMD01814433 COVID-19_Lipid_C179 Serum sample from individuals with COVID-19 Sample collection C179 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C179_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C179_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C18 Homo sapiens 9606 2020 Japan 77 SARS-CoV-2 COVID-19 6 serum Days 13-15 SAMD01814434 COVID-19_Lipid_C18 Serum sample from individuals with COVID-19 Sample collection C18 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C18_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C18_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C180 Homo sapiens 9606 2020 Japan 61 SARS-CoV-2 COVID-19 41 serum Days 7-9 SAMD01814435 COVID-19_Lipid_C180 Serum sample from individuals with COVID-19 Sample collection C180 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C180_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C180_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C181 Homo sapiens 9606 2020 Japan 61 SARS-CoV-2 COVID-19 41 serum Days 10-12 SAMD01814436 COVID-19_Lipid_C181 Serum sample from individuals with COVID-19 Sample collection C181 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C181_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C181_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C182 Homo sapiens 9606 2020 Japan 47 SARS-CoV-2 COVID-19 42 serum Days 7-9 SAMD01814437 COVID-19_Lipid_C182 Serum sample from individuals with COVID-19 Sample collection C182 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C182_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C182_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C183 Homo sapiens 9606 2020 Japan 47 SARS-CoV-2 COVID-19 42 serum Days 10-12 SAMD01814438 COVID-19_Lipid_C183 Serum sample from individuals with COVID-19 Sample collection C183 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C183_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C183_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C184 Homo sapiens 9606 2020 Japan 84 SARS-CoV-2 COVID-19 43 serum Days 7-9 SAMD01814439 COVID-19_Lipid_C184 Serum sample from individuals with COVID-19 Sample collection C184 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C184_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C184_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C185 Homo sapiens 9606 2020 Japan 38 SARS-CoV-2 COVID-19 44 serum Days 10-12 SAMD01814440 COVID-19_Lipid_C185 Serum sample from individuals with COVID-19 Sample collection C185 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C185_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C185_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C186 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 45 serum Days 4-6 SAMD01814441 COVID-19_Lipid_C186 Serum sample from individuals with COVID-19 Sample collection C186 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C186_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C186_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C187 Homo sapiens 9606 2020 Japan 84 SARS-CoV-2 COVID-19 43 serum Days 10-12 SAMD01814442 COVID-19_Lipid_C187 Serum sample from individuals with COVID-19 Sample collection C187 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C187_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C187_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C188 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 45 serum Days 7-9 SAMD01814443 COVID-19_Lipid_C188 Serum sample from individuals with COVID-19 Sample collection C188 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C188_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C188_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C189 Homo sapiens 9606 2020 Japan 65 SARS-CoV-2 COVID-19 46 serum Days 4-6 SAMD01814444 COVID-19_Lipid_C189 Serum sample from individuals with COVID-19 Sample collection C189 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C189_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C189_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C19 Homo sapiens 9606 2020 Japan 77 SARS-CoV-2 COVID-19 6 serum Days 16-18 SAMD01814445 COVID-19_Lipid_C19 Serum sample from individuals with COVID-19 Sample collection C19 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C19_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C19_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C190 Homo sapiens 9606 2020 Japan 65 SARS-CoV-2 COVID-19 46 serum Days 7-9 SAMD01814446 COVID-19_Lipid_C190 Serum sample from individuals with COVID-19 Sample collection C190 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C190_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C190_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C191 Homo sapiens 9606 2020 Japan 80 SARS-CoV-2 COVID-19 47 serum Days 4-6 SAMD01814447 COVID-19_Lipid_C191 Serum sample from individuals with COVID-19 Sample collection C191 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C191_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C191_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C192 Homo sapiens 9606 2020 Japan 80 SARS-CoV-2 COVID-19 47 serum Days 7-9 SAMD01814448 COVID-19_Lipid_C192 Serum sample from individuals with COVID-19 Sample collection C192 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C192_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C192_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C193 Homo sapiens 9606 2020 Japan 84 SARS-CoV-2 COVID-19 43 serum Days 13-15 SAMD01814449 COVID-19_Lipid_C193 Serum sample from individuals with COVID-19 Sample collection C193 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C193_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C193_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C194 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 48 serum Days 10-12 SAMD01814450 COVID-19_Lipid_C194 Serum sample from individuals with COVID-19 Sample collection C194 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C194_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C194_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C195 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 48 serum Days 13-15 SAMD01814451 COVID-19_Lipid_C195 Serum sample from individuals with COVID-19 Sample collection C195 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C195_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C195_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C196 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 48 serum Days 16-18 SAMD01814452 COVID-19_Lipid_C196 Serum sample from individuals with COVID-19 Sample collection C196 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C196_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C196_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C197 Homo sapiens 9606 2020 Japan 84 SARS-CoV-2 COVID-19 43 serum Days 16-18 SAMD01814453 COVID-19_Lipid_C197 Serum sample from individuals with COVID-19 Sample collection C197 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C197_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C197_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C198 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 45 serum Days 10-12 SAMD01814454 COVID-19_Lipid_C198 Serum sample from individuals with COVID-19 Sample collection C198 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C198_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C198_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C199 Homo sapiens 9606 2020 Japan 65 SARS-CoV-2 COVID-19 46 serum Days 10-12 SAMD01814455 COVID-19_Lipid_C199 Serum sample from individuals with COVID-19 Sample collection C199 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C199_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C199_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C2 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 13 serum Days 7-9 SAMD01814456 COVID-19_Lipid_C2 Serum sample from individuals with COVID-19 Sample collection C2 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C2_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C2_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C20 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 17 serum Days 16-18 SAMD01814457 COVID-19_Lipid_C20 Serum sample from individuals with COVID-19 Sample collection C20 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C20_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C20_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C200 Homo sapiens 9606 2020 Japan 87 SARS-CoV-2 COVID-19 49 serum Days 4-6 SAMD01814458 COVID-19_Lipid_C200 Serum sample from individuals with COVID-19 Sample collection C200 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C200_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C200_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C201 Homo sapiens 9606 2020 Japan 87 SARS-CoV-2 COVID-19 49 serum Days 10-12 SAMD01814459 COVID-19_Lipid_C201 Serum sample from individuals with COVID-19 Sample collection C201 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C201_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C201_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C202 Homo sapiens 9606 2020 Japan 80 SARS-CoV-2 COVID-19 47 serum Days 10-12 SAMD01814460 COVID-19_Lipid_C202 Serum sample from individuals with COVID-19 Sample collection C202 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C202_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C202_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C203 Homo sapiens 9606 2020 Japan 65 SARS-CoV-2 COVID-19 46 serum Days 13-15 SAMD01814461 COVID-19_Lipid_C203 Serum sample from individuals with COVID-19 Sample collection C203 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C203_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C203_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C204 Homo sapiens 9606 2020 Japan 74 SARS-CoV-2 COVID-19 34 serum beyond Day 25 SAMD01814462 COVID-19_Lipid_C204 Serum sample from individuals with COVID-19 Sample collection C204 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C204_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C204_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C205 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 48 serum Days 19-24 SAMD01814463 COVID-19_Lipid_C205 Serum sample from individuals with COVID-19 Sample collection C205 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C205_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C205_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C206 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 45 serum Days 13-15 SAMD01814464 COVID-19_Lipid_C206 Serum sample from individuals with COVID-19 Sample collection C206 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C206_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C206_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C207 Homo sapiens 9606 2020 Japan 84 SARS-CoV-2 COVID-19 43 serum Days 19-24 SAMD01814465 COVID-19_Lipid_C207 Serum sample from individuals with COVID-19 Sample collection C207 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C207_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C207_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C208 Homo sapiens 9606 2020 Japan 87 SARS-CoV-2 COVID-19 49 serum Days 13-15 SAMD01814466 COVID-19_Lipid_C208 Serum sample from individuals with COVID-19 Sample collection C208 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C208_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C208_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C209 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 50 serum Days 10-12 SAMD01814467 COVID-19_Lipid_C209 Serum sample from individuals with COVID-19 Sample collection C209 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C209_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C209_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C21 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 7 serum Days 10-12 SAMD01814468 COVID-19_Lipid_C21 Serum sample from individuals with COVID-19 Sample collection C21 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C21_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C21_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C210 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 50 serum Days 13-15 SAMD01814469 COVID-19_Lipid_C210 Serum sample from individuals with COVID-19 Sample collection C210 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C210_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C210_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C211 Homo sapiens 9606 2020 Japan 87 SARS-CoV-2 COVID-19 49 serum Days 16-18 SAMD01814470 COVID-19_Lipid_C211 Serum sample from individuals with COVID-19 Sample collection C211 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C211_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C211_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C212 Homo sapiens 9606 2020 Japan 80 SARS-CoV-2 COVID-19 47 serum Days 16-18 SAMD01814471 COVID-19_Lipid_C212 Serum sample from individuals with COVID-19 Sample collection C212 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C212_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C212_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C213 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 45 serum Days 19-24 SAMD01814472 COVID-19_Lipid_C213 Serum sample from individuals with COVID-19 Sample collection C213 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C213_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C213_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C214 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 50 serum Days 13-15 SAMD01814473 COVID-19_Lipid_C214 Serum sample from individuals with COVID-19 Sample collection C214 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C214_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C214_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C215 Homo sapiens 9606 2020 Japan 87 SARS-CoV-2 COVID-19 49 serum Days 19-24 SAMD01814474 COVID-19_Lipid_C215 Serum sample from individuals with COVID-19 Sample collection C215 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C215_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C215_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C216 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 50 serum Days 16-18 SAMD01814475 COVID-19_Lipid_C216 Serum sample from individuals with COVID-19 Sample collection C216 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C216_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C216_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C217 Homo sapiens 9606 2020 Japan 48 SARS-CoV-2 COVID-19 42 serum beyond Day 25 SAMD01814476 COVID-19_Lipid_C217 Serum sample from individuals with COVID-19 Sample collection C217 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C217_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C217_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C218 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 50 serum Days 19-24 SAMD01814477 COVID-19_Lipid_C218 Serum sample from individuals with COVID-19 Sample collection C218 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C218_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C218_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C219 Homo sapiens 9606 2020 Japan 66 SARS-CoV-2 COVID-19 37 serum beyond Day 25 SAMD01814478 COVID-19_Lipid_C219 Serum sample from individuals with COVID-19 Sample collection C219 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C219_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C219_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C22 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 7 serum Days 13-15 SAMD01814479 COVID-19_Lipid_C22 Serum sample from individuals with COVID-19 Sample collection C22 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C22_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C22_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C220 Homo sapiens 9606 2020 Japan 74 SARS-CoV-2 COVID-19 53 serum SAMD01814480 COVID-19_Lipid_C220 Serum sample from individuals with COVID-19 Sample collection C220 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C220_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C220_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 missing C221 Homo sapiens 9606 2020 Japan 19 SARS-CoV-2 COVID-19 52 serum SAMD01814481 COVID-19_Lipid_C221 Serum sample from individuals with COVID-19 Sample collection C221 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C221_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C221_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 missing C222 Homo sapiens 9606 2020 Japan 87 SARS-CoV-2 COVID-19 49 serum beyond Day 25 SAMD01814482 COVID-19_Lipid_C222 Serum sample from individuals with COVID-19 Sample collection C222 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C222_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C222_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C223 Homo sapiens 9606 2020 Japan 74 SARS-CoV-2 COVID-19 53 serum SAMD01814483 COVID-19_Lipid_C223 Serum sample from individuals with COVID-19 Sample collection C223 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C223_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C223_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 missing C224 Homo sapiens 9606 2020 Japan 74 SARS-CoV-2 COVID-19 53 serum SAMD01814484 COVID-19_Lipid_C224 Serum sample from individuals with COVID-19 Sample collection C224 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C224_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C224_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 missing C225 Homo sapiens 9606 2020 Japan 92 SARS-CoV-2 COVID-19 54 serum Days 7-9 SAMD01814485 COVID-19_Lipid_C225 Serum sample from individuals with COVID-19 Sample collection C225 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C225_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C225_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C226 Homo sapiens 9606 2020 Japan 84 SARS-CoV-2 COVID-19 43 serum beyond Day 25 SAMD01814486 COVID-19_Lipid_C226 Serum sample from individuals with COVID-19 Sample collection C226 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C226_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C226_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C227 Homo sapiens 9606 2020 Japan 19 SARS-CoV-2 COVID-19 52 serum SAMD01814487 COVID-19_Lipid_C227 Serum sample from individuals with COVID-19 Sample collection C227 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C227_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C227_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 missing C229 Homo sapiens 9606 2020 Japan 92 SARS-CoV-2 COVID-19 54 serum Days 4-6 SAMD01814488 COVID-19_Lipid_C229 Serum sample from individuals with COVID-19 Sample collection C229 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C229_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C229_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C23 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 7 serum Days 16-18 SAMD01814489 COVID-19_Lipid_C23 Serum sample from individuals with COVID-19 Sample collection C23 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C23_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C23_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C230 Homo sapiens 9606 2020 Japan 54 SARS-CoV-2 COVID-19 55 serum Days 7-9 SAMD01814490 COVID-19_Lipid_C230 Serum sample from individuals with COVID-19 Sample collection C230 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C230_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C230_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C231 Homo sapiens 9606 2020 Japan 54 SARS-CoV-2 COVID-19 55 serum Days 10-12 SAMD01814491 COVID-19_Lipid_C231 Serum sample from individuals with COVID-19 Sample collection C231 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C231_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C231_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C232 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 40 serum beyond Day 25 SAMD01814492 COVID-19_Lipid_C232 Serum sample from individuals with COVID-19 Sample collection C232 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C232_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C232_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C233 Homo sapiens 9606 2020 Japan 87 SARS-CoV-2 COVID-19 36 serum beyond Day 25 SAMD01814493 COVID-19_Lipid_C233 Serum sample from individuals with COVID-19 Sample collection C233 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C233_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C233_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C234 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 41 serum beyond Day 25 SAMD01814494 COVID-19_Lipid_C234 Serum sample from individuals with COVID-19 Sample collection C234 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C234_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C234_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C235 Homo sapiens 9606 2020 Japan 65 SARS-CoV-2 COVID-19 46 serum beyond Day 25 SAMD01814495 COVID-19_Lipid_C235 Serum sample from individuals with COVID-19 Sample collection C235 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C235_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C235_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C236 Homo sapiens 9606 2020 Japan 92 SARS-CoV-2 COVID-19 54 serum Days 10-12 SAMD01814496 COVID-19_Lipid_C236 Serum sample from individuals with COVID-19 Sample collection C236 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C236_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C236_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C237 Homo sapiens 9606 2020 Japan 54 SARS-CoV-2 COVID-19 55 serum Days 13-15 SAMD01814497 COVID-19_Lipid_C237 Serum sample from individuals with COVID-19 Sample collection C237 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C237_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C237_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C238 Homo sapiens 9606 2020 Japan 56 SARS-CoV-2 COVID-19 53 serum Days 7-9 SAMD01814498 COVID-19_Lipid_C238 Serum sample from individuals with COVID-19 Sample collection C238 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C238_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C238_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C239 Homo sapiens 9606 2020 Japan 56 SARS-CoV-2 COVID-19 53 serum Days 10-12 SAMD01814499 COVID-19_Lipid_C239 Serum sample from individuals with COVID-19 Sample collection C239 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C239_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C239_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C24 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 7 serum Days 19-24 SAMD01814500 COVID-19_Lipid_C24 Serum sample from individuals with COVID-19 Sample collection C24 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C24_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C24_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C240 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 57 serum Days 7-9 SAMD01814501 COVID-19_Lipid_C240 Serum sample from individuals with COVID-19 Sample collection C240 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C240_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C240_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C241 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 57 serum Days 10-12 SAMD01814502 COVID-19_Lipid_C241 Serum sample from individuals with COVID-19 Sample collection C241 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C241_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C241_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C242 Homo sapiens 9606 2020 Japan 54 SARS-CoV-2 COVID-19 55 serum Days 16-18 SAMD01814503 COVID-19_Lipid_C242 Serum sample from individuals with COVID-19 Sample collection C242 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C242_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C242_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C243 Homo sapiens 9606 2020 Japan 92 SARS-CoV-2 COVID-19 54 serum Days 16-18 SAMD01814504 COVID-19_Lipid_C243 Serum sample from individuals with COVID-19 Sample collection C243 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C243_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C243_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C244 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 50 serum beyond Day 25 SAMD01814505 COVID-19_Lipid_C244 Serum sample from individuals with COVID-19 Sample collection C244 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C244_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C244_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C245 Homo sapiens 9606 2020 Japan 77 SARS-CoV-2 COVID-19 58 serum Days 10-12 SAMD01814506 COVID-19_Lipid_C245 Serum sample from individuals with COVID-19 Sample collection C245 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C245_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C245_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C246 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 59 serum Days 7-9 SAMD01814507 COVID-19_Lipid_C246 Serum sample from individuals with COVID-19 Sample collection C246 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C246_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C246_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C247 Homo sapiens 9606 2020 Japan 77 SARS-CoV-2 COVID-19 58 serum Days 13-15 SAMD01814508 COVID-19_Lipid_C247 Serum sample from individuals with COVID-19 Sample collection C247 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C247_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C247_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C248 Homo sapiens 9606 2020 Japan 92 SARS-CoV-2 COVID-19 54 serum Days 19-24 SAMD01814509 COVID-19_Lipid_C248 Serum sample from individuals with COVID-19 Sample collection C248 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C248_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C248_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C249 Homo sapiens 9606 2020 Japan 56 SARS-CoV-2 COVID-19 53 serum Days 19-24 SAMD01814510 COVID-19_Lipid_C249 Serum sample from individuals with COVID-19 Sample collection C249 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C249_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C249_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C25 Homo sapiens 9606 2020 Japan 36 SARS-CoV-2 COVID-19 9 serum Days 13-15 SAMD01814511 COVID-19_Lipid_C25 Serum sample from individuals with COVID-19 Sample collection C25 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C25_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C25_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C250 Homo sapiens 9606 2020 Japan 77 SARS-CoV-2 COVID-19 58 serum Days 16-18 SAMD01814512 COVID-19_Lipid_C250 Serum sample from individuals with COVID-19 Sample collection C250 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C250_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C250_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C251 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 59 serum Days 10-12 SAMD01814513 COVID-19_Lipid_C251 Serum sample from individuals with COVID-19 Sample collection C251 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C251_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C251_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C252 Homo sapiens 9606 2020 Japan 77 SARS-CoV-2 COVID-19 58 serum Days 19-24 SAMD01814514 COVID-19_Lipid_C252 Serum sample from individuals with COVID-19 Sample collection C252 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C252_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C252_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C253 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 59 serum Days 13-15 SAMD01814515 COVID-19_Lipid_C253 Serum sample from individuals with COVID-19 Sample collection C253 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C253_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C253_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C254 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 59 serum Days 16-18 SAMD01814516 COVID-19_Lipid_C254 Serum sample from individuals with COVID-19 Sample collection C254 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C254_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C254_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C255 Homo sapiens 9606 2020 Japan 81 SARS-CoV-2 COVID-19 47 serum beyond Day 25 SAMD01814517 COVID-19_Lipid_C255 Serum sample from individuals with COVID-19 Sample collection C255 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C255_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C255_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C256 Homo sapiens 9606 2020 Japan 45 SARS-CoV-2 COVID-19 63 serum Days 4-6 SAMD01814518 COVID-19_Lipid_C256 Serum sample from individuals with COVID-19 Sample collection C256 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C256_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C256_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C257 Homo sapiens 9606 2020 Japan 45 SARS-CoV-2 COVID-19 63 serum Days 7-9 SAMD01814519 COVID-19_Lipid_C257 Serum sample from individuals with COVID-19 Sample collection C257 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C257_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C257_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C258 Homo sapiens 9606 2020 Japan 45 SARS-CoV-2 COVID-19 63 serum Days 10-12 SAMD01814520 COVID-19_Lipid_C258 Serum sample from individuals with COVID-19 Sample collection C258 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C258_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C258_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C259 Homo sapiens 9606 2020 Japan 45 SARS-CoV-2 COVID-19 63 serum Days 13-15 SAMD01814521 COVID-19_Lipid_C259 Serum sample from individuals with COVID-19 Sample collection C259 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C259_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C259_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C26 Homo sapiens 9606 2020 Japan 36 SARS-CoV-2 COVID-19 9 serum Days 16-18 SAMD01814522 COVID-19_Lipid_C26 Serum sample from individuals with COVID-19 Sample collection C26 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C26_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C26_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C260 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 48 serum beyond Day 25 SAMD01814523 COVID-19_Lipid_C260 Serum sample from individuals with COVID-19 Sample collection C260 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C260_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C260_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C261 Homo sapiens 9606 2020 Japan 78 SARS-CoV-2 COVID-19 64 serum Days 7-9 SAMD01814524 COVID-19_Lipid_C261 Serum sample from individuals with COVID-19 Sample collection C261 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C261_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C261_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C262 Homo sapiens 9606 2020 Japan 78 SARS-CoV-2 COVID-19 64 serum Days 10-12 SAMD01814525 COVID-19_Lipid_C262 Serum sample from individuals with COVID-19 Sample collection C262 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C262_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C262_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C263 Homo sapiens 9606 2020 Japan 78 SARS-CoV-2 COVID-19 64 serum Days 13-15 SAMD01814526 COVID-19_Lipid_C263 Serum sample from individuals with COVID-19 Sample collection C263 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C263_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C263_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C264 Homo sapiens 9606 2020 Japan 45 SARS-CoV-2 COVID-19 63 serum Days 19-24 SAMD01814527 COVID-19_Lipid_C264 Serum sample from individuals with COVID-19 Sample collection C264 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C264_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C264_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C265 Homo sapiens 9606 2020 Japan 92 SARS-CoV-2 COVID-19 54 serum beyond Day 25 SAMD01814528 COVID-19_Lipid_C265 Serum sample from individuals with COVID-19 Sample collection C265 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C265_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C265_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C266 Homo sapiens 9606 2020 Japan 48 SARS-CoV-2 COVID-19 65 serum Days 4-6 SAMD01814529 COVID-19_Lipid_C266 Serum sample from individuals with COVID-19 Sample collection C266 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C266_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C266_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C267 Homo sapiens 9606 2020 Japan 48 SARS-CoV-2 COVID-19 65 serum Days 7-9 SAMD01814530 COVID-19_Lipid_C267 Serum sample from individuals with COVID-19 Sample collection C267 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C267_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C267_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C268 Homo sapiens 9606 2020 Japan 36 SARS-CoV-2 COVID-19 66 serum Days 4-6 SAMD01814531 COVID-19_Lipid_C268 Serum sample from individuals with COVID-19 Sample collection C268 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C268_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C268_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C269 Homo sapiens 9606 2020 Japan 36 SARS-CoV-2 COVID-19 66 serum Days 10-12 SAMD01814532 COVID-19_Lipid_C269 Serum sample from individuals with COVID-19 Sample collection C269 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C269_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C269_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C27 Homo sapiens 9606 2020 Japan 36 SARS-CoV-2 COVID-19 9 serum Days 19-24 SAMD01814533 COVID-19_Lipid_C27 Serum sample from individuals with COVID-19 Sample collection C27 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C27_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C27_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C270 Homo sapiens 9606 2020 Japan 36 SARS-CoV-2 COVID-19 66 serum Days 10-12 SAMD01814534 COVID-19_Lipid_C270 Serum sample from individuals with COVID-19 Sample collection C270 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C270_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C270_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C271 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 57 serum beyond Day 25 SAMD01814535 COVID-19_Lipid_C271 Serum sample from individuals with COVID-19 Sample collection C271 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C271_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C271_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C272 Homo sapiens 9606 2020 Japan 56 SARS-CoV-2 COVID-19 67 serum Days 4-6 SAMD01814536 COVID-19_Lipid_C272 Serum sample from individuals with COVID-19 Sample collection C272 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C272_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C272_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C273 Homo sapiens 9606 2020 Japan 56 SARS-CoV-2 COVID-19 67 serum Days 7-9 SAMD01814537 COVID-19_Lipid_C273 Serum sample from individuals with COVID-19 Sample collection C273 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C273_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C273_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C274 Homo sapiens 9606 2020 Japan 48 SARS-CoV-2 COVID-19 65 serum Days 7-9 SAMD01814538 COVID-19_Lipid_C274 Serum sample from individuals with COVID-19 Sample collection C274 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C274_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C274_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C275 Homo sapiens 9606 2020 Japan 36 SARS-CoV-2 COVID-19 66 serum Days 13-15 SAMD01814539 COVID-19_Lipid_C275 Serum sample from individuals with COVID-19 Sample collection C275 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C275_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C275_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C276 Homo sapiens 9606 2020 Japan 36 SARS-CoV-2 COVID-19 66 serum Days 16-18 SAMD01814540 COVID-19_Lipid_C276 Serum sample from individuals with COVID-19 Sample collection C276 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C276_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C276_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C277 Homo sapiens 9606 2020 Japan 56 SARS-CoV-2 COVID-19 67 serum Days 10-12 SAMD01814541 COVID-19_Lipid_C277 Serum sample from individuals with COVID-19 Sample collection C277 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C277_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C277_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C278 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 67 serum Days 13-15 SAMD01814542 COVID-19_Lipid_C278 Serum sample from individuals with COVID-19 Sample collection C278 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C278_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C278_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C279 Homo sapiens 9606 2020 Japan 45 SARS-CoV-2 COVID-19 81 serum Days 13-15 SAMD01814543 COVID-19_Lipid_C279 Serum sample from individuals with COVID-19 Sample collection C279 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C279_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C279_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C28 Homo sapiens 9606 2020 Japan 49 SARS-CoV-2 COVID-19 12 serum Days 13-15 SAMD01814544 COVID-19_Lipid_C28 Serum sample from individuals with COVID-19 Sample collection C28 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C28_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C28_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C280 Homo sapiens 9606 2020 Japan 78 SARS-CoV-2 COVID-19 74 serum Days 1-3 SAMD01814545 COVID-19_Lipid_C280 Serum sample from individuals with COVID-19 Sample collection C280 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C280_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C280_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 1-3 C281 Homo sapiens 9606 2020 Japan 78 SARS-CoV-2 COVID-19 74 serum Days 4-6 SAMD01814546 COVID-19_Lipid_C281 Serum sample from individuals with COVID-19 Sample collection C281 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C281_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C281_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C282 Homo sapiens 9606 2020 Japan 78 SARS-CoV-2 COVID-19 74 serum Days 7-9 SAMD01814547 COVID-19_Lipid_C282 Serum sample from individuals with COVID-19 Sample collection C282 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C282_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C282_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C283 Homo sapiens 9606 2020 Japan 45 SARS-CoV-2 COVID-19 63 serum beyond Day 25 SAMD01814548 COVID-19_Lipid_C283 Serum sample from individuals with COVID-19 Sample collection C283 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C283_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C283_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C284 Homo sapiens 9606 2020 Japan 45 SARS-CoV-2 COVID-19 81 serum Days 16-18 SAMD01814549 COVID-19_Lipid_C284 Serum sample from individuals with COVID-19 Sample collection C284 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C284_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C284_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C285 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 59 serum beyond Day 25 SAMD01814550 COVID-19_Lipid_C285 Serum sample from individuals with COVID-19 Sample collection C285 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C285_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C285_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C286 Homo sapiens 9606 2020 Japan 76 SARS-CoV-2 COVID-19 69 serum SAMD01814551 COVID-19_Lipid_C286 Serum sample from individuals with COVID-19 Sample collection C286 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C286_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C286_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 missing C287 Homo sapiens 9606 2020 Japan 45 SARS-CoV-2 COVID-19 79 serum Days 1-3 SAMD01814552 COVID-19_Lipid_C287 Serum sample from individuals with COVID-19 Sample collection C287 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C287_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C287_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 1-3 C288 Homo sapiens 9606 2020 Japan 45 SARS-CoV-2 COVID-19 79 serum Days 4-6 SAMD01814553 COVID-19_Lipid_C288 Serum sample from individuals with COVID-19 Sample collection C288 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C288_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C288_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C289 Homo sapiens 9606 2020 Japan 84 SARS-CoV-2 COVID-19 70 serum Days 7-9 SAMD01814554 COVID-19_Lipid_C289 Serum sample from individuals with COVID-19 Sample collection C289 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C289_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C289_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C29 Homo sapiens 9606 2020 Japan 49 SARS-CoV-2 COVID-19 12 serum Days 16-18 SAMD01814555 COVID-19_Lipid_C29 Serum sample from individuals with COVID-19 Sample collection C29 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C29_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C29_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C290 Homo sapiens 9606 2020 Japan 84 SARS-CoV-2 COVID-19 70 serum Days 10-12 SAMD01814556 COVID-19_Lipid_C290 Serum sample from individuals with COVID-19 Sample collection C290 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C290_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C290_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C291 Homo sapiens 9606 2020 Japan 72 SARS-CoV-2 COVID-19 71 serum Days 7-9 SAMD01814557 COVID-19_Lipid_C291 Serum sample from individuals with COVID-19 Sample collection C291 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C291_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C291_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C292 Homo sapiens 9606 2020 Japan 72 SARS-CoV-2 COVID-19 71 serum Days 10-12 SAMD01814558 COVID-19_Lipid_C292 Serum sample from individuals with COVID-19 Sample collection C292 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C292_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C292_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C293 Homo sapiens 9606 2020 Japan 48 SARS-CoV-2 COVID-19 72 serum Days 10-12 SAMD01814559 COVID-19_Lipid_C293 Serum sample from individuals with COVID-19 Sample collection C293 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C293_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C293_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C294 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 73 serum Days 7-9 SAMD01814560 COVID-19_Lipid_C294 Serum sample from individuals with COVID-19 Sample collection C294 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C294_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C294_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C295 Homo sapiens 9606 2020 Japan 54 SARS-CoV-2 COVID-19 55 serum beyond Day 25 SAMD01814561 COVID-19_Lipid_C295 Serum sample from individuals with COVID-19 Sample collection C295 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C295_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C295_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C296 Homo sapiens 9606 2020 Japan 78 SARS-CoV-2 COVID-19 74 serum Days 10-12 SAMD01814562 COVID-19_Lipid_C296 Serum sample from individuals with COVID-19 Sample collection C296 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C296_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C296_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C297 Homo sapiens 9606 2020 Japan 78 SARS-CoV-2 COVID-19 74 serum Days 13-15 SAMD01814563 COVID-19_Lipid_C297 Serum sample from individuals with COVID-19 Sample collection C297 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C297_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C297_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C298 Homo sapiens 9606 2020 Japan 50 SARS-CoV-2 COVID-19 76 serum Days 4-6 SAMD01814564 COVID-19_Lipid_C298 Serum sample from individuals with COVID-19 Sample collection C298 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C298_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C298_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C299 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 73 serum Days 10-12 SAMD01814565 COVID-19_Lipid_C299 Serum sample from individuals with COVID-19 Sample collection C299 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C299_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C299_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C3 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 13 serum Days 10-12 SAMD01814566 COVID-19_Lipid_C3 Serum sample from individuals with COVID-19 Sample collection C3 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C3_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C3_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C30 Homo sapiens 9606 2020 Japan 49 SARS-CoV-2 COVID-19 12 serum Days 19-24 SAMD01814567 COVID-19_Lipid_C30 Serum sample from individuals with COVID-19 Sample collection C30 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C30_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C30_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C300 Homo sapiens 9606 2020 Japan 53 SARS-CoV-2 COVID-19 77 serum Days 7-9 SAMD01814568 COVID-19_Lipid_C300 Serum sample from individuals with COVID-19 Sample collection C300 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C300_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C300_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C301 Homo sapiens 9606 2020 Japan 84 SARS-CoV-2 COVID-19 70 serum Days 10-12 SAMD01814569 COVID-19_Lipid_C301 Serum sample from individuals with COVID-19 Sample collection C301 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C301_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C301_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C302 Homo sapiens 9606 2020 Japan 48 SARS-CoV-2 COVID-19 78 serum Days 4-6 SAMD01814570 COVID-19_Lipid_C302 Serum sample from individuals with COVID-19 Sample collection C302 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C302_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C302_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C303 Homo sapiens 9606 2020 Japan 45 SARS-CoV-2 COVID-19 79 serum Days 7-9 SAMD01814571 COVID-19_Lipid_C303 Serum sample from individuals with COVID-19 Sample collection C303 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C303_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C303_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C304 Homo sapiens 9606 2020 Japan 76 SARS-CoV-2 COVID-19 69 serum SAMD01814572 COVID-19_Lipid_C304 Serum sample from individuals with COVID-19 Sample collection C304 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C304_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C304_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 missing C305 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 73 serum pre-onset SAMD01814573 COVID-19_Lipid_C305 Serum sample from individuals with COVID-19 Sample collection C305 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C305_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C305_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 pre-onset C306 Homo sapiens 9606 2020 Japan 45 SARS-CoV-2 COVID-19 81 serum Days 7-9 SAMD01814574 COVID-19_Lipid_C306 Serum sample from individuals with COVID-19 Sample collection C306 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C306_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C306_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C307 Homo sapiens 9606 2020 Japan 45 SARS-CoV-2 COVID-19 81 serum Days 10-12 SAMD01814575 COVID-19_Lipid_C307 Serum sample from individuals with COVID-19 Sample collection C307 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C307_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C307_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C308 Homo sapiens 9606 2020 Japan 84 SARS-CoV-2 COVID-19 70 serum Days 13-15 SAMD01814576 COVID-19_Lipid_C308 Serum sample from individuals with COVID-19 Sample collection C308 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C308_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C308_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C309 Homo sapiens 9606 2020 Japan 30 SARS-CoV-2 COVID-19 83 serum SAMD01814577 COVID-19_Lipid_C309 Serum sample from individuals with COVID-19 Sample collection C309 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C309_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C309_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 missing C31 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 10 serum Days 13-15 SAMD01814578 COVID-19_Lipid_C31 Serum sample from individuals with COVID-19 Sample collection C31 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C31_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C31_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C310 Homo sapiens 9606 2020 Japan 53 SARS-CoV-2 COVID-19 77 serum Days 10-12 SAMD01814579 COVID-19_Lipid_C310 Serum sample from individuals with COVID-19 Sample collection C310 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C310_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C310_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C311 Homo sapiens 9606 2020 Japan 45 SARS-CoV-2 COVID-19 79 serum Days 7-9 SAMD01814580 COVID-19_Lipid_C311 Serum sample from individuals with COVID-19 Sample collection C311 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C311_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C311_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C312 Homo sapiens 9606 2020 Japan 72 SARS-CoV-2 COVID-19 71 serum Days 13-15 SAMD01814581 COVID-19_Lipid_C312 Serum sample from individuals with COVID-19 Sample collection C312 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C312_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C312_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C313 Homo sapiens 9606 2020 Japan 51 SARS-CoV-2 COVID-19 76 serum Days 7-9 SAMD01814582 COVID-19_Lipid_C313 Serum sample from individuals with COVID-19 Sample collection C313 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C313_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C313_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C314 Homo sapiens 9606 2020 Japan 78 SARS-CoV-2 COVID-19 74 serum Days 16-18 SAMD01814583 COVID-19_Lipid_C314 Serum sample from individuals with COVID-19 Sample collection C314 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C314_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C314_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C315 Homo sapiens 9606 2020 Japan 76 SARS-CoV-2 COVID-19 69 serum SAMD01814584 COVID-19_Lipid_C315 Serum sample from individuals with COVID-19 Sample collection C315 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C315_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C315_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 missing C316 Homo sapiens 9606 2020 Japan 48 SARS-CoV-2 COVID-19 78 serum Days 7-9 SAMD01814585 COVID-19_Lipid_C316 Serum sample from individuals with COVID-19 Sample collection C316 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C316_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C316_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C317 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 73 serum Days 13-15 SAMD01814586 COVID-19_Lipid_C317 Serum sample from individuals with COVID-19 Sample collection C317 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C317_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C317_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C318 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 82 serum Days 4-6 SAMD01814587 COVID-19_Lipid_C318 Serum sample from individuals with COVID-19 Sample collection C318 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C318_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C318_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C319 Homo sapiens 9606 2020 Japan 48 SARS-CoV-2 COVID-19 78 serum Days 10-12 SAMD01814588 COVID-19_Lipid_C319 Serum sample from individuals with COVID-19 Sample collection C319 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C319_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C319_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C32 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 10 serum Days 16-18 SAMD01814589 COVID-19_Lipid_C32 Serum sample from individuals with COVID-19 Sample collection C32 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C32_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C32_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C320 Homo sapiens 9606 2020 Japan 84 SARS-CoV-2 COVID-19 70 serum Days 16-18 SAMD01814590 COVID-19_Lipid_C320 Serum sample from individuals with COVID-19 Sample collection C320 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C320_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C320_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C321 Homo sapiens 9606 2020 Japan 45 SARS-CoV-2 COVID-19 79 serum Days 10-12 SAMD01814591 COVID-19_Lipid_C321 Serum sample from individuals with COVID-19 Sample collection C321 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C321_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C321_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C322 Homo sapiens 9606 2020 Japan 53 SARS-CoV-2 COVID-19 77 serum Days 13-15 SAMD01814592 COVID-19_Lipid_C322 Serum sample from individuals with COVID-19 Sample collection C322 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C322_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C322_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C323 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 84 serum Days 7-9 SAMD01814593 COVID-19_Lipid_C323 Serum sample from individuals with COVID-19 Sample collection C323 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C323_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C323_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C324 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 84 serum Days 10-12 SAMD01814594 COVID-19_Lipid_C324 Serum sample from individuals with COVID-19 Sample collection C324 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C324_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C324_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C325 Homo sapiens 9606 2020 Japan 53 SARS-CoV-2 COVID-19 77 serum Days 16-18 SAMD01814595 COVID-19_Lipid_C325 Serum sample from individuals with COVID-19 Sample collection C325 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C325_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C325_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C326 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 85 serum Days 1-3 SAMD01814596 COVID-19_Lipid_C326 Serum sample from individuals with COVID-19 Sample collection C326 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C326_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C326_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 1-3 C327 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 85 serum Days 4-6 SAMD01814597 COVID-19_Lipid_C327 Serum sample from individuals with COVID-19 Sample collection C327 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C327_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C327_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C328 Homo sapiens 9606 2020 Japan 84 SARS-CoV-2 COVID-19 70 serum Days 19-24 SAMD01814598 COVID-19_Lipid_C328 Serum sample from individuals with COVID-19 Sample collection C328 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C328_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C328_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C329 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 82 serum Days 7-9 SAMD01814599 COVID-19_Lipid_C329 Serum sample from individuals with COVID-19 Sample collection C329 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C329_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C329_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C33 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 10 serum Days 19-24 SAMD01814600 COVID-19_Lipid_C33 Serum sample from individuals with COVID-19 Sample collection C33 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C33_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C33_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C330 Homo sapiens 9606 2020 Japan 48 SARS-CoV-2 COVID-19 78 serum Days 13-15 SAMD01814601 COVID-19_Lipid_C330 Serum sample from individuals with COVID-19 Sample collection C330 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C330_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C330_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C331 Homo sapiens 9606 2020 Japan 34 SARS-CoV-2 COVID-19 87 serum Days 1-3 SAMD01814602 COVID-19_Lipid_C331 Serum sample from individuals with COVID-19 Sample collection C331 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C331_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C331_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 1-3 C332 Homo sapiens 9606 2020 Japan 66 SARS-CoV-2 COVID-19 88 serum Days 7-9 SAMD01814603 COVID-19_Lipid_C332 Serum sample from individuals with COVID-19 Sample collection C332 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C332_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C332_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C333 Homo sapiens 9606 2020 Japan 73 SARS-CoV-2 COVID-19 89 serum Days 10-12 SAMD01814604 COVID-19_Lipid_C333 Serum sample from individuals with COVID-19 Sample collection C333 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C333_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C333_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C334 Homo sapiens 9606 2020 Japan 51 SARS-CoV-2 COVID-19 76 serum Days 13-15 SAMD01814605 COVID-19_Lipid_C334 Serum sample from individuals with COVID-19 Sample collection C334 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C334_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C334_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C335 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 67 serum beyond Day 25 SAMD01814606 COVID-19_Lipid_C335 Serum sample from individuals with COVID-19 Sample collection C335 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C335_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C335_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C336 Homo sapiens 9606 2020 Japan 76 SARS-CoV-2 COVID-19 69 serum SAMD01814607 COVID-19_Lipid_C336 Serum sample from individuals with COVID-19 Sample collection C336 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C336_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C336_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 missing C337 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 82 serum Days 10-12 SAMD01814608 COVID-19_Lipid_C337 Serum sample from individuals with COVID-19 Sample collection C337 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C337_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C337_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C338 Homo sapiens 9606 2020 Japan 28 SARS-CoV-2 COVID-19 90 serum Days 4-6 SAMD01814609 COVID-19_Lipid_C338 Serum sample from individuals with COVID-19 Sample collection C338 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C338_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C338_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C339 Homo sapiens 9606 2020 Japan 28 SARS-CoV-2 COVID-19 90 serum pre-onset SAMD01814610 COVID-19_Lipid_C339 Serum sample from individuals with COVID-19 Sample collection C339 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C339_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C339_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 pre-onset C34 Homo sapiens 9606 2020 Japan 47 SARS-CoV-2 COVID-19 2 serum Days 16-18 SAMD01814611 COVID-19_Lipid_C34 Serum sample from individuals with COVID-19 Sample collection C34 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C34_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C34_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C340 Homo sapiens 9606 2020 Japan 66 SARS-CoV-2 COVID-19 88 serum Days 10-12 SAMD01814612 COVID-19_Lipid_C340 Serum sample from individuals with COVID-19 Sample collection C340 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C340_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C340_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C341 Homo sapiens 9606 2020 Japan 48 SARS-CoV-2 COVID-19 72 serum beyond Day 25 SAMD01814613 COVID-19_Lipid_C341 Serum sample from individuals with COVID-19 Sample collection C341 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C341_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C341_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C342 Homo sapiens 9606 2020 Japan 53 SARS-CoV-2 COVID-19 77 serum Days 19-24 SAMD01814614 COVID-19_Lipid_C342 Serum sample from individuals with COVID-19 Sample collection C342 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C342_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C342_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C343 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 85 serum Days 7-9 SAMD01814615 COVID-19_Lipid_C343 Serum sample from individuals with COVID-19 Sample collection C343 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C343_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C343_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C344 Homo sapiens 9606 2020 Japan 78 SARS-CoV-2 COVID-19 64 serum beyond Day 25 SAMD01814616 COVID-19_Lipid_C344 Serum sample from individuals with COVID-19 Sample collection C344 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C344_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C344_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C345 Homo sapiens 9606 2020 Japan 71 SARS-CoV-2 COVID-19 97 serum Days 7-9 SAMD01814617 COVID-19_Lipid_C345 Serum sample from individuals with COVID-19 Sample collection C345 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C345_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C345_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C346 Homo sapiens 9606 2020 Japan 73 SARS-CoV-2 COVID-19 89 serum Days 13-15 SAMD01814618 COVID-19_Lipid_C346 Serum sample from individuals with COVID-19 Sample collection C346 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C346_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C346_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C347 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 85 serum Days 10-12 SAMD01814619 COVID-19_Lipid_C347 Serum sample from individuals with COVID-19 Sample collection C347 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C347_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C347_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C348 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 82 serum Days 13-15 SAMD01814620 COVID-19_Lipid_C348 Serum sample from individuals with COVID-19 Sample collection C348 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C348_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C348_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C349 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 82 serum Days 16-18 SAMD01814621 COVID-19_Lipid_C349 Serum sample from individuals with COVID-19 Sample collection C349 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C349_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C349_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C35 Homo sapiens 9606 2020 Japan 47 SARS-CoV-2 COVID-19 2 serum Days 19-24 SAMD01814622 COVID-19_Lipid_C35 Serum sample from individuals with COVID-19 Sample collection C35 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C35_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C35_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C350 Homo sapiens 9606 2020 Japan 66 SARS-CoV-2 COVID-19 88 serum Days 10-12 SAMD01814623 COVID-19_Lipid_C350 Serum sample from individuals with COVID-19 Sample collection C350 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C350_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C350_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C351 Homo sapiens 9606 2020 Japan 71 SARS-CoV-2 COVID-19 97 serum Days 10-12 SAMD01814624 COVID-19_Lipid_C351 Serum sample from individuals with COVID-19 Sample collection C351 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C351_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C351_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C352 Homo sapiens 9606 2020 Japan 73 SARS-CoV-2 COVID-19 89 serum Days 16-18 SAMD01814625 COVID-19_Lipid_C352 Serum sample from individuals with COVID-19 Sample collection C352 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C352_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C352_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C353 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 84 serum Days 13-15 SAMD01814626 COVID-19_Lipid_C353 Serum sample from individuals with COVID-19 Sample collection C353 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C353_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C353_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C354 Homo sapiens 9606 2020 Japan 73 SARS-CoV-2 COVID-19 96 serum Days 7-9 SAMD01814627 COVID-19_Lipid_C354 Serum sample from individuals with COVID-19 Sample collection C354 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C354_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C354_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C355 Homo sapiens 9606 2020 Japan 78 SARS-CoV-2 COVID-19 74 serum beyond Day 25 SAMD01814628 COVID-19_Lipid_C355 Serum sample from individuals with COVID-19 Sample collection C355 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C355_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C355_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C356 Homo sapiens 9606 2020 Japan 71 SARS-CoV-2 COVID-19 97 serum Days 10-12 SAMD01814629 COVID-19_Lipid_C356 Serum sample from individuals with COVID-19 Sample collection C356 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C356_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C356_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C357 Homo sapiens 9606 2020 Japan 79 SARS-CoV-2 COVID-19 98 serum Days 4-6 SAMD01814630 COVID-19_Lipid_C357 Serum sample from individuals with COVID-19 Sample collection C357 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C357_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C357_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C358 Homo sapiens 9606 2020 Japan 29 SARS-CoV-2 COVID-19 90 serum Days 10-12 SAMD01814631 COVID-19_Lipid_C358 Serum sample from individuals with COVID-19 Sample collection C358 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C358_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C358_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C359 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 85 serum Days 13-15 SAMD01814632 COVID-19_Lipid_C359 Serum sample from individuals with COVID-19 Sample collection C359 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C359_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C359_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C36 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 14 serum Days 13-15 SAMD01814633 COVID-19_Lipid_C36 Serum sample from individuals with COVID-19 Sample collection C36 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C36_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C36_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C360 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 73 serum beyond Day 25 SAMD01814634 COVID-19_Lipid_C360 Serum sample from individuals with COVID-19 Sample collection C360 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C360_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C360_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C361 Homo sapiens 9606 2020 Japan 73 SARS-CoV-2 COVID-19 96 serum Days 13-15 SAMD01814635 COVID-19_Lipid_C361 Serum sample from individuals with COVID-19 Sample collection C361 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C361_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C361_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C362 Homo sapiens 9606 2020 Japan 28 SARS-CoV-2 COVID-19 90 serum Days 13-15 SAMD01814636 COVID-19_Lipid_C362 Serum sample from individuals with COVID-19 Sample collection C362 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C362_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C362_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C363 Homo sapiens 9606 2020 Japan 48 SARS-CoV-2 COVID-19 65 serum beyond Day 25 SAMD01814637 COVID-19_Lipid_C363 Serum sample from individuals with COVID-19 Sample collection C363 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C363_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C363_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C364 Homo sapiens 9606 2020 Japan 73 SARS-CoV-2 COVID-19 89 serum Days 19-24 SAMD01814638 COVID-19_Lipid_C364 Serum sample from individuals with COVID-19 Sample collection C364 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C364_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C364_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C365 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 82 serum Days 19-24 SAMD01814639 COVID-19_Lipid_C365 Serum sample from individuals with COVID-19 Sample collection C365 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C365_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C365_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C366 Homo sapiens 9606 2020 Japan 71 SARS-CoV-2 COVID-19 97 serum Days 13-15 SAMD01814640 COVID-19_Lipid_C366 Serum sample from individuals with COVID-19 Sample collection C366 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C366_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C366_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C367 Homo sapiens 9606 2020 Japan 79 SARS-CoV-2 COVID-19 98 serum Days 7-9 SAMD01814641 COVID-19_Lipid_C367 Serum sample from individuals with COVID-19 Sample collection C367 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C367_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C367_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C368 Homo sapiens 9606 2020 Japan 66 SARS-CoV-2 COVID-19 95 serum Days 10-12 SAMD01814642 COVID-19_Lipid_C368 Serum sample from individuals with COVID-19 Sample collection C368 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C368_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C368_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C369 Homo sapiens 9606 2020 Japan 66 SARS-CoV-2 COVID-19 95 serum Days 13-15 SAMD01814643 COVID-19_Lipid_C369 Serum sample from individuals with COVID-19 Sample collection C369 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C369_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C369_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C37 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 14 serum Days 16-18 SAMD01814644 COVID-19_Lipid_C37 Serum sample from individuals with COVID-19 Sample collection C37 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C37_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C37_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C370 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 84 serum Days 19-24 SAMD01814645 COVID-19_Lipid_C370 Serum sample from individuals with COVID-19 Sample collection C370 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C370_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C370_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C371 Homo sapiens 9606 2020 Japan 73 SARS-CoV-2 COVID-19 89 serum Days 19-24 SAMD01814646 COVID-19_Lipid_C371 Serum sample from individuals with COVID-19 Sample collection C371 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C371_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C371_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C372 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 94 serum Days 10-12 SAMD01814647 COVID-19_Lipid_C372 Serum sample from individuals with COVID-19 Sample collection C372 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C372_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C372_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C373 Homo sapiens 9606 2020 Japan 79 SARS-CoV-2 COVID-19 98 serum Days 10-12 SAMD01814648 COVID-19_Lipid_C373 Serum sample from individuals with COVID-19 Sample collection C373 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C373_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C373_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C374 Homo sapiens 9606 2020 Japan 73 SARS-CoV-2 COVID-19 96 serum Days 16-18 SAMD01814649 COVID-19_Lipid_C374 Serum sample from individuals with COVID-19 Sample collection C374 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C374_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C374_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C375 Homo sapiens 9606 2020 Japan 79 SARS-CoV-2 COVID-19 92 serum Days 4-6 SAMD01814650 COVID-19_Lipid_C375 Serum sample from individuals with COVID-19 Sample collection C375 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C375_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C375_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C376 Homo sapiens 9606 2020 Japan 53 SARS-CoV-2 COVID-19 77 serum beyond Day 25 SAMD01814651 COVID-19_Lipid_C376 Serum sample from individuals with COVID-19 Sample collection C376 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C376_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C376_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C377 Homo sapiens 9606 2020 Japan 21 SARS-CoV-2 COVID-19 93 serum Days 1-3 SAMD01814652 COVID-19_Lipid_C377 Serum sample from individuals with COVID-19 Sample collection C377 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C377_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C377_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 1-3 C378 Homo sapiens 9606 2020 Japan 77 SARS-CoV-2 COVID-19 91 serum SAMD01814653 COVID-19_Lipid_C378 Serum sample from individuals with COVID-19 Sample collection C378 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C378_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C378_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 missing C379 Homo sapiens 9606 2020 Japan 77 SARS-CoV-2 COVID-19 91 serum SAMD01814654 COVID-19_Lipid_C379 Serum sample from individuals with COVID-19 Sample collection C379 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C379_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C379_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 missing C38 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 14 serum Days 19-24 SAMD01814655 COVID-19_Lipid_C38 Serum sample from individuals with COVID-19 Sample collection C38 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C38_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C38_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C380 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 85 serum Days 19-24 SAMD01814656 COVID-19_Lipid_C380 Serum sample from individuals with COVID-19 Sample collection C380 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C380_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C380_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C381 Homo sapiens 9606 2020 Japan 48 SARS-CoV-2 COVID-19 99 serum Days 1-3 SAMD01814657 COVID-19_Lipid_C381 Serum sample from individuals with COVID-19 Sample collection C381 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C381_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C381_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 1-3 C382 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 100 serum Days 4-6 SAMD01814658 COVID-19_Lipid_C382 Serum sample from individuals with COVID-19 Sample collection C382 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C382_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C382_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C383 Homo sapiens 9606 2020 Japan 79 SARS-CoV-2 COVID-19 92 serum Days 7-9 SAMD01814659 COVID-19_Lipid_C383 Serum sample from individuals with COVID-19 Sample collection C383 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C383_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C383_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C384 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 82 serum beyond Day 25 SAMD01814660 COVID-19_Lipid_C384 Serum sample from individuals with COVID-19 Sample collection C384 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C384_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C384_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C385 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 94 serum Days 13-15 SAMD01814661 COVID-19_Lipid_C385 Serum sample from individuals with COVID-19 Sample collection C385 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C385_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C385_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C386 Homo sapiens 9606 2020 Japan 77 SARS-CoV-2 COVID-19 91 serum SAMD01814662 COVID-19_Lipid_C386 Serum sample from individuals with COVID-19 Sample collection C386 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C386_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C386_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 missing C387 Homo sapiens 9606 2020 Japan 51 SARS-CoV-2 COVID-19 76 serum beyond Day 25 SAMD01814663 COVID-19_Lipid_C387 Serum sample from individuals with COVID-19 Sample collection C387 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C387_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C387_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C388 Homo sapiens 9606 2020 Japan 48 SARS-CoV-2 COVID-19 78 serum beyond Day 25 SAMD01814664 COVID-19_Lipid_C388 Serum sample from individuals with COVID-19 Sample collection C388 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C388_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C388_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C389 Homo sapiens 9606 2020 Japan 45 SARS-CoV-2 COVID-19 79 serum beyond Day 25 SAMD01814665 COVID-19_Lipid_C389 Serum sample from individuals with COVID-19 Sample collection C389 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C389_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C389_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C39 Homo sapiens 9606 2020 Japan 71 SARS-CoV-2 COVID-19 20 serum Days 10-12 SAMD01814666 COVID-19_Lipid_C39 Serum sample from individuals with COVID-19 Sample collection C39 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C39_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C39_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C390 Homo sapiens 9606 2020 Japan 71 SARS-CoV-2 COVID-19 101 serum Days 7-9 SAMD01814667 COVID-19_Lipid_C390 Serum sample from individuals with COVID-19 Sample collection C390 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C390_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C390_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C391 Homo sapiens 9606 2020 Japan 77 SARS-CoV-2 COVID-19 91 serum SAMD01814668 COVID-19_Lipid_C391 Serum sample from individuals with COVID-19 Sample collection C391 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C391_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C391_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 missing C392 Homo sapiens 9606 2020 Japan 48 SARS-CoV-2 COVID-19 99 serum Days 4-6 SAMD01814669 COVID-19_Lipid_C392 Serum sample from individuals with COVID-19 Sample collection C392 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C392_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C392_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C393 Homo sapiens 9606 2020 Japan 79 SARS-CoV-2 COVID-19 92 serum Days 10-12 SAMD01814670 COVID-19_Lipid_C393 Serum sample from individuals with COVID-19 Sample collection C393 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C393_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C393_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C394 Homo sapiens 9606 2020 Japan 66 SARS-CoV-2 COVID-19 95 serum Days 16-18 SAMD01814671 COVID-19_Lipid_C394 Serum sample from individuals with COVID-19 Sample collection C394 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C394_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C394_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C395 Homo sapiens 9606 2020 Japan 79 SARS-CoV-2 COVID-19 98 serum Days 13-15 SAMD01814672 COVID-19_Lipid_C395 Serum sample from individuals with COVID-19 Sample collection C395 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C395_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C395_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C396 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 100 serum Days 7-9 SAMD01814673 COVID-19_Lipid_C396 Serum sample from individuals with COVID-19 Sample collection C396 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C396_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C396_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C397 Homo sapiens 9606 2020 Japan 71 SARS-CoV-2 COVID-19 101 serum Days 10-12 SAMD01814674 COVID-19_Lipid_C397 Serum sample from individuals with COVID-19 Sample collection C397 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C397_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C397_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C398 Homo sapiens 9606 2020 Japan 86 SARS-CoV-2 COVID-19 102 serum SAMD01814675 COVID-19_Lipid_C398 Serum sample from individuals with COVID-19 Sample collection C398 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C398_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C398_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 missing C399 Homo sapiens 9606 2020 Japan 86 SARS-CoV-2 COVID-19 102 serum SAMD01814676 COVID-19_Lipid_C399 Serum sample from individuals with COVID-19 Sample collection C399 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C399_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C399_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 missing C4 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 13 serum Days 13-15 SAMD01814677 COVID-19_Lipid_C4 Serum sample from individuals with COVID-19 Sample collection C4 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C4_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C4_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C40 Homo sapiens 9606 2020 Japan 24 SARS-CoV-2 COVID-19 3 serum Days 4-6 SAMD01814678 COVID-19_Lipid_C40 Serum sample from individuals with COVID-19 Sample collection C40 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C40_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C40_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C400 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 103 serum Days 4-6 SAMD01814679 COVID-19_Lipid_C400 Serum sample from individuals with COVID-19 Sample collection C400 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C400_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C400_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C401 Homo sapiens 9606 2020 Japan 71 SARS-CoV-2 COVID-19 101 serum Days 13-15 SAMD01814680 COVID-19_Lipid_C401 Serum sample from individuals with COVID-19 Sample collection C401 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C401_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C401_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C402 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 100 serum Days 10-12 SAMD01814681 COVID-19_Lipid_C402 Serum sample from individuals with COVID-19 Sample collection C402 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C402_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C402_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C403 Homo sapiens 9606 2020 Japan 79 SARS-CoV-2 COVID-19 92 serum Days 10-12 SAMD01814682 COVID-19_Lipid_C403 Serum sample from individuals with COVID-19 Sample collection C403 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C403_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C403_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C404 Homo sapiens 9606 2020 Japan 46 SARS-CoV-2 COVID-19 104 serum Days 1-3 SAMD01814683 COVID-19_Lipid_C404 Serum sample from individuals with COVID-19 Sample collection C404 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C404_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C404_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 1-3 C405 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 105 serum Days 10-12 SAMD01814684 COVID-19_Lipid_C405 Serum sample from individuals with COVID-19 Sample collection C405 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C405_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C405_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C406 Homo sapiens 9606 2020 Japan 79 SARS-CoV-2 COVID-19 92 serum Days 13-15 SAMD01814685 COVID-19_Lipid_C406 Serum sample from individuals with COVID-19 Sample collection C406 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C406_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C406_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C407 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 103 serum Days 7-9 SAMD01814686 COVID-19_Lipid_C407 Serum sample from individuals with COVID-19 Sample collection C407 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C407_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C407_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C408 Homo sapiens 9606 2020 Japan 46 SARS-CoV-2 COVID-19 104 serum Days 4-6 SAMD01814687 COVID-19_Lipid_C408 Serum sample from individuals with COVID-19 Sample collection C408 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C408_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C408_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C409 Homo sapiens 9606 2020 Japan 48 SARS-CoV-2 COVID-19 99 serum Days 10-12 SAMD01814688 COVID-19_Lipid_C409 Serum sample from individuals with COVID-19 Sample collection C409 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C409_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C409_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C41 Homo sapiens 9606 2020 Japan 24 SARS-CoV-2 COVID-19 3 serum Days 7-9 SAMD01814689 COVID-19_Lipid_C41 Serum sample from individuals with COVID-19 Sample collection C41 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C41_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C41_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C410 Homo sapiens 9606 2020 Japan 34 SARS-CoV-2 COVID-19 106 serum Days 4-6 SAMD01814690 COVID-19_Lipid_C410 Serum sample from individuals with COVID-19 Sample collection C410 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C410_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C410_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C411 Homo sapiens 9606 2020 Japan 36 SARS-CoV-2 COVID-19 107 serum Days 4-6 SAMD01814691 COVID-19_Lipid_C411 Serum sample from individuals with COVID-19 Sample collection C411 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C411_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C411_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C412 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 103 serum Days 10-12 SAMD01814692 COVID-19_Lipid_C412 Serum sample from individuals with COVID-19 Sample collection C412 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C412_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C412_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C413 Homo sapiens 9606 2020 Japan 79 SARS-CoV-2 COVID-19 92 serum Days 16-18 SAMD01814693 COVID-19_Lipid_C413 Serum sample from individuals with COVID-19 Sample collection C413 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C413_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C413_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C414 Homo sapiens 9606 2020 Japan 86 SARS-CoV-2 COVID-19 102 serum SAMD01814694 COVID-19_Lipid_C414 Serum sample from individuals with COVID-19 Sample collection C414 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C414_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C414_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 missing C415 Homo sapiens 9606 2020 Japan 26 SARS-CoV-2 COVID-19 108 serum Days 7-9 SAMD01814695 COVID-19_Lipid_C415 Serum sample from individuals with COVID-19 Sample collection C415 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C415_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C415_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C416 Homo sapiens 9606 2020 Japan 45 SARS-CoV-2 COVID-19 81 serum beyond Day 25 SAMD01814696 COVID-19_Lipid_C416 Serum sample from individuals with COVID-19 Sample collection C416 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C416_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C416_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C417 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 100 serum Days 13-15 SAMD01814697 COVID-19_Lipid_C417 Serum sample from individuals with COVID-19 Sample collection C417 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C417_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C417_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C418 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 105 serum Days 13-15 SAMD01814698 COVID-19_Lipid_C418 Serum sample from individuals with COVID-19 Sample collection C418 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C418_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C418_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C419 Homo sapiens 9606 2020 Japan 71 SARS-CoV-2 COVID-19 101 serum Days 16-18 SAMD01814699 COVID-19_Lipid_C419 Serum sample from individuals with COVID-19 Sample collection C419 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C419_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C419_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C420 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 110 serum Days 10-12 SAMD01814700 COVID-19_Lipid_C420 Serum sample from individuals with COVID-19 Sample collection C420 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C420_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C420_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C421 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 105 serum Days 13-15 SAMD01814701 COVID-19_Lipid_C421 Serum sample from individuals with COVID-19 Sample collection C421 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C421_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C421_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C422 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 100 serum Days 13-15 SAMD01814702 COVID-19_Lipid_C422 Serum sample from individuals with COVID-19 Sample collection C422 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C422_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C422_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C423 Homo sapiens 9606 2020 Japan 34 SARS-CoV-2 COVID-19 106 serum Days 7-9 SAMD01814703 COVID-19_Lipid_C423 Serum sample from individuals with COVID-19 Sample collection C423 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C423_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C423_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C424 Homo sapiens 9606 2020 Japan 32 SARS-CoV-2 COVID-19 109 serum Days 7-9 SAMD01814704 COVID-19_Lipid_C424 Serum sample from individuals with COVID-19 Sample collection C424 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C424_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C424_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C425 Homo sapiens 9606 2020 Japan 46 SARS-CoV-2 COVID-19 104 serum Days 10-12 SAMD01814705 COVID-19_Lipid_C425 Serum sample from individuals with COVID-19 Sample collection C425 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C425_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C425_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C426 Homo sapiens 9606 2020 Japan 32 SARS-CoV-2 COVID-19 109 serum Days 10-12 SAMD01814706 COVID-19_Lipid_C426 Serum sample from individuals with COVID-19 Sample collection C426 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C426_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C426_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C427 Homo sapiens 9606 2020 Japan 76 SARS-CoV-2 COVID-19 69 serum SAMD01814707 COVID-19_Lipid_C427 Serum sample from individuals with COVID-19 Sample collection C427 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C427_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C427_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 missing C428 Homo sapiens 9606 2020 Japan 73 SARS-CoV-2 COVID-19 71 serum beyond Day 25 SAMD01814708 COVID-19_Lipid_C428 Serum sample from individuals with COVID-19 Sample collection C428 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C428_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C428_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C429 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 100 serum Days 19-24 SAMD01814709 COVID-19_Lipid_C429 Serum sample from individuals with COVID-19 Sample collection C429 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C429_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C429_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C43 Homo sapiens 9606 2020 Japan 68 SARS-CoV-2 COVID-19 8 serum Days 10-12 SAMD01814710 COVID-19_Lipid_C43 Serum sample from individuals with COVID-19 Sample collection C43 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C43_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C43_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C430 Homo sapiens 9606 2020 Japan 74 SARS-CoV-2 COVID-19 111 serum SAMD01814711 COVID-19_Lipid_C430 Serum sample from individuals with COVID-19 Sample collection C430 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C430_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C430_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 missing C431 Homo sapiens 9606 2020 Japan 32 SARS-CoV-2 COVID-19 109 serum Days 13-15 SAMD01814712 COVID-19_Lipid_C431 Serum sample from individuals with COVID-19 Sample collection C431 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C431_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C431_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C432 Homo sapiens 9606 2020 Japan 54 SARS-CoV-2 COVID-19 112 serum Days 7-9 SAMD01814713 COVID-19_Lipid_C432 Serum sample from individuals with COVID-19 Sample collection C432 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C432_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C432_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C433 Homo sapiens 9606 2020 Japan 36 SARS-CoV-2 COVID-19 113 serum SAMD01814714 COVID-19_Lipid_C433 Serum sample from individuals with COVID-19 Sample collection C433 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C433_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C433_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 missing C434 Homo sapiens 9606 2020 Japan 36 SARS-CoV-2 COVID-19 113 serum SAMD01814715 COVID-19_Lipid_C434 Serum sample from individuals with COVID-19 Sample collection C434 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C434_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C434_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 missing C435 Homo sapiens 9606 2020 Japan 46 SARS-CoV-2 COVID-19 116 serum Days 7-9 SAMD01814716 COVID-19_Lipid_C435 Serum sample from individuals with COVID-19 Sample collection C435 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C435_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C435_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C436 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 110 serum Days 19-24 SAMD01814717 COVID-19_Lipid_C436 Serum sample from individuals with COVID-19 Sample collection C436 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C436_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C436_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C437 Homo sapiens 9606 2020 Japan 36 SARS-CoV-2 COVID-19 113 serum SAMD01814718 COVID-19_Lipid_C437 Serum sample from individuals with COVID-19 Sample collection C437 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C437_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C437_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 missing C438 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 115 serum Days 13-15 SAMD01814719 COVID-19_Lipid_C438 Serum sample from individuals with COVID-19 Sample collection C438 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C438_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C438_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C439 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 115 serum Days 16-18 SAMD01814720 COVID-19_Lipid_C439 Serum sample from individuals with COVID-19 Sample collection C439 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C439_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C439_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C44 Homo sapiens 9606 2020 Japan 68 SARS-CoV-2 COVID-19 8 serum Days 13-15 SAMD01814721 COVID-19_Lipid_C44 Serum sample from individuals with COVID-19 Sample collection C44 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C44_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C44_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C440 Homo sapiens 9606 2020 Japan 53 SARS-CoV-2 COVID-19 120 serum Days 10-12 SAMD01814722 COVID-19_Lipid_C440 Serum sample from individuals with COVID-19 Sample collection C440 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C440_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C440_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C441 Homo sapiens 9606 2020 Japan 53 SARS-CoV-2 COVID-19 120 serum Days 13-15 SAMD01814723 COVID-19_Lipid_C441 Serum sample from individuals with COVID-19 Sample collection C441 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C441_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C441_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C442 Homo sapiens 9606 2020 Japan 53 SARS-CoV-2 COVID-19 120 serum Days 16-18 SAMD01814724 COVID-19_Lipid_C442 Serum sample from individuals with COVID-19 Sample collection C442 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C442_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C442_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C443 Homo sapiens 9606 2020 Japan 54 SARS-CoV-2 COVID-19 112 serum Days 10-12 SAMD01814725 COVID-19_Lipid_C443 Serum sample from individuals with COVID-19 Sample collection C443 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C443_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C443_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C444 Homo sapiens 9606 2020 Japan 54 SARS-CoV-2 COVID-19 112 serum Days 10-12 SAMD01814726 COVID-19_Lipid_C444 Serum sample from individuals with COVID-19 Sample collection C444 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C444_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C444_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C445 Homo sapiens 9606 2020 Japan 26 SARS-CoV-2 COVID-19 118 serum Days 4-6 SAMD01814727 COVID-19_Lipid_C445 Serum sample from individuals with COVID-19 Sample collection C445 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C445_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C445_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C446 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 119 serum Days 4-6 SAMD01814728 COVID-19_Lipid_C446 Serum sample from individuals with COVID-19 Sample collection C446 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C446_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C446_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C447 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 119 serum Days 7-9 SAMD01814729 COVID-19_Lipid_C447 Serum sample from individuals with COVID-19 Sample collection C447 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C447_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C447_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C448 Homo sapiens 9606 2020 Japan 65 SARS-CoV-2 COVID-19 117 serum Days 7-9 SAMD01814730 COVID-19_Lipid_C448 Serum sample from individuals with COVID-19 Sample collection C448 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C448_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C448_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C449 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 124 serum Days 7-9 SAMD01814731 COVID-19_Lipid_C449 Serum sample from individuals with COVID-19 Sample collection C449 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C449_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C449_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C45 Homo sapiens 9606 2020 Japan 68 SARS-CoV-2 COVID-19 8 serum Days 16-18 SAMD01814732 COVID-19_Lipid_C45 Serum sample from individuals with COVID-19 Sample collection C45 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C45_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C45_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C450 Homo sapiens 9606 2020 Japan 77 SARS-CoV-2 COVID-19 121 serum Days 7-9 SAMD01814733 COVID-19_Lipid_C450 Serum sample from individuals with COVID-19 Sample collection C450 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C450_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C450_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C451 Homo sapiens 9606 2020 Japan 77 SARS-CoV-2 COVID-19 121 serum Days 10-12 SAMD01814734 COVID-19_Lipid_C451 Serum sample from individuals with COVID-19 Sample collection C451 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C451_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C451_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C452 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 128 serum Days 7-9 SAMD01814735 COVID-19_Lipid_C452 Serum sample from individuals with COVID-19 Sample collection C452 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C452_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C452_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C453 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 128 serum Days 10-12 SAMD01814736 COVID-19_Lipid_C453 Serum sample from individuals with COVID-19 Sample collection C453 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C453_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C453_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C454 Homo sapiens 9606 2020 Japan 65 SARS-CoV-2 COVID-19 117 serum Days 13-15 SAMD01814737 COVID-19_Lipid_C454 Serum sample from individuals with COVID-19 Sample collection C454 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C454_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C454_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C455 Homo sapiens 9606 2020 Japan 65 SARS-CoV-2 COVID-19 117 serum Days 16-18 SAMD01814738 COVID-19_Lipid_C455 Serum sample from individuals with COVID-19 Sample collection C455 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C455_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C455_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C456 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 123 serum Days 7-9 SAMD01814739 COVID-19_Lipid_C456 Serum sample from individuals with COVID-19 Sample collection C456 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C456_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C456_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C457 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 123 serum Days 10-12 SAMD01814740 COVID-19_Lipid_C457 Serum sample from individuals with COVID-19 Sample collection C457 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C457_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C457_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C458 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 105 serum beyond Day 25 SAMD01814741 COVID-19_Lipid_C458 Serum sample from individuals with COVID-19 Sample collection C458 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C458_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C458_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C459 Homo sapiens 9606 2020 Japan 46 SARS-CoV-2 COVID-19 116 serum Days 13-15 SAMD01814742 COVID-19_Lipid_C459 Serum sample from individuals with COVID-19 Sample collection C459 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C459_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C459_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C46 Homo sapiens 9606 2020 Japan 68 SARS-CoV-2 COVID-19 8 serum Days 19-24 SAMD01814743 COVID-19_Lipid_C46 Serum sample from individuals with COVID-19 Sample collection C46 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C46_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C46_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C460 Homo sapiens 9606 2020 Japan 83 SARS-CoV-2 COVID-19 122 serum Days 4-6 SAMD01814744 COVID-19_Lipid_C460 Serum sample from individuals with COVID-19 Sample collection C460 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C460_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C460_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C461 Homo sapiens 9606 2020 Japan 83 SARS-CoV-2 COVID-19 122 serum Days 7-9 SAMD01814745 COVID-19_Lipid_C461 Serum sample from individuals with COVID-19 Sample collection C461 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C461_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C461_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C462 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 125 serum Days 13-15 SAMD01814746 COVID-19_Lipid_C462 Serum sample from individuals with COVID-19 Sample collection C462 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C462_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C462_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C463 Homo sapiens 9606 2020 Japan 64 SARS-CoV-2 COVID-19 125 serum Days 16-18 SAMD01814747 COVID-19_Lipid_C463 Serum sample from individuals with COVID-19 Sample collection C463 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C463_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C463_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C464 Homo sapiens 9606 2020 Japan 70 SARS-CoV-2 COVID-19 127 serum Days 16-18 SAMD01814748 COVID-19_Lipid_C464 Serum sample from individuals with COVID-19 Sample collection C464 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C464_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C464_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C465 Homo sapiens 9606 2020 Japan 70 SARS-CoV-2 COVID-19 127 serum Days 16-18 SAMD01814749 COVID-19_Lipid_C465 Serum sample from individuals with COVID-19 Sample collection C465 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C465_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C465_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C466 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 126 serum Days 7-9 SAMD01814750 COVID-19_Lipid_C466 Serum sample from individuals with COVID-19 Sample collection C466 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C466_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C466_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C467 Homo sapiens 9606 2020 Japan 55 SARS-CoV-2 COVID-19 129 serum Days 10-12 SAMD01814751 COVID-19_Lipid_C467 Serum sample from individuals with COVID-19 Sample collection C467 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C467_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C467_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C468 Homo sapiens 9606 2020 Japan 55 SARS-CoV-2 COVID-19 129 serum Days 13-15 SAMD01814752 COVID-19_Lipid_C468 Serum sample from individuals with COVID-19 Sample collection C468 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C468_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C468_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C469 Homo sapiens 9606 2020 Japan 77 SARS-CoV-2 COVID-19 121 serum pre-onset SAMD01814753 COVID-19_Lipid_C469 Serum sample from individuals with COVID-19 Sample collection C469 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C469_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C469_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 pre-onset C47 Homo sapiens 9606 2020 Japan 68 SARS-CoV-2 COVID-19 1 serum Days 10-12 SAMD01814754 COVID-19_Lipid_C47 Serum sample from individuals with COVID-19 Sample collection C47 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C47_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C47_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C470 Homo sapiens 9606 2020 Japan 77 SARS-CoV-2 COVID-19 121 serum Days 4-6 SAMD01814755 COVID-19_Lipid_C470 Serum sample from individuals with COVID-19 Sample collection C470 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C470_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C470_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C471 Homo sapiens 9606 2020 Japan 83 SARS-CoV-2 COVID-19 122 serum Days 1-3 SAMD01814756 COVID-19_Lipid_C471 Serum sample from individuals with COVID-19 Sample collection C471 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C471_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C471_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 1-3 C472 Homo sapiens 9606 2020 Japan 65 SARS-CoV-2 COVID-19 117 serum Days 10-12 SAMD01814757 COVID-19_Lipid_C472 Serum sample from individuals with COVID-19 Sample collection C472 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C472_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C472_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C473 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 123 serum pre-onset SAMD01814758 COVID-19_Lipid_C473 Serum sample from individuals with COVID-19 Sample collection C473 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C473_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C473_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 pre-onset C474 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 123 serum Days 4-6 SAMD01814759 COVID-19_Lipid_C474 Serum sample from individuals with COVID-19 Sample collection C474 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C474_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C474_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C475 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 100 serum beyond Day 25 SAMD01814760 COVID-19_Lipid_C475 Serum sample from individuals with COVID-19 Sample collection C475 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C475_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C475_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C476 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 124 serum Days 4-6 SAMD01814761 COVID-19_Lipid_C476 Serum sample from individuals with COVID-19 Sample collection C476 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C476_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C476_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C477 Homo sapiens 9606 2020 Japan 46 SARS-CoV-2 COVID-19 116 serum Days 10-12 SAMD01814762 COVID-19_Lipid_C477 Serum sample from individuals with COVID-19 Sample collection C477 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C477_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C477_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C478 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 115 serum Days 16-18 SAMD01814763 COVID-19_Lipid_C478 Serum sample from individuals with COVID-19 Sample collection C478 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C478_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C478_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C479 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 125 serum Days 10-12 SAMD01814764 COVID-19_Lipid_C479 Serum sample from individuals with COVID-19 Sample collection C479 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C479_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C479_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C48 Homo sapiens 9606 2020 Japan 77 SARS-CoV-2 COVID-19 6 serum Days 19-24 SAMD01814765 COVID-19_Lipid_C48 Serum sample from individuals with COVID-19 Sample collection C48 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C48_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C48_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C480 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 119 serum Days 10-12 SAMD01814766 COVID-19_Lipid_C480 Serum sample from individuals with COVID-19 Sample collection C480 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C480_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C480_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C481 Homo sapiens 9606 2020 Japan 70 SARS-CoV-2 COVID-19 127 serum Days 13-15 SAMD01814767 COVID-19_Lipid_C481 Serum sample from individuals with COVID-19 Sample collection C481 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C481_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C481_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C482 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 126 serum Days 4-6 SAMD01814768 COVID-19_Lipid_C482 Serum sample from individuals with COVID-19 Sample collection C482 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C482_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C482_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C483 Homo sapiens 9606 2020 Japan 86 SARS-CoV-2 COVID-19 130 serum Days 7-9 SAMD01814769 COVID-19_Lipid_C483 Serum sample from individuals with COVID-19 Sample collection C483 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C483_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C483_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C484 Homo sapiens 9606 2020 Japan 73 SARS-CoV-2 COVID-19 131 serum Days 4-6 SAMD01814770 COVID-19_Lipid_C484 Serum sample from individuals with COVID-19 Sample collection C484 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C484_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C484_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C485 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 123 serum Days 10-12 SAMD01814771 COVID-19_Lipid_C485 Serum sample from individuals with COVID-19 Sample collection C485 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C485_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C485_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C486 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 126 serum Days 7-9 SAMD01814772 COVID-19_Lipid_C486 Serum sample from individuals with COVID-19 Sample collection C486 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C486_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C486_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C487 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 124 serum Days 10-12 SAMD01814773 COVID-19_Lipid_C487 Serum sample from individuals with COVID-19 Sample collection C487 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C487_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C487_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C488 Homo sapiens 9606 2021 Japan 38 SARS-CoV-2 COVID-19 149 serum Days 10-12 SAMD01814774 COVID-19_Lipid_C488 Serum sample from individuals with COVID-19 Sample collection C488 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C488_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C488_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C489 Homo sapiens 9606 2021 Japan 15 SARS-CoV-2 COVID-19 132 serum Days 1-3 SAMD01814775 COVID-19_Lipid_C489 Serum sample from individuals with COVID-19 Sample collection C489 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C489_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C489_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 1-3 C49 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 17 serum Days 19-24 SAMD01814776 COVID-19_Lipid_C49 Serum sample from individuals with COVID-19 Sample collection C49 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C49_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C49_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C490 Homo sapiens 9606 2021 Japan 15 SARS-CoV-2 COVID-19 132 serum Days 4-6 SAMD01814777 COVID-19_Lipid_C490 Serum sample from individuals with COVID-19 Sample collection C490 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C490_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C490_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C491 Homo sapiens 9606 2021 Japan 20 SARS-CoV-2 COVID-19 148 serum Days 1-3 SAMD01814778 COVID-19_Lipid_C491 Serum sample from individuals with COVID-19 Sample collection C491 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C491_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C491_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 1-3 C492 Homo sapiens 9606 2021 Japan 67 SARS-CoV-2 COVID-19 133 serum Days 4-6 SAMD01814779 COVID-19_Lipid_C492 Serum sample from individuals with COVID-19 Sample collection C492 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C492_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C492_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C493 Homo sapiens 9606 2020 Japan 77 SARS-CoV-2 COVID-19 121 serum Days 13-15 SAMD01814780 COVID-19_Lipid_C493 Serum sample from individuals with COVID-19 Sample collection C493 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C493_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C493_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C494 Homo sapiens 9606 2020 Japan 83 SARS-CoV-2 COVID-19 122 serum Days 10-12 SAMD01814781 COVID-19_Lipid_C494 Serum sample from individuals with COVID-19 Sample collection C494 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C494_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C494_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C495 Homo sapiens 9606 2020 Japan 55 SARS-CoV-2 COVID-19 129 serum Days 16-18 SAMD01814782 COVID-19_Lipid_C495 Serum sample from individuals with COVID-19 Sample collection C495 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C495_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C495_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C496 Homo sapiens 9606 2020 Japan 73 SARS-CoV-2 COVID-19 131 serum Days 7-9 SAMD01814783 COVID-19_Lipid_C496 Serum sample from individuals with COVID-19 Sample collection C496 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C496_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C496_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C497 Homo sapiens 9606 2020 Japan 64 SARS-CoV-2 COVID-19 125 serum Days 19-24 SAMD01814784 COVID-19_Lipid_C497 Serum sample from individuals with COVID-19 Sample collection C497 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C497_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C497_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C498 Homo sapiens 9606 2020 Japan 66 SARS-CoV-2 COVID-19 95 serum beyond Day 25 SAMD01814785 COVID-19_Lipid_C498 Serum sample from individuals with COVID-19 Sample collection C498 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C498_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C498_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C499 Homo sapiens 9606 2020 Japan 60 SARS-CoV-2 COVID-19 147 serum Days 7-9 SAMD01814786 COVID-19_Lipid_C499 Serum sample from individuals with COVID-19 Sample collection C499 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C499_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C499_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C5 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 13 serum Days 16-18 SAMD01814787 COVID-19_Lipid_C5 Serum sample from individuals with COVID-19 Sample collection C5 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C5_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C5_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C50 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 19 serum Days 16-18 SAMD01814788 COVID-19_Lipid_C50 Serum sample from individuals with COVID-19 Sample collection C50 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C50_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C50_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C500 Homo sapiens 9606 2020 Japan 73 SARS-CoV-2 COVID-19 131 serum Days 10-12 SAMD01814789 COVID-19_Lipid_C500 Serum sample from individuals with COVID-19 Sample collection C500 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C500_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C500_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C501 Homo sapiens 9606 2021 Japan 15 SARS-CoV-2 COVID-19 132 serum Days 7-9 SAMD01814790 COVID-19_Lipid_C501 Serum sample from individuals with COVID-19 Sample collection C501 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C501_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C501_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C502 Homo sapiens 9606 2021 Japan 20 SARS-CoV-2 COVID-19 148 serum Days 4-6 SAMD01814791 COVID-19_Lipid_C502 Serum sample from individuals with COVID-19 Sample collection C502 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C502_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C502_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C503 Homo sapiens 9606 2020 Japan 54 SARS-CoV-2 COVID-19 135 serum Days 10-12 SAMD01814792 COVID-19_Lipid_C503 Serum sample from individuals with COVID-19 Sample collection C503 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C503_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C503_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C504 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 134 serum Days 7-9 SAMD01814793 COVID-19_Lipid_C504 Serum sample from individuals with COVID-19 Sample collection C504 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C504_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C504_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C505 Homo sapiens 9606 2020 Japan 38 SARS-CoV-2 COVID-19 149 serum Days 13-15 SAMD01814794 COVID-19_Lipid_C505 Serum sample from individuals with COVID-19 Sample collection C505 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C505_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C505_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C506 Homo sapiens 9606 2020 Japan 47 SARS-CoV-2 COVID-19 141 serum Days 10-12 SAMD01814795 COVID-19_Lipid_C506 Serum sample from individuals with COVID-19 Sample collection C506 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C506_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C506_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C507 Homo sapiens 9606 2020 Japan 47 SARS-CoV-2 COVID-19 141 serum Days 13-15 SAMD01814796 COVID-19_Lipid_C507 Serum sample from individuals with COVID-19 Sample collection C507 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C507_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C507_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C508 Homo sapiens 9606 2020 Japan 83 SARS-CoV-2 COVID-19 122 serum Days 13-15 SAMD01814797 COVID-19_Lipid_C508 Serum sample from individuals with COVID-19 Sample collection C508 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C508_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C508_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C509 Homo sapiens 9606 2020 Japan 83 SARS-CoV-2 COVID-19 122 serum Days 16-18 SAMD01814798 COVID-19_Lipid_C509 Serum sample from individuals with COVID-19 Sample collection C509 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C509_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C509_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C51 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 21 serum Days 4-6 SAMD01814799 COVID-19_Lipid_C51 Serum sample from individuals with COVID-19 Sample collection C51 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C51_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C51_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C510 Homo sapiens 9606 2021 Japan 67 SARS-CoV-2 COVID-19 133 serum Days 7-9 SAMD01814800 COVID-19_Lipid_C510 Serum sample from individuals with COVID-19 Sample collection C510 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C510_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C510_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C511 Homo sapiens 9606 2021 Japan 67 SARS-CoV-2 COVID-19 133 serum Days 10-12 SAMD01814801 COVID-19_Lipid_C511 Serum sample from individuals with COVID-19 Sample collection C511 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C511_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C511_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C512 Homo sapiens 9606 2020 Japan 55 SARS-CoV-2 COVID-19 129 serum Days 19-24 SAMD01814802 COVID-19_Lipid_C512 Serum sample from individuals with COVID-19 Sample collection C512 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C512_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C512_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C513 Homo sapiens 9606 2020 Japan 60 SARS-CoV-2 COVID-19 147 serum Days 10-12 SAMD01814803 COVID-19_Lipid_C513 Serum sample from individuals with COVID-19 Sample collection C513 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C513_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C513_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C514 Homo sapiens 9606 2021 Japan 15 SARS-CoV-2 COVID-19 132 serum Days 7-9 SAMD01814804 COVID-19_Lipid_C514 Serum sample from individuals with COVID-19 Sample collection C514 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C514_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C514_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C515 Homo sapiens 9606 2021 Japan 20 SARS-CoV-2 COVID-19 148 serum Days 7-9 SAMD01814805 COVID-19_Lipid_C515 Serum sample from individuals with COVID-19 Sample collection C515 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C515_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C515_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C516 Homo sapiens 9606 2020 Japan 73 SARS-CoV-2 COVID-19 131 serum Days 13-15 SAMD01814806 COVID-19_Lipid_C516 Serum sample from individuals with COVID-19 Sample collection C516 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C516_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C516_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C517 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 134 serum Days 10-12 SAMD01814807 COVID-19_Lipid_C517 Serum sample from individuals with COVID-19 Sample collection C517 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C517_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C517_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C518 Homo sapiens 9606 2020 Japan 70 SARS-CoV-2 COVID-19 138 serum Days 10-12 SAMD01814808 COVID-19_Lipid_C518 Serum sample from individuals with COVID-19 Sample collection C518 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C518_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C518_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C519 Homo sapiens 9606 2020 Japan 54 SARS-CoV-2 COVID-19 135 serum Days 13-15 SAMD01814809 COVID-19_Lipid_C519 Serum sample from individuals with COVID-19 Sample collection C519 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C519_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C519_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C52 Homo sapiens 9606 2020 Japan 68 SARS-CoV-2 COVID-19 1 serum Days 13-15 SAMD01814810 COVID-19_Lipid_C52 Serum sample from individuals with COVID-19 Sample collection C52 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C52_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C52_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C520 Homo sapiens 9606 2021 Japan 72 SARS-CoV-2 COVID-19 136 serum Days 4-6 SAMD01814811 COVID-19_Lipid_C520 Serum sample from individuals with COVID-19 Sample collection C520 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C520_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C520_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C521 Homo sapiens 9606 2021 Japan 72 SARS-CoV-2 COVID-19 136 serum Days 7-9 SAMD01814812 COVID-19_Lipid_C521 Serum sample from individuals with COVID-19 Sample collection C521 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C521_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C521_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C522 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 139 serum Days 10-12 SAMD01814813 COVID-19_Lipid_C522 Serum sample from individuals with COVID-19 Sample collection C522 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C522_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C522_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C523 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 139 serum Days 13-15 SAMD01814814 COVID-19_Lipid_C523 Serum sample from individuals with COVID-19 Sample collection C523 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C523_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C523_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C524 Homo sapiens 9606 2021 Japan 60 SARS-CoV-2 COVID-19 140 serum Days 7-9 SAMD01814815 COVID-19_Lipid_C524 Serum sample from individuals with COVID-19 Sample collection C524 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C524_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C524_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C525 Homo sapiens 9606 2021 Japan 57 SARS-CoV-2 COVID-19 137 serum Days 7-9 SAMD01814816 COVID-19_Lipid_C525 Serum sample from individuals with COVID-19 Sample collection C525 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C525_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C525_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C526 Homo sapiens 9606 2020 Japan 26 SARS-CoV-2 COVID-19 108 serum beyond Day 25 SAMD01814817 COVID-19_Lipid_C526 Serum sample from individuals with COVID-19 Sample collection C526 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C526_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C526_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C527 Homo sapiens 9606 2021 Japan 47 SARS-CoV-2 COVID-19 144 serum Days 10-12 SAMD01814818 COVID-19_Lipid_C527 Serum sample from individuals with COVID-19 Sample collection C527 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C527_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C527_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C528 Homo sapiens 9606 2021 Japan 58 SARS-CoV-2 COVID-19 142 serum Days 7-9 SAMD01814819 COVID-19_Lipid_C528 Serum sample from individuals with COVID-19 Sample collection C528 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C528_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C528_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C529 Homo sapiens 9606 2021 Japan 60 SARS-CoV-2 COVID-19 143 serum Days 4-6 SAMD01814820 COVID-19_Lipid_C529 Serum sample from individuals with COVID-19 Sample collection C529 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C529_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C529_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C53 Homo sapiens 9606 2020 Japan 36 SARS-CoV-2 COVID-19 9 serum beyond Day 25 SAMD01814821 COVID-19_Lipid_C53 Serum sample from individuals with COVID-19 Sample collection C53 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C53_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C53_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C530 Homo sapiens 9606 2020 Japan 47 SARS-CoV-2 COVID-19 141 serum Days 16-18 SAMD01814822 COVID-19_Lipid_C530 Serum sample from individuals with COVID-19 Sample collection C530 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C530_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C530_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C531 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 134 serum Days 13-15 SAMD01814823 COVID-19_Lipid_C531 Serum sample from individuals with COVID-19 Sample collection C531 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C531_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C531_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C532 Homo sapiens 9606 2020 Japan 60 SARS-CoV-2 COVID-19 147 serum Days 13-15 SAMD01814824 COVID-19_Lipid_C532 Serum sample from individuals with COVID-19 Sample collection C532 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C532_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C532_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C533 Homo sapiens 9606 2020 Japan 70 SARS-CoV-2 COVID-19 138 serum Days 13-15 SAMD01814825 COVID-19_Lipid_C533 Serum sample from individuals with COVID-19 Sample collection C533 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C533_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C533_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C534 Homo sapiens 9606 2021 Japan 68 SARS-CoV-2 COVID-19 146 serum Days 13-15 SAMD01814826 COVID-19_Lipid_C534 Serum sample from individuals with COVID-19 Sample collection C534 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C534_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C534_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C535 Homo sapiens 9606 2021 Japan 54 SARS-CoV-2 COVID-19 145 serum Days 4-6 SAMD01814827 COVID-19_Lipid_C535 Serum sample from individuals with COVID-19 Sample collection C535 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C535_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C535_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C536 Homo sapiens 9606 2021 Japan 54 SARS-CoV-2 COVID-19 145 serum Days 7-9 SAMD01814828 COVID-19_Lipid_C536 Serum sample from individuals with COVID-19 Sample collection C536 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C536_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C536_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C537 Homo sapiens 9606 2021 Japan 72 SARS-CoV-2 COVID-19 136 serum Days 7-9 SAMD01814829 COVID-19_Lipid_C537 Serum sample from individuals with COVID-19 Sample collection C537 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C537_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C537_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C538 Homo sapiens 9606 2020 Japan 79 SARS-CoV-2 COVID-19 98 serum beyond Day 25 SAMD01814830 COVID-19_Lipid_C538 Serum sample from individuals with COVID-19 Sample collection C538 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C538_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C538_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C539 Homo sapiens 9606 2020 Japan 66 SARS-CoV-2 COVID-19 88 serum beyond Day 25 SAMD01814831 COVID-19_Lipid_C539 Serum sample from individuals with COVID-19 Sample collection C539 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C539_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C539_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C54 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 16 serum Days 16-18 SAMD01814832 COVID-19_Lipid_C54 Serum sample from individuals with COVID-19 Sample collection C54 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C54_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C54_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C540 Homo sapiens 9606 2020 Japan 46 SARS-CoV-2 COVID-19 104 serum beyond Day 25 SAMD01814833 COVID-19_Lipid_C540 Serum sample from individuals with COVID-19 Sample collection C540 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C540_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C540_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C541 Homo sapiens 9606 2021 Japan 47 SARS-CoV-2 COVID-19 144 serum Days 13-15 SAMD01814834 COVID-19_Lipid_C541 Serum sample from individuals with COVID-19 Sample collection C541 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C541_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C541_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C542 Homo sapiens 9606 2020 Japan 60 SARS-CoV-2 COVID-19 147 serum Days 16-18 SAMD01814835 COVID-19_Lipid_C542 Serum sample from individuals with COVID-19 Sample collection C542 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C542_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C542_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C543 Homo sapiens 9606 2021 Japan 67 SARS-CoV-2 COVID-19 133 serum Days 13-15 SAMD01814836 COVID-19_Lipid_C543 Serum sample from individuals with COVID-19 Sample collection C543 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C543_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C543_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C544 Homo sapiens 9606 2021 Japan 60 SARS-CoV-2 COVID-19 143 serum Days 7-9 SAMD01814837 COVID-19_Lipid_C544 Serum sample from individuals with COVID-19 Sample collection C544 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C544_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C544_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C545 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 134 serum Days 13-15 SAMD01814838 COVID-19_Lipid_C545 Serum sample from individuals with COVID-19 Sample collection C545 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C545_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C545_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C546 Homo sapiens 9606 2020 Japan 73 SARS-CoV-2 COVID-19 96 serum beyond Day 25 SAMD01814839 COVID-19_Lipid_C546 Serum sample from individuals with COVID-19 Sample collection C546 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C546_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C546_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C547 Homo sapiens 9606 2021 Japan 60 SARS-CoV-2 COVID-19 140 serum Days 10-12 SAMD01814840 COVID-19_Lipid_C547 Serum sample from individuals with COVID-19 Sample collection C547 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C547_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C547_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C548 Homo sapiens 9606 2020 Japan 70 SARS-CoV-2 COVID-19 138 serum Days 16-18 SAMD01814841 COVID-19_Lipid_C548 Serum sample from individuals with COVID-19 Sample collection C548 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C548_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C548_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C549 Homo sapiens 9606 2020 Japan 47 SARS-CoV-2 COVID-19 141 serum Days 19-24 SAMD01814842 COVID-19_Lipid_C549 Serum sample from individuals with COVID-19 Sample collection C549 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C549_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C549_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C55 Homo sapiens 9606 2020 Japan 71 SARS-CoV-2 COVID-19 20 serum Days 13-15 SAMD01814843 COVID-19_Lipid_C55 Serum sample from individuals with COVID-19 Sample collection C55 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C55_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C55_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C550 Homo sapiens 9606 2021 Japan 60 SARS-CoV-2 COVID-19 140 serum Days 13-15 SAMD01814844 COVID-19_Lipid_C550 Serum sample from individuals with COVID-19 Sample collection C550 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C550_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C550_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C551 Homo sapiens 9606 2021 Japan 47 SARS-CoV-2 COVID-19 144 serum Days 16-18 SAMD01814845 COVID-19_Lipid_C551 Serum sample from individuals with COVID-19 Sample collection C551 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C551_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C551_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C552 Homo sapiens 9606 2021 Japan 60 SARS-CoV-2 COVID-19 143 serum Days 10-12 SAMD01814846 COVID-19_Lipid_C552 Serum sample from individuals with COVID-19 Sample collection C552 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C552_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C552_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C553 Homo sapiens 9606 2021 Japan 68 SARS-CoV-2 COVID-19 146 serum Days 16-18 SAMD01814847 COVID-19_Lipid_C553 Serum sample from individuals with COVID-19 Sample collection C553 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C553_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C553_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C554 Homo sapiens 9606 2021 Japan 58 SARS-CoV-2 COVID-19 152 serum Days 10-12 SAMD01814848 COVID-19_Lipid_C554 Serum sample from individuals with COVID-19 Sample collection C554 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C554_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C554_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C555 Homo sapiens 9606 2021 Japan 78 SARS-CoV-2 COVID-19 153 serum Days 7-9 SAMD01814849 COVID-19_Lipid_C555 Serum sample from individuals with COVID-19 Sample collection C555 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C555_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C555_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C556 Homo sapiens 9606 2021 Japan 40 SARS-CoV-2 COVID-19 154 serum Days 7-9 SAMD01814850 COVID-19_Lipid_C556 Serum sample from individuals with COVID-19 Sample collection C556 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C556_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C556_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C557 Homo sapiens 9606 2021 Japan 97 SARS-CoV-2 COVID-19 155 serum Days 4-6 SAMD01814851 COVID-19_Lipid_C557 Serum sample from individuals with COVID-19 Sample collection C557 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C557_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C557_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C558 Homo sapiens 9606 2021 Japan 15 SARS-CoV-2 COVID-19 156 serum pre-onset SAMD01814852 COVID-19_Lipid_C558 Serum sample from individuals with COVID-19 Sample collection C558 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C558_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C558_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 pre-onset C559 Homo sapiens 9606 2021 Japan 15 SARS-CoV-2 COVID-19 156 serum Days 1-3 SAMD01814853 COVID-19_Lipid_C559 Serum sample from individuals with COVID-19 Sample collection C559 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C559_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C559_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 1-3 C56 Homo sapiens 9606 2020 Japan 76 SARS-CoV-2 COVID-19 18 serum Days 19-24 SAMD01814854 COVID-19_Lipid_C56 Serum sample from individuals with COVID-19 Sample collection C56 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C56_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C56_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C560 Homo sapiens 9606 2021 Japan 88 SARS-CoV-2 COVID-19 151 serum Days 4-6 SAMD01814855 COVID-19_Lipid_C560 Serum sample from individuals with COVID-19 Sample collection C560 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C560_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C560_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C561 Homo sapiens 9606 2021 Japan 88 SARS-CoV-2 COVID-19 151 serum Days 7-9 SAMD01814856 COVID-19_Lipid_C561 Serum sample from individuals with COVID-19 Sample collection C561 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C561_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C561_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C562 Homo sapiens 9606 2021 Japan 58 SARS-CoV-2 COVID-19 142 serum Days 13-15 SAMD01814857 COVID-19_Lipid_C562 Serum sample from individuals with COVID-19 Sample collection C562 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C562_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C562_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C563 Homo sapiens 9606 2021 Japan 71 SARS-CoV-2 COVID-19 158 serum Days 4-6 SAMD01814858 COVID-19_Lipid_C563 Serum sample from individuals with COVID-19 Sample collection C563 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C563_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C563_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C564 Homo sapiens 9606 2021 Japan 67 SARS-CoV-2 COVID-19 133 serum Days 16-18 SAMD01814859 COVID-19_Lipid_C564 Serum sample from individuals with COVID-19 Sample collection C564 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C564_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C564_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C565 Homo sapiens 9606 2021 Japan 65 SARS-CoV-2 COVID-19 159 serum Days 10-12 SAMD01814860 COVID-19_Lipid_C565 Serum sample from individuals with COVID-19 Sample collection C565 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C565_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C565_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C566 Homo sapiens 9606 2021 Japan 78 SARS-CoV-2 COVID-19 153 serum Days 10-12 SAMD01814861 COVID-19_Lipid_C566 Serum sample from individuals with COVID-19 Sample collection C566 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C566_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C566_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C567 Homo sapiens 9606 2021 Japan 40 SARS-CoV-2 COVID-19 154 serum Days 10-12 SAMD01814862 COVID-19_Lipid_C567 Serum sample from individuals with COVID-19 Sample collection C567 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C567_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C567_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C568 Homo sapiens 9606 2021 Japan 58 SARS-CoV-2 COVID-19 152 serum Days 13-15 SAMD01814863 COVID-19_Lipid_C568 Serum sample from individuals with COVID-19 Sample collection C568 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C568_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C568_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C569 Homo sapiens 9606 2021 Japan 97 SARS-CoV-2 COVID-19 155 serum Days 7-9 SAMD01814864 COVID-19_Lipid_C569 Serum sample from individuals with COVID-19 Sample collection C569 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C569_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C569_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C57 Homo sapiens 9606 2020 Japan 24 SARS-CoV-2 COVID-19 3 serum Days 13-15 SAMD01814865 COVID-19_Lipid_C57 Serum sample from individuals with COVID-19 Sample collection C57 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C57_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C57_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C570 Homo sapiens 9606 2021 Japan 71 SARS-CoV-2 COVID-19 157 serum Days 13-15 SAMD01814866 COVID-19_Lipid_C570 Serum sample from individuals with COVID-19 Sample collection C570 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C570_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C570_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C571 Homo sapiens 9606 2021 Japan 15 SARS-CoV-2 COVID-19 156 serum Days 4-6 SAMD01814867 COVID-19_Lipid_C571 Serum sample from individuals with COVID-19 Sample collection C571 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C571_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C571_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C572 Homo sapiens 9606 2021 Japan 47 SARS-CoV-2 COVID-19 144 serum Days 19-24 SAMD01814868 COVID-19_Lipid_C572 Serum sample from individuals with COVID-19 Sample collection C572 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C572_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C572_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C573 Homo sapiens 9606 2021 Japan 60 SARS-CoV-2 COVID-19 140 serum Days 16-18 SAMD01814869 COVID-19_Lipid_C573 Serum sample from individuals with COVID-19 Sample collection C573 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C573_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C573_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C574 Homo sapiens 9606 2021 Japan 67 SARS-CoV-2 COVID-19 133 serum Days 19-24 SAMD01814870 COVID-19_Lipid_C574 Serum sample from individuals with COVID-19 Sample collection C574 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C574_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C574_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C575 Homo sapiens 9606 2021 Japan 75 SARS-CoV-2 COVID-19 168 serum SAMD01814871 COVID-19_Lipid_C575 Serum sample from individuals with COVID-19 Sample collection C575 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C575_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C575_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 missing C576 Homo sapiens 9606 2021 Japan 71 SARS-CoV-2 COVID-19 158 serum Days 7-9 SAMD01814872 COVID-19_Lipid_C576 Serum sample from individuals with COVID-19 Sample collection C576 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C576_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C576_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C577 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 123 serum beyond Day 25 SAMD01814873 COVID-19_Lipid_C577 Serum sample from individuals with COVID-19 Sample collection C577 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C577_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C577_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C578 Homo sapiens 9606 2021 Japan 46 SARS-CoV-2 COVID-19 160 serum Days 4-6 SAMD01814874 COVID-19_Lipid_C578 Serum sample from individuals with COVID-19 Sample collection C578 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C578_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C578_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C579 Homo sapiens 9606 2021 Japan 73 SARS-CoV-2 COVID-19 161 serum Days 10-12 SAMD01814875 COVID-19_Lipid_C579 Serum sample from individuals with COVID-19 Sample collection C579 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C579_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C579_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C58 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 19 serum Days 19-24 SAMD01814876 COVID-19_Lipid_C58 Serum sample from individuals with COVID-19 Sample collection C58 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C58_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C58_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C580 Homo sapiens 9606 2020 Japan 63 SARS-CoV-2 COVID-19 94 serum beyond Day 25 SAMD01814877 COVID-19_Lipid_C580 Serum sample from individuals with COVID-19 Sample collection C580 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C580_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C580_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C581 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 103 serum beyond Day 25 SAMD01814878 COVID-19_Lipid_C581 Serum sample from individuals with COVID-19 Sample collection C581 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C581_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C581_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C582 Homo sapiens 9606 2021 Japan 40 SARS-CoV-2 COVID-19 154 serum Days 13-15 SAMD01814879 COVID-19_Lipid_C582 Serum sample from individuals with COVID-19 Sample collection C582 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C582_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C582_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C583 Homo sapiens 9606 2021 Japan 88 SARS-CoV-2 COVID-19 151 serum Days 10-12 SAMD01814880 COVID-19_Lipid_C583 Serum sample from individuals with COVID-19 Sample collection C583 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C583_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C583_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C584 Homo sapiens 9606 2021 Japan 65 SARS-CoV-2 COVID-19 159 serum Days 13-15 SAMD01814881 COVID-19_Lipid_C584 Serum sample from individuals with COVID-19 Sample collection C584 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C584_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C584_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C585 Homo sapiens 9606 2021 Japan 68 SARS-CoV-2 COVID-19 146 serum Days 19-24 SAMD01814882 COVID-19_Lipid_C585 Serum sample from individuals with COVID-19 Sample collection C585 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C585_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C585_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C586 Homo sapiens 9606 2020 Japan 64 SARS-CoV-2 COVID-19 125 serum beyond Day 25 SAMD01814883 COVID-19_Lipid_C586 Serum sample from individuals with COVID-19 Sample collection C586 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C586_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C586_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C587 Homo sapiens 9606 2021 Japan 46 SARS-CoV-2 COVID-19 160 serum Days 7-9 SAMD01814884 COVID-19_Lipid_C587 Serum sample from individuals with COVID-19 Sample collection C587 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C587_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C587_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C588 Homo sapiens 9606 2021 Japan 15 SARS-CoV-2 COVID-19 156 serum Days 7-9 SAMD01814885 COVID-19_Lipid_C588 Serum sample from individuals with COVID-19 Sample collection C588 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C588_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C588_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C589 Homo sapiens 9606 2021 Japan 75 SARS-CoV-2 COVID-19 168 serum SAMD01814886 COVID-19_Lipid_C589 Serum sample from individuals with COVID-19 Sample collection C589 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C589_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C589_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 missing C59 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 21 serum Days 7-9 SAMD01814887 COVID-19_Lipid_C59 Serum sample from individuals with COVID-19 Sample collection C59 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C59_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C59_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C590 Homo sapiens 9606 2020 Japan 79 SARS-CoV-2 COVID-19 92 serum beyond Day 25 SAMD01814888 COVID-19_Lipid_C590 Serum sample from individuals with COVID-19 Sample collection C590 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C590_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C590_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C591 Homo sapiens 9606 2021 Japan 71 SARS-CoV-2 COVID-19 158 serum Days 10-12 SAMD01814889 COVID-19_Lipid_C591 Serum sample from individuals with COVID-19 Sample collection C591 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C591_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C591_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C592 Homo sapiens 9606 2021 Japan 61 SARS-CoV-2 COVID-19 163 serum Days 10-12 SAMD01814890 COVID-19_Lipid_C592 Serum sample from individuals with COVID-19 Sample collection C592 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C592_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C592_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C593 Homo sapiens 9606 2021 Japan 47 SARS-CoV-2 COVID-19 162 serum pre-onset SAMD01814891 COVID-19_Lipid_C593 Serum sample from individuals with COVID-19 Sample collection C593 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C593_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C593_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 pre-onset C594 Homo sapiens 9606 2021 Japan 47 SARS-CoV-2 COVID-19 162 serum Days 4-6 SAMD01814892 COVID-19_Lipid_C594 Serum sample from individuals with COVID-19 Sample collection C594 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C594_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C594_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C595 Homo sapiens 9606 2021 Japan 47 SARS-CoV-2 COVID-19 162 serum Days 7-9 SAMD01814893 COVID-19_Lipid_C595 Serum sample from individuals with COVID-19 Sample collection C595 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C595_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C595_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C596 Homo sapiens 9606 2021 Japan 47 SARS-CoV-2 COVID-19 162 serum Days 10-12 SAMD01814894 COVID-19_Lipid_C596 Serum sample from individuals with COVID-19 Sample collection C596 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C596_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C596_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C597 Homo sapiens 9606 2021 Japan 73 SARS-CoV-2 COVID-19 161 serum Days 13-15 SAMD01814895 COVID-19_Lipid_C597 Serum sample from individuals with COVID-19 Sample collection C597 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C597_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C597_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C598 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 164 serum Days 4-6 SAMD01814896 COVID-19_Lipid_C598 Serum sample from individuals with COVID-19 Sample collection C598 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C598_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C598_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C599 Homo sapiens 9606 2021 Japan 78 SARS-CoV-2 COVID-19 166 serum Days 7-9 SAMD01814897 COVID-19_Lipid_C599 Serum sample from individuals with COVID-19 Sample collection C599 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C599_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C599_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C6 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 16 serum Days 7-9 SAMD01814898 COVID-19_Lipid_C6 Serum sample from individuals with COVID-19 Sample collection C6 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C6_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C6_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C60 Homo sapiens 9606 2020 Japan 68 SARS-CoV-2 COVID-19 1 serum Days 16-18 SAMD01814899 COVID-19_Lipid_C60 Serum sample from individuals with COVID-19 Sample collection C60 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C60_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C60_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C600 Homo sapiens 9606 2021 Japan 78 SARS-CoV-2 COVID-19 166 serum Days 10-12 SAMD01814900 COVID-19_Lipid_C600 Serum sample from individuals with COVID-19 Sample collection C600 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C600_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C600_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C601 Homo sapiens 9606 2021 Japan 88 SARS-CoV-2 COVID-19 151 serum Days 13-15 SAMD01814901 COVID-19_Lipid_C601 Serum sample from individuals with COVID-19 Sample collection C601 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C601_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C601_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C602 Homo sapiens 9606 2021 Japan 65 SARS-CoV-2 COVID-19 159 serum Days 16-18 SAMD01814902 COVID-19_Lipid_C602 Serum sample from individuals with COVID-19 Sample collection C602 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C602_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C602_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C603 Homo sapiens 9606 2021 Japan 40 SARS-CoV-2 COVID-19 154 serum Days 16-18 SAMD01814903 COVID-19_Lipid_C603 Serum sample from individuals with COVID-19 Sample collection C603 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C603_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C603_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C604 Homo sapiens 9606 2021 Japan 83 SARS-CoV-2 COVID-19 167 serum Days 10-12 SAMD01814904 COVID-19_Lipid_C604 Serum sample from individuals with COVID-19 Sample collection C604 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C604_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C604_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C605 Homo sapiens 9606 2021 Japan 15 SARS-CoV-2 COVID-19 156 serum Days 10-12 SAMD01814905 COVID-19_Lipid_C605 Serum sample from individuals with COVID-19 Sample collection C605 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C605_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C605_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C606 Homo sapiens 9606 2020 Japan 48 SARS-CoV-2 COVID-19 99 serum beyond Day 25 SAMD01814906 COVID-19_Lipid_C606 Serum sample from individuals with COVID-19 Sample collection C606 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C606_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C606_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C607 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 110 serum beyond Day 25 SAMD01814907 COVID-19_Lipid_C607 Serum sample from individuals with COVID-19 Sample collection C607 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C607_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C607_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C608 Homo sapiens 9606 2021 Japan 46 SARS-CoV-2 COVID-19 160 serum Days 10-12 SAMD01814908 COVID-19_Lipid_C608 Serum sample from individuals with COVID-19 Sample collection C608 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C608_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C608_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C609 Homo sapiens 9606 2021 Japan 61 SARS-CoV-2 COVID-19 163 serum Days 13-15 SAMD01814909 COVID-19_Lipid_C609 Serum sample from individuals with COVID-19 Sample collection C609 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C609_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C609_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C61 Homo sapiens 9606 2020 Japan 68 SARS-CoV-2 COVID-19 8 serum beyond Day 25 SAMD01814910 COVID-19_Lipid_C61 Serum sample from individuals with COVID-19 Sample collection C61 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C61_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C61_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C610 Homo sapiens 9606 2021 Japan 73 SARS-CoV-2 COVID-19 169 serum Days 7-9 SAMD01814911 COVID-19_Lipid_C610 Serum sample from individuals with COVID-19 Sample collection C610 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C610_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C610_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C611 Homo sapiens 9606 2021 Japan 61 SARS-CoV-2 COVID-19 163 serum Days 16-18 SAMD01814912 COVID-19_Lipid_C611 Serum sample from individuals with COVID-19 Sample collection C611 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C611_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C611_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C612 Homo sapiens 9606 2021 Japan 71 SARS-CoV-2 COVID-19 158 serum Days 13-15 SAMD01814913 COVID-19_Lipid_C612 Serum sample from individuals with COVID-19 Sample collection C612 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C612_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C612_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C613 Homo sapiens 9606 2021 Japan 47 SARS-CoV-2 COVID-19 162 serum Days 10-12 SAMD01814914 COVID-19_Lipid_C613 Serum sample from individuals with COVID-19 Sample collection C613 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C613_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C613_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C614 Homo sapiens 9606 2021 Japan 97 SARS-CoV-2 COVID-19 155 serum Days 13-15 SAMD01814915 COVID-19_Lipid_C614 Serum sample from individuals with COVID-19 Sample collection C614 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C614_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C614_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C615 Homo sapiens 9606 2021 Japan 75 SARS-CoV-2 COVID-19 168 serum SAMD01814916 COVID-19_Lipid_C615 Serum sample from individuals with COVID-19 Sample collection C615 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C615_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C615_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 missing C616 Homo sapiens 9606 2020 Japan 60 SARS-CoV-2 COVID-19 147 serum beyond Day 25 SAMD01814917 COVID-19_Lipid_C616 Serum sample from individuals with COVID-19 Sample collection C616 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C616_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C616_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C617 Homo sapiens 9606 2021 Japan 78 SARS-CoV-2 COVID-19 170 serum Days 10-12 SAMD01814918 COVID-19_Lipid_C617 Serum sample from individuals with COVID-19 Sample collection C617 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C617_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C617_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C618 Homo sapiens 9606 2021 Japan 40 SARS-CoV-2 COVID-19 154 serum Days 19-24 SAMD01814919 COVID-19_Lipid_C618 Serum sample from individuals with COVID-19 Sample collection C618 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C618_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C618_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C619 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 164 serum Days 7-9 SAMD01814920 COVID-19_Lipid_C619 Serum sample from individuals with COVID-19 Sample collection C619 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C619_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C619_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C62 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 16 serum Days 19-24 SAMD01814921 COVID-19_Lipid_C62 Serum sample from individuals with COVID-19 Sample collection C62 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C62_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C62_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C620 Homo sapiens 9606 2021 Japan 88 SARS-CoV-2 COVID-19 151 serum Days 16-18 SAMD01814922 COVID-19_Lipid_C620 Serum sample from individuals with COVID-19 Sample collection C620 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C620_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C620_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C621 Homo sapiens 9606 2021 Japan 65 SARS-CoV-2 COVID-19 159 serum Days 19-24 SAMD01814923 COVID-19_Lipid_C621 Serum sample from individuals with COVID-19 Sample collection C621 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C621_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C621_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C622 Homo sapiens 9606 2021 Japan 83 SARS-CoV-2 COVID-19 167 serum Days 13-15 SAMD01814924 COVID-19_Lipid_C622 Serum sample from individuals with COVID-19 Sample collection C622 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C622_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C622_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C623 Homo sapiens 9606 2021 Japan 78 SARS-CoV-2 COVID-19 170 serum Days 13-15 SAMD01814925 COVID-19_Lipid_C623 Serum sample from individuals with COVID-19 Sample collection C623 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C623_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C623_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C624 Homo sapiens 9606 2021 Japan 47 SARS-CoV-2 COVID-19 162 serum Days 13-15 SAMD01814926 COVID-19_Lipid_C624 Serum sample from individuals with COVID-19 Sample collection C624 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C624_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C624_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C625 Homo sapiens 9606 2020 Japan 32 SARS-CoV-2 COVID-19 109 serum beyond Day 25 SAMD01814927 COVID-19_Lipid_C625 Serum sample from individuals with COVID-19 Sample collection C625 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C625_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C625_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C626 Homo sapiens 9606 2021 Japan 53 SARS-CoV-2 COVID-19 171 serum pre-onset SAMD01814928 COVID-19_Lipid_C626 Serum sample from individuals with COVID-19 Sample collection C626 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C626_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C626_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 pre-onset C627 Homo sapiens 9606 2021 Japan 53 SARS-CoV-2 COVID-19 171 serum Days 1-3 SAMD01814929 COVID-19_Lipid_C627 Serum sample from individuals with COVID-19 Sample collection C627 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C627_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C627_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 1-3 C628 Homo sapiens 9606 2021 Japan 73 SARS-CoV-2 COVID-19 169 serum Days 10-12 SAMD01814930 COVID-19_Lipid_C628 Serum sample from individuals with COVID-19 Sample collection C628 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C628_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C628_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C629 Homo sapiens 9606 2021 Japan 78 SARS-CoV-2 COVID-19 166 serum Days 13-15 SAMD01814931 COVID-19_Lipid_C629 Serum sample from individuals with COVID-19 Sample collection C629 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C629_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C629_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C63 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 21 serum Days 4-6 SAMD01814932 COVID-19_Lipid_C63 Serum sample from individuals with COVID-19 Sample collection C63 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C63_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C63_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C630 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 128 serum beyond Day 25 SAMD01814933 COVID-19_Lipid_C630 Serum sample from individuals with COVID-19 Sample collection C630 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C630_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C630_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C631 Homo sapiens 9606 2020 Japan 52 SARS-CoV-2 COVID-19 126 serum beyond Day 25 SAMD01814934 COVID-19_Lipid_C631 Serum sample from individuals with COVID-19 Sample collection C631 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C631_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C631_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C632 Homo sapiens 9606 2021 Japan 46 SARS-CoV-2 COVID-19 160 serum Days 13-15 SAMD01814935 COVID-19_Lipid_C632 Serum sample from individuals with COVID-19 Sample collection C632 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C632_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C632_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C633 Homo sapiens 9606 2021 Japan 19 SARS-CoV-2 COVID-19 173 serum SAMD01814936 COVID-19_Lipid_C633 Serum sample from individuals with COVID-19 Sample collection C633 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C633_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C633_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 missing C634 Homo sapiens 9606 2021 Japan 32 SARS-CoV-2 COVID-19 174 serum Days 4-6 SAMD01814937 COVID-19_Lipid_C634 Serum sample from individuals with COVID-19 Sample collection C634 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C634_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C634_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C635 Homo sapiens 9606 2021 Japan 53 SARS-CoV-2 COVID-19 171 serum Days 4-6 SAMD01814938 COVID-19_Lipid_C635 Serum sample from individuals with COVID-19 Sample collection C635 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C635_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C635_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C636 Homo sapiens 9606 2021 Japan 71 SARS-CoV-2 COVID-19 158 serum Days 16-18 SAMD01814939 COVID-19_Lipid_C636 Serum sample from individuals with COVID-19 Sample collection C636 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C636_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C636_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C637 Homo sapiens 9606 2021 Japan 65 SARS-CoV-2 COVID-19 175 serum Days 1-3 SAMD01814940 COVID-19_Lipid_C637 Serum sample from individuals with COVID-19 Sample collection C637 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C637_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C637_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 1-3 C638 Homo sapiens 9606 2021 Japan 65 SARS-CoV-2 COVID-19 175 serum Days 4-6 SAMD01814941 COVID-19_Lipid_C638 Serum sample from individuals with COVID-19 Sample collection C638 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C638_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C638_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C639 Homo sapiens 9606 2021 Japan 31 SARS-CoV-2 COVID-19 173 serum SAMD01814942 COVID-19_Lipid_C639 Serum sample from individuals with COVID-19 Sample collection C639 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C639_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C639_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 missing C64 Homo sapiens 9606 2020 Japan 68 SARS-CoV-2 COVID-19 1 serum Days 16-18 SAMD01814943 COVID-19_Lipid_C64 Serum sample from individuals with COVID-19 Sample collection C64 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C64_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C64_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C640 Homo sapiens 9606 2021 Japan 73 SARS-CoV-2 COVID-19 169 serum Days 13-15 SAMD01814944 COVID-19_Lipid_C640 Serum sample from individuals with COVID-19 Sample collection C640 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C640_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C640_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C641 Homo sapiens 9606 2021 Japan 78 SARS-CoV-2 COVID-19 170 serum Days 16-18 SAMD01814945 COVID-19_Lipid_C641 Serum sample from individuals with COVID-19 Sample collection C641 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C641_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C641_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C642 Homo sapiens 9606 2021 Japan 71 SARS-CoV-2 COVID-19 158 serum Days 19-24 SAMD01814946 COVID-19_Lipid_C642 Serum sample from individuals with COVID-19 Sample collection C642 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C642_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C642_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C643 Homo sapiens 9606 2021 Japan 83 SARS-CoV-2 COVID-19 167 serum Days 16-18 SAMD01814947 COVID-19_Lipid_C643 Serum sample from individuals with COVID-19 Sample collection C643 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C643_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C643_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C644 Homo sapiens 9606 2021 Japan 53 SARS-CoV-2 COVID-19 171 serum Days 7-9 SAMD01814948 COVID-19_Lipid_C644 Serum sample from individuals with COVID-19 Sample collection C644 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C644_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C644_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C645 Homo sapiens 9606 2021 Japan 78 SARS-CoV-2 COVID-19 166 serum Days 16-18 SAMD01814949 COVID-19_Lipid_C645 Serum sample from individuals with COVID-19 Sample collection C645 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C645_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C645_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C646 Homo sapiens 9606 2021 Japan 86 SARS-CoV-2 COVID-19 186 serum Days 10-12 SAMD01814950 COVID-19_Lipid_C646 Serum sample from individuals with COVID-19 Sample collection C646 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C646_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C646_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C647 Homo sapiens 9606 2021 Japan 97 SARS-CoV-2 COVID-19 155 serum Days 19-24 SAMD01814951 COVID-19_Lipid_C647 Serum sample from individuals with COVID-19 Sample collection C647 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C647_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C647_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C648 Homo sapiens 9606 2021 Japan 83 SARS-CoV-2 COVID-19 167 serum Days 19-24 SAMD01814952 COVID-19_Lipid_C648 Serum sample from individuals with COVID-19 Sample collection C648 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C648_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C648_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C649 Homo sapiens 9606 2021 Japan 78 SARS-CoV-2 COVID-19 166 serum Days 19-24 SAMD01814953 COVID-19_Lipid_C649 Serum sample from individuals with COVID-19 Sample collection C649 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C649_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C649_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C65 Homo sapiens 9606 2020 Japan 71 SARS-CoV-2 COVID-19 20 serum Days 16-18 SAMD01814954 COVID-19_Lipid_C65 Serum sample from individuals with COVID-19 Sample collection C65 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C65_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C65_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C650 Homo sapiens 9606 2021 Japan 73 SARS-CoV-2 COVID-19 169 serum Days 16-18 SAMD01814955 COVID-19_Lipid_C650 Serum sample from individuals with COVID-19 Sample collection C650 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C650_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C650_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C651 Homo sapiens 9606 2021 Japan 78 SARS-CoV-2 COVID-19 170 serum Days 19-24 SAMD01814956 COVID-19_Lipid_C651 Serum sample from individuals with COVID-19 Sample collection C651 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C651_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C651_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C652 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 115 serum beyond Day 25 SAMD01814957 COVID-19_Lipid_C652 Serum sample from individuals with COVID-19 Sample collection C652 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C652_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C652_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C653 Homo sapiens 9606 2020 Japan 46 SARS-CoV-2 COVID-19 116 serum beyond Day 25 SAMD01814958 COVID-19_Lipid_C653 Serum sample from individuals with COVID-19 Sample collection C653 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C653_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C653_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C654 Homo sapiens 9606 2020 Japan 54 SARS-CoV-2 COVID-19 112 serum beyond Day 25 SAMD01814959 COVID-19_Lipid_C654 Serum sample from individuals with COVID-19 Sample collection C654 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C654_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C654_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C655 Homo sapiens 9606 2021 Japan 47 SARS-CoV-2 COVID-19 162 serum Days 19-24 SAMD01814960 COVID-19_Lipid_C655 Serum sample from individuals with COVID-19 Sample collection C655 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C655_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C655_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C656 Homo sapiens 9606 2021 Japan 46 SARS-CoV-2 COVID-19 160 serum Days 19-24 SAMD01814961 COVID-19_Lipid_C656 Serum sample from individuals with COVID-19 Sample collection C656 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C656_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C656_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C657 Homo sapiens 9606 2021 Japan 65 SARS-CoV-2 COVID-19 175 serum Days 7-9 SAMD01814962 COVID-19_Lipid_C657 Serum sample from individuals with COVID-19 Sample collection C657 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C657_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C657_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C658 Homo sapiens 9606 2021 Japan 91 SARS-CoV-2 COVID-19 179 serum Days 10-12 SAMD01814963 COVID-19_Lipid_C658 Serum sample from individuals with COVID-19 Sample collection C658 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C658_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C658_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C659 Homo sapiens 9606 2021 Japan 67 SARS-CoV-2 COVID-19 133 serum beyond Day 25 SAMD01814964 COVID-19_Lipid_C659 Serum sample from individuals with COVID-19 Sample collection C659 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C659_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C659_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C66 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 21 serum Days 10-12 SAMD01814965 COVID-19_Lipid_C66 Serum sample from individuals with COVID-19 Sample collection C66 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C66_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C66_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C660 Homo sapiens 9606 2021 Japan 44 SARS-CoV-2 COVID-19 178 serum Days 7-9 SAMD01814966 COVID-19_Lipid_C660 Serum sample from individuals with COVID-19 Sample collection C660 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C660_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C660_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C661 Homo sapiens 9606 2021 Japan 48 SARS-CoV-2 COVID-19 176 serum Days 10-12 SAMD01814967 COVID-19_Lipid_C661 Serum sample from individuals with COVID-19 Sample collection C661 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C661_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C661_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C662 Homo sapiens 9606 2020 Japan 57 SARS-CoV-2 COVID-19 119 serum beyond Day 25 SAMD01814968 COVID-19_Lipid_C662 Serum sample from individuals with COVID-19 Sample collection C662 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C662_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C662_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C663 Homo sapiens 9606 2020 Japan 47 SARS-CoV-2 COVID-19 141 serum beyond Day 25 SAMD01814969 COVID-19_Lipid_C663 Serum sample from individuals with COVID-19 Sample collection C663 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C663_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C663_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C664 Homo sapiens 9606 2021 Japan 72 SARS-CoV-2 COVID-19 177 serum Days 13-15 SAMD01814970 COVID-19_Lipid_C664 Serum sample from individuals with COVID-19 Sample collection C664 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C664_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C664_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C665 Homo sapiens 9606 2021 Japan 80 SARS-CoV-2 COVID-19 180 serum Days 4-6 SAMD01814971 COVID-19_Lipid_C665 Serum sample from individuals with COVID-19 Sample collection C665 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C665_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C665_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C666 Homo sapiens 9606 2021 Japan 86 SARS-CoV-2 COVID-19 186 serum Days 13-15 SAMD01814972 COVID-19_Lipid_C666 Serum sample from individuals with COVID-19 Sample collection C666 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C666_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C666_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C667 Homo sapiens 9606 2021 Japan 47 SARS-CoV-2 COVID-19 144 serum beyond Day 25 SAMD01814973 COVID-19_Lipid_C667 Serum sample from individuals with COVID-19 Sample collection C667 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C667_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C667_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C668 Homo sapiens 9606 2021 Japan 73 SARS-CoV-2 COVID-19 169 serum Days 19-24 SAMD01814974 COVID-19_Lipid_C668 Serum sample from individuals with COVID-19 Sample collection C668 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C668_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C668_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C669 Homo sapiens 9606 2021 Japan 65 SARS-CoV-2 COVID-19 159 serum beyond Day 25 SAMD01814975 COVID-19_Lipid_C669 Serum sample from individuals with COVID-19 Sample collection C669 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C669_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C669_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C67 Homo sapiens 9606 2020 Japan 24 SARS-CoV-2 COVID-19 3 serum Days 16-18 SAMD01814976 COVID-19_Lipid_C67 Serum sample from individuals with COVID-19 Sample collection C67 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C67_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C67_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C670 Homo sapiens 9606 2021 Japan 72 SARS-CoV-2 COVID-19 177 serum Days 16-18 SAMD01814977 COVID-19_Lipid_C670 Serum sample from individuals with COVID-19 Sample collection C670 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C670_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C670_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C671 Homo sapiens 9606 2021 Japan 44 SARS-CoV-2 COVID-19 178 serum Days 10-12 SAMD01814978 COVID-19_Lipid_C671 Serum sample from individuals with COVID-19 Sample collection C671 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C671_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C671_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C672 Homo sapiens 9606 2021 Japan 91 SARS-CoV-2 COVID-19 179 serum Days 13-15 SAMD01814979 COVID-19_Lipid_C672 Serum sample from individuals with COVID-19 Sample collection C672 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C672_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C672_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C673 Homo sapiens 9606 2021 Japan 80 SARS-CoV-2 COVID-19 180 serum Days 7-9 SAMD01814980 COVID-19_Lipid_C673 Serum sample from individuals with COVID-19 Sample collection C673 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C673_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C673_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C674 Homo sapiens 9606 2021 Japan 48 SARS-CoV-2 COVID-19 176 serum Days 13-15 SAMD01814981 COVID-19_Lipid_C674 Serum sample from individuals with COVID-19 Sample collection C674 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C674_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C674_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C675 Homo sapiens 9606 2021 Japan 83 SARS-CoV-2 COVID-19 181 serum Days 1-3 SAMD01814982 COVID-19_Lipid_C675 Serum sample from individuals with COVID-19 Sample collection C675 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C675_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C675_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 1-3 C676 Homo sapiens 9606 2021 Japan 42 SARS-CoV-2 COVID-19 182 serum Days 7-9 SAMD01814983 COVID-19_Lipid_C676 Serum sample from individuals with COVID-19 Sample collection C676 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C676_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C676_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C677 Homo sapiens 9606 2021 Japan 91 SARS-CoV-2 COVID-19 179 serum Days 16-18 SAMD01814984 COVID-19_Lipid_C677 Serum sample from individuals with COVID-19 Sample collection C677 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C677_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C677_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C678 Homo sapiens 9606 2021 Japan 42 SARS-CoV-2 COVID-19 182 serum Days 10-12 SAMD01814985 COVID-19_Lipid_C678 Serum sample from individuals with COVID-19 Sample collection C678 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C678_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C678_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C679 Homo sapiens 9606 2021 Japan 15 SARS-CoV-2 COVID-19 132 serum beyond Day 25 SAMD01814986 COVID-19_Lipid_C679 Serum sample from individuals with COVID-19 Sample collection C679 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C679_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C679_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C68 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 10 serum beyond Day 25 SAMD01814987 COVID-19_Lipid_C68 Serum sample from individuals with COVID-19 Sample collection C68 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C68_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C68_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C680 Homo sapiens 9606 2021 Japan 83 SARS-CoV-2 COVID-19 181 serum Days 4-6 SAMD01814988 COVID-19_Lipid_C680 Serum sample from individuals with COVID-19 Sample collection C680 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C680_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C680_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C681 Homo sapiens 9606 2021 Japan 72 SARS-CoV-2 COVID-19 177 serum Days 19-24 SAMD01814989 COVID-19_Lipid_C681 Serum sample from individuals with COVID-19 Sample collection C681 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C681_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C681_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C682 Homo sapiens 9606 2021 Japan 27 SARS-CoV-2 COVID-19 183 serum Days 1-3 SAMD01814990 COVID-19_Lipid_C682 Serum sample from individuals with COVID-19 Sample collection C682 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C682_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C682_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 1-3 C683 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 284 serum Days 7-9 SAMD01814991 COVID-19_Lipid_C683 Serum sample from individuals with COVID-19 Sample collection C683 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C683_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C683_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C684 Homo sapiens 9606 2021 Japan 80 SARS-CoV-2 COVID-19 180 serum Days 10-12 SAMD01814992 COVID-19_Lipid_C684 Serum sample from individuals with COVID-19 Sample collection C684 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C684_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C684_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C685 Homo sapiens 9606 2021 Japan 27 SARS-CoV-2 COVID-19 183 serum Days 4-6 SAMD01814993 COVID-19_Lipid_C685 Serum sample from individuals with COVID-19 Sample collection C685 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C685_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C685_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C686 Homo sapiens 9606 2021 Japan 83 SARS-CoV-2 COVID-19 167 serum beyond Day 25 SAMD01814994 COVID-19_Lipid_C686 Serum sample from individuals with COVID-19 Sample collection C686 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C686_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C686_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C687 Homo sapiens 9606 2021 Japan 64 SARS-CoV-2 COVID-19 185 serum Days 10-12 SAMD01814995 COVID-19_Lipid_C687 Serum sample from individuals with COVID-19 Sample collection C687 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C687_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C687_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C688 Homo sapiens 9606 2021 Japan 75 SARS-CoV-2 COVID-19 187 serum Days 4-6 SAMD01814996 COVID-19_Lipid_C688 Serum sample from individuals with COVID-19 Sample collection C688 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C688_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C688_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C689 Homo sapiens 9606 2021 Japan 75 SARS-CoV-2 COVID-19 187 serum Days 7-9 SAMD01814997 COVID-19_Lipid_C689 Serum sample from individuals with COVID-19 Sample collection C689 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C689_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C689_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C69 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 15 serum beyond Day 25 SAMD01814998 COVID-19_Lipid_C69 Serum sample from individuals with COVID-19 Sample collection C69 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C69_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C69_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C690 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 284 serum Days 10-12 SAMD01814999 COVID-19_Lipid_C690 Serum sample from individuals with COVID-19 Sample collection C690 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C690_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C690_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C691 Homo sapiens 9606 2021 Japan 64 SARS-CoV-2 COVID-19 185 serum Days 13-15 SAMD01815000 COVID-19_Lipid_C691 Serum sample from individuals with COVID-19 Sample collection C691 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C691_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C691_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C692 Homo sapiens 9606 2021 Japan 91 SARS-CoV-2 COVID-19 179 serum Days 19-24 SAMD01815001 COVID-19_Lipid_C692 Serum sample from individuals with COVID-19 Sample collection C692 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C692_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C692_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C693 Homo sapiens 9606 2021 Japan 78 SARS-CoV-2 COVID-19 170 serum beyond Day 25 SAMD01815002 COVID-19_Lipid_C693 Serum sample from individuals with COVID-19 Sample collection C693 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C693_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C693_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C694 Homo sapiens 9606 2021 Japan 20 SARS-CoV-2 COVID-19 148 serum beyond Day 25 SAMD01815003 COVID-19_Lipid_C694 Serum sample from individuals with COVID-19 Sample collection C694 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C694_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C694_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C695 Homo sapiens 9606 2021 Japan 80 SARS-CoV-2 COVID-19 180 serum Days 16-18 SAMD01815004 COVID-19_Lipid_C695 Serum sample from individuals with COVID-19 Sample collection C695 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C695_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C695_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C696 Homo sapiens 9606 2021 Japan 15 SARS-CoV-2 COVID-19 156 serum beyond Day 25 SAMD01815005 COVID-19_Lipid_C696 Serum sample from individuals with COVID-19 Sample collection C696 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C696_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C696_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C697 Homo sapiens 9606 2021 Japan 46 SARS-CoV-2 COVID-19 160 serum beyond Day 25 SAMD01815006 COVID-19_Lipid_C697 Serum sample from individuals with COVID-19 Sample collection C697 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C697_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C697_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C698 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 284 serum Days 13-15 SAMD01815007 COVID-19_Lipid_C698 Serum sample from individuals with COVID-19 Sample collection C698 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C698_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C698_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C699 Homo sapiens 9606 2021 Japan 80 SARS-CoV-2 COVID-19 180 serum Days 19-24 SAMD01815008 COVID-19_Lipid_C699 Serum sample from individuals with COVID-19 Sample collection C699 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C699_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C699_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C7 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 16 serum Days 10-12 SAMD01815009 COVID-19_Lipid_C7 Serum sample from individuals with COVID-19 Sample collection C7 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C7_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C7_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C70 Homo sapiens 9606 2020 Japan 76 SARS-CoV-2 COVID-19 22 serum Days 4-6 SAMD01815010 COVID-19_Lipid_C70 Serum sample from individuals with COVID-19 Sample collection C70 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C70_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C70_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C700 Homo sapiens 9606 2021 Japan 69 SARS-CoV-2 COVID-19 124 serum beyond Day 25 SAMD01815011 COVID-19_Lipid_C700 Serum sample from individuals with COVID-19 Sample collection C700 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C700_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C700_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C701 Homo sapiens 9606 2021 Japan 44 SARS-CoV-2 COVID-19 188 serum Days 4-6 SAMD01815012 COVID-19_Lipid_C701 Serum sample from individuals with COVID-19 Sample collection C701 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C701_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C701_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C702 Homo sapiens 9606 2021 Japan 88 SARS-CoV-2 COVID-19 151 serum beyond Day 25 SAMD01815013 COVID-19_Lipid_C702 Serum sample from individuals with COVID-19 Sample collection C702 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C702_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C702_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C703 Homo sapiens 9606 2021 Japan 47 SARS-CoV-2 COVID-19 162 serum beyond Day 25 SAMD01815014 COVID-19_Lipid_C703 Serum sample from individuals with COVID-19 Sample collection C703 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C703_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C703_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C704 Homo sapiens 9606 2021 Japan 56 SARS-CoV-2 COVID-19 189 serum Days 1-3 SAMD01815015 COVID-19_Lipid_C704 Serum sample from individuals with COVID-19 Sample collection C704 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C704_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C704_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 1-3 C705 Homo sapiens 9606 2021 Japan 56 SARS-CoV-2 COVID-19 189 serum Days 4-6 SAMD01815016 COVID-19_Lipid_C705 Serum sample from individuals with COVID-19 Sample collection C705 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C705_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C705_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C706 Homo sapiens 9606 2021 Japan 54 SARS-CoV-2 COVID-19 190 serum Days 7-9 SAMD01815017 COVID-19_Lipid_C706 Serum sample from individuals with COVID-19 Sample collection C706 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C706_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C706_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C707 Homo sapiens 9606 2021 Japan 56 SARS-CoV-2 COVID-19 189 serum Days 7-9 SAMD01815018 COVID-19_Lipid_C707 Serum sample from individuals with COVID-19 Sample collection C707 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C707_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C707_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C708 Homo sapiens 9606 2021 Japan 54 SARS-CoV-2 COVID-19 145 serum beyond Day 25 SAMD01815019 COVID-19_Lipid_C708 Serum sample from individuals with COVID-19 Sample collection C708 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C708_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C708_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C709 Homo sapiens 9606 2021 Japan 44 SARS-CoV-2 COVID-19 188 serum Days 7-9 SAMD01815020 COVID-19_Lipid_C709 Serum sample from individuals with COVID-19 Sample collection C709 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C709_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C709_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C71 Homo sapiens 9606 2020 Japan 76 SARS-CoV-2 COVID-19 22 serum pre-onset SAMD01815021 COVID-19_Lipid_C71 Serum sample from individuals with COVID-19 Sample collection C71 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C71_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C71_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 pre-onset C710 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 191 serum Days 1-3 SAMD01815022 COVID-19_Lipid_C710 Serum sample from individuals with COVID-19 Sample collection C710 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C710_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C710_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 1-3 C711 Homo sapiens 9606 2021 Japan 32 SARS-CoV-2 COVID-19 192 serum Days 1-3 SAMD01815023 COVID-19_Lipid_C711 Serum sample from individuals with COVID-19 Sample collection C711 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C711_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C711_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 1-3 C712 Homo sapiens 9606 2020 Japan 70 SARS-CoV-2 COVID-19 138 serum beyond Day 25 SAMD01815024 COVID-19_Lipid_C712 Serum sample from individuals with COVID-19 Sample collection C712 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C712_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C712_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C713 Homo sapiens 9606 2021 Japan 88 SARS-CoV-2 COVID-19 202 serum Days 4-6 SAMD01815025 COVID-19_Lipid_C713 Serum sample from individuals with COVID-19 Sample collection C713 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C713_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C713_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C714 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 191 serum Days 4-6 SAMD01815026 COVID-19_Lipid_C714 Serum sample from individuals with COVID-19 Sample collection C714 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C714_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C714_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C715 Homo sapiens 9606 2021 Japan 54 SARS-CoV-2 COVID-19 190 serum Days 10-12 SAMD01815027 COVID-19_Lipid_C715 Serum sample from individuals with COVID-19 Sample collection C715 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C715_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C715_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C716 Homo sapiens 9606 2020 Japan 67 SARS-CoV-2 COVID-19 134 serum beyond Day 25 SAMD01815028 COVID-19_Lipid_C716 Serum sample from individuals with COVID-19 Sample collection C716 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C716_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C716_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C717 Homo sapiens 9606 2021 Japan 44 SARS-CoV-2 COVID-19 188 serum Days 10-12 SAMD01815029 COVID-19_Lipid_C717 Serum sample from individuals with COVID-19 Sample collection C717 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C717_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C717_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C718 Homo sapiens 9606 2020 Japan 55 SARS-CoV-2 COVID-19 129 serum beyond Day 25 SAMD01815030 COVID-19_Lipid_C718 Serum sample from individuals with COVID-19 Sample collection C718 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C718_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C718_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C719 Homo sapiens 9606 2021 Japan 58 SARS-CoV-2 COVID-19 152 serum beyond Day 25 SAMD01815031 COVID-19_Lipid_C719 Serum sample from individuals with COVID-19 Sample collection C719 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C719_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C719_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C72 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 23 serum pre-onset SAMD01815032 COVID-19_Lipid_C72 Serum sample from individuals with COVID-19 Sample collection C72 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C72_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C72_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 pre-onset C720 Homo sapiens 9606 2021 Japan 88 SARS-CoV-2 COVID-19 202 serum Days 7-9 SAMD01815033 COVID-19_Lipid_C720 Serum sample from individuals with COVID-19 Sample collection C720 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C720_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C720_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C721 Homo sapiens 9606 2021 Japan 65 SARS-CoV-2 COVID-19 175 serum beyond Day 25 SAMD01815034 COVID-19_Lipid_C721 Serum sample from individuals with COVID-19 Sample collection C721 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C721_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C721_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C722 Homo sapiens 9606 2021 Japan 32 SARS-CoV-2 COVID-19 192 serum Days 4-6 SAMD01815035 COVID-19_Lipid_C722 Serum sample from individuals with COVID-19 Sample collection C722 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C722_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C722_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C723 Homo sapiens 9606 2021 Japan 54 SARS-CoV-2 COVID-19 190 serum Days 13-15 SAMD01815036 COVID-19_Lipid_C723 Serum sample from individuals with COVID-19 Sample collection C723 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C723_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C723_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C724 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 191 serum Days 7-9 SAMD01815037 COVID-19_Lipid_C724 Serum sample from individuals with COVID-19 Sample collection C724 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C724_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C724_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C725 Homo sapiens 9606 2021 Japan 88 SARS-CoV-2 COVID-19 202 serum Days 10-12 SAMD01815038 COVID-19_Lipid_C725 Serum sample from individuals with COVID-19 Sample collection C725 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C725_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C725_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C726 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 191 serum Days 10-12 SAMD01815039 COVID-19_Lipid_C726 Serum sample from individuals with COVID-19 Sample collection C726 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C726_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C726_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C727 Homo sapiens 9606 2021 Japan 32 SARS-CoV-2 COVID-19 192 serum Days 7-9 SAMD01815040 COVID-19_Lipid_C727 Serum sample from individuals with COVID-19 Sample collection C727 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C727_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C727_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C728 Homo sapiens 9606 2021 Japan 44 SARS-CoV-2 COVID-19 194 serum pre-onset SAMD01815041 COVID-19_Lipid_C728 Serum sample from individuals with COVID-19 Sample collection C728 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C728_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C728_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 pre-onset C729 Homo sapiens 9606 2021 Japan 44 SARS-CoV-2 COVID-19 194 serum Days 1-3 SAMD01815042 COVID-19_Lipid_C729 Serum sample from individuals with COVID-19 Sample collection C729 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C729_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C729_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 1-3 C73 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 23 serum Days 1-3 SAMD01815043 COVID-19_Lipid_C73 Serum sample from individuals with COVID-19 Sample collection C73 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C73_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C73_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 1-3 C730 Homo sapiens 9606 2021 Japan 44 SARS-CoV-2 COVID-19 194 serum Days 4-6 SAMD01815044 COVID-19_Lipid_C730 Serum sample from individuals with COVID-19 Sample collection C730 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C730_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C730_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C731 Homo sapiens 9606 2021 Japan 61 SARS-CoV-2 COVID-19 195 serum pre-onset SAMD01815045 COVID-19_Lipid_C731 Serum sample from individuals with COVID-19 Sample collection C731 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C731_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C731_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 pre-onset C732 Homo sapiens 9606 2021 Japan 61 SARS-CoV-2 COVID-19 195 serum Days 1-3 SAMD01815046 COVID-19_Lipid_C732 Serum sample from individuals with COVID-19 Sample collection C732 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C732_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C732_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 1-3 C733 Homo sapiens 9606 2021 Japan 61 SARS-CoV-2 COVID-19 195 serum Days 4-6 SAMD01815047 COVID-19_Lipid_C733 Serum sample from individuals with COVID-19 Sample collection C733 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C733_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C733_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C734 Homo sapiens 9606 2021 Japan 44 SARS-CoV-2 COVID-19 194 serum Days 10-12 SAMD01815048 COVID-19_Lipid_C734 Serum sample from individuals with COVID-19 Sample collection C734 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C734_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C734_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C735 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 139 serum beyond Day 25 SAMD01815049 COVID-19_Lipid_C735 Serum sample from individuals with COVID-19 Sample collection C735 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C735_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C735_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C736 Homo sapiens 9606 2021 Japan 32 SARS-CoV-2 COVID-19 192 serum Days 10-12 SAMD01815050 COVID-19_Lipid_C736 Serum sample from individuals with COVID-19 Sample collection C736 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C736_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C736_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C737 Homo sapiens 9606 2021 Japan 71 SARS-CoV-2 COVID-19 157 serum beyond Day 25 SAMD01815051 COVID-19_Lipid_C737 Serum sample from individuals with COVID-19 Sample collection C737 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C737_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C737_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C738 Homo sapiens 9606 2021 Japan 58 SARS-CoV-2 COVID-19 142 serum beyond Day 25 SAMD01815052 COVID-19_Lipid_C738 Serum sample from individuals with COVID-19 Sample collection C738 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C738_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C738_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C739 Homo sapiens 9606 2021 Japan 61 SARS-CoV-2 COVID-19 143 serum beyond Day 25 SAMD01815053 COVID-19_Lipid_C739 Serum sample from individuals with COVID-19 Sample collection C739 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C739_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C739_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C74 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 23 serum Days 4-6 SAMD01815054 COVID-19_Lipid_C74 Serum sample from individuals with COVID-19 Sample collection C74 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C74_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C74_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C740 Homo sapiens 9606 2020 Japan 39 SARS-CoV-2 COVID-19 149 serum beyond Day 25 SAMD01815055 COVID-19_Lipid_C740 Serum sample from individuals with COVID-19 Sample collection C740 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C740_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C740_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C741 Homo sapiens 9606 2021 Japan 61 SARS-CoV-2 COVID-19 195 serum Days 7-9 SAMD01815056 COVID-19_Lipid_C741 Serum sample from individuals with COVID-19 Sample collection C741 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C741_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C741_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C742 Homo sapiens 9606 2021 Japan 73 SARS-CoV-2 COVID-19 161 serum beyond Day 25 SAMD01815057 COVID-19_Lipid_C742 Serum sample from individuals with COVID-19 Sample collection C742 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C742_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C742_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C743 Homo sapiens 9606 2021 Japan 61 SARS-CoV-2 COVID-19 163 serum beyond Day 25 SAMD01815058 COVID-19_Lipid_C743 Serum sample from individuals with COVID-19 Sample collection C743 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C743_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C743_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C744 Homo sapiens 9606 2021 Japan 77 SARS-CoV-2 COVID-19 197 serum SAMD01815059 COVID-19_Lipid_C744 Serum sample from individuals with COVID-19 Sample collection C744 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C744_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C744_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 missing C745 Homo sapiens 9606 2021 Japan 77 SARS-CoV-2 COVID-19 197 serum SAMD01815060 COVID-19_Lipid_C745 Serum sample from individuals with COVID-19 Sample collection C745 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C745_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C745_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 missing C746 Homo sapiens 9606 2021 Japan 61 SARS-CoV-2 COVID-19 195 serum Days 13-15 SAMD01815061 COVID-19_Lipid_C746 Serum sample from individuals with COVID-19 Sample collection C746 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C746_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C746_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C747 Homo sapiens 9606 2021 Japan 77 SARS-CoV-2 COVID-19 197 serum SAMD01815062 COVID-19_Lipid_C747 Serum sample from individuals with COVID-19 Sample collection C747 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C747_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C747_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 missing C748 Homo sapiens 9606 2021 Japan 40 SARS-CoV-2 COVID-19 154 serum beyond Day 25 SAMD01815063 COVID-19_Lipid_C748 Serum sample from individuals with COVID-19 Sample collection C748 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C748_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C748_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C749 Homo sapiens 9606 2021 Japan 71 SARS-CoV-2 COVID-19 158 serum beyond Day 25 SAMD01815064 COVID-19_Lipid_C749 Serum sample from individuals with COVID-19 Sample collection C749 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C749_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C749_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C75 Homo sapiens 9606 2020 Japan 68 SARS-CoV-2 COVID-19 1 serum Days 19-24 SAMD01815065 COVID-19_Lipid_C75 Serum sample from individuals with COVID-19 Sample collection C75 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C75_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C75_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C750 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 164 serum beyond Day 25 SAMD01815066 COVID-19_Lipid_C750 Serum sample from individuals with COVID-19 Sample collection C750 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C750_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C750_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C751 Homo sapiens 9606 2021 Japan 74 SARS-CoV-2 COVID-19 201 serum Days 10-12 SAMD01815067 COVID-19_Lipid_C751 Serum sample from individuals with COVID-19 Sample collection C751 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C751_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C751_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C752 Homo sapiens 9606 2021 Japan 73 SARS-CoV-2 COVID-19 199 serum SAMD01815068 COVID-19_Lipid_C752 Serum sample from individuals with COVID-19 Sample collection C752 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C752_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C752_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 missing C753 Homo sapiens 9606 2021 Japan 72 SARS-CoV-2 COVID-19 200 serum Days 4-6 SAMD01815069 COVID-19_Lipid_C753 Serum sample from individuals with COVID-19 Sample collection C753 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C753_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C753_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C754 Homo sapiens 9606 2021 Japan 72 SARS-CoV-2 COVID-19 200 serum Days 7-9 SAMD01815070 COVID-19_Lipid_C754 Serum sample from individuals with COVID-19 Sample collection C754 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C754_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C754_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C755 Homo sapiens 9606 2021 Japan 44 SARS-CoV-2 COVID-19 178 serum beyond Day 25 SAMD01815071 COVID-19_Lipid_C755 Serum sample from individuals with COVID-19 Sample collection C755 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C755_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C755_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C756 Homo sapiens 9606 2021 Japan 48 SARS-CoV-2 COVID-19 176 serum beyond Day 25 SAMD01815072 COVID-19_Lipid_C756 Serum sample from individuals with COVID-19 Sample collection C756 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C756_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C756_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C757 Homo sapiens 9606 2021 Japan 83 SARS-CoV-2 COVID-19 203 serum Days 7-9 SAMD01815073 COVID-19_Lipid_C757 Serum sample from individuals with COVID-19 Sample collection C757 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C757_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C757_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C758 Homo sapiens 9606 2021 Japan 83 SARS-CoV-2 COVID-19 203 serum Days 10-12 SAMD01815074 COVID-19_Lipid_C758 Serum sample from individuals with COVID-19 Sample collection C758 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C758_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C758_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C759 Homo sapiens 9606 2021 Japan 57 SARS-CoV-2 COVID-19 204 serum Days 4-6 SAMD01815075 COVID-19_Lipid_C759 Serum sample from individuals with COVID-19 Sample collection C759 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C759_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C759_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C76 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 23 serum Days 7-9 SAMD01815076 COVID-19_Lipid_C76 Serum sample from individuals with COVID-19 Sample collection C76 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C76_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C76_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C760 Homo sapiens 9606 2021 Japan 83 SARS-CoV-2 COVID-19 203 serum Days 13-15 SAMD01815077 COVID-19_Lipid_C760 Serum sample from individuals with COVID-19 Sample collection C760 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C760_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C760_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C761 Homo sapiens 9606 2021 Japan 69 SARS-CoV-2 COVID-19 205 serum pre-onset SAMD01815078 COVID-19_Lipid_C761 Serum sample from individuals with COVID-19 Sample collection C761 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C761_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C761_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 pre-onset C762 Homo sapiens 9606 2021 Japan 69 SARS-CoV-2 COVID-19 205 serum Days 4-6 SAMD01815079 COVID-19_Lipid_C762 Serum sample from individuals with COVID-19 Sample collection C762 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C762_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C762_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C763 Homo sapiens 9606 2021 Japan 69 SARS-CoV-2 COVID-19 205 serum Days 7-9 SAMD01815080 COVID-19_Lipid_C763 Serum sample from individuals with COVID-19 Sample collection C763 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C763_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C763_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C764 Homo sapiens 9606 2021 Japan 71 SARS-CoV-2 COVID-19 206 serum Days 1-3 SAMD01815081 COVID-19_Lipid_C764 Serum sample from individuals with COVID-19 Sample collection C764 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C764_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C764_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 1-3 C765 Homo sapiens 9606 2021 Japan 71 SARS-CoV-2 COVID-19 206 serum pre-onset SAMD01815082 COVID-19_Lipid_C765 Serum sample from individuals with COVID-19 Sample collection C765 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C765_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C765_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 pre-onset C766 Homo sapiens 9606 2021 Japan 75 SARS-CoV-2 COVID-19 208 serum Days 4-6 SAMD01815083 COVID-19_Lipid_C766 Serum sample from individuals with COVID-19 Sample collection C766 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C766_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C766_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C767 Homo sapiens 9606 2021 Japan 72 SARS-CoV-2 COVID-19 207 serum Days 4-6 SAMD01815084 COVID-19_Lipid_C767 Serum sample from individuals with COVID-19 Sample collection C767 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C767_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C767_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C768 Homo sapiens 9606 2021 Japan 75 SARS-CoV-2 COVID-19 187 serum beyond Day 25 SAMD01815085 COVID-19_Lipid_C768 Serum sample from individuals with COVID-19 Sample collection C768 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C768_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C768_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C769 Homo sapiens 9606 2021 Japan 56 SARS-CoV-2 COVID-19 189 serum beyond Day 25 SAMD01815086 COVID-19_Lipid_C769 Serum sample from individuals with COVID-19 Sample collection C769 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C769_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C769_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C77 Homo sapiens 9606 2020 Japan 76 SARS-CoV-2 COVID-19 22 serum Days 7-9 SAMD01815087 COVID-19_Lipid_C77 Serum sample from individuals with COVID-19 Sample collection C77 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C77_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C77_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C770 Homo sapiens 9606 2021 Japan 64 SARS-CoV-2 COVID-19 185 serum beyond Day 25 SAMD01815088 COVID-19_Lipid_C770 Serum sample from individuals with COVID-19 Sample collection C770 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C770_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C770_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C771 Homo sapiens 9606 2021 Japan 57 SARS-CoV-2 COVID-19 204 serum Days 7-9 SAMD01815089 COVID-19_Lipid_C771 Serum sample from individuals with COVID-19 Sample collection C771 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C771_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C771_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C772 Homo sapiens 9606 2021 Japan 71 SARS-CoV-2 COVID-19 206 serum Days 4-6 SAMD01815090 COVID-19_Lipid_C772 Serum sample from individuals with COVID-19 Sample collection C772 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C772_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C772_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C773 Homo sapiens 9606 2021 Japan 75 SARS-CoV-2 COVID-19 208 serum Days 7-9 SAMD01815091 COVID-19_Lipid_C773 Serum sample from individuals with COVID-19 Sample collection C773 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C773_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C773_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C774 Homo sapiens 9606 2021 Japan 75 SARS-CoV-2 COVID-19 208 serum Days 10-12 SAMD01815092 COVID-19_Lipid_C774 Serum sample from individuals with COVID-19 Sample collection C774 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C774_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C774_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C775 Homo sapiens 9606 2021 Japan 83 SARS-CoV-2 COVID-19 203 serum Days 16-18 SAMD01815093 COVID-19_Lipid_C775 Serum sample from individuals with COVID-19 Sample collection C775 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C775_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C775_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C776 Homo sapiens 9606 2021 Japan 57 SARS-CoV-2 COVID-19 204 serum Days 10-12 SAMD01815094 COVID-19_Lipid_C776 Serum sample from individuals with COVID-19 Sample collection C776 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C776_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C776_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C777 Homo sapiens 9606 2021 Japan 69 SARS-CoV-2 COVID-19 205 serum Days 10-12 SAMD01815095 COVID-19_Lipid_C777 Serum sample from individuals with COVID-19 Sample collection C777 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C777_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C777_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C778 Homo sapiens 9606 2021 Japan 68 SARS-CoV-2 COVID-19 209 serum Days 7-9 SAMD01815096 COVID-19_Lipid_C778 Serum sample from individuals with COVID-19 Sample collection C778 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C778_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C778_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C779 Homo sapiens 9606 2021 Japan 68 SARS-CoV-2 COVID-19 209 serum Days 10-12 SAMD01815097 COVID-19_Lipid_C779 Serum sample from individuals with COVID-19 Sample collection C779 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C779_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C779_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C78 Homo sapiens 9606 2020 Japan 58 SARS-CoV-2 COVID-19 7 serum beyond Day 25 SAMD01815098 COVID-19_Lipid_C78 Serum sample from individuals with COVID-19 Sample collection C78 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C78_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C78_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C780 Homo sapiens 9606 2021 Japan 83 SARS-CoV-2 COVID-19 203 serum Days 19-24 SAMD01815099 COVID-19_Lipid_C780 Serum sample from individuals with COVID-19 Sample collection C780 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C780_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C780_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C781 Homo sapiens 9606 2021 Japan 71 SARS-CoV-2 COVID-19 206 serum Days 7-9 SAMD01815100 COVID-19_Lipid_C781 Serum sample from individuals with COVID-19 Sample collection C781 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C781_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C781_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C782 Homo sapiens 9606 2021 Japan 75 SARS-CoV-2 COVID-19 208 serum Days 13-15 SAMD01815101 COVID-19_Lipid_C782 Serum sample from individuals with COVID-19 Sample collection C782 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C782_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C782_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C783 Homo sapiens 9606 2021 Japan 68 SARS-CoV-2 COVID-19 209 serum Days 13-15 SAMD01815102 COVID-19_Lipid_C783 Serum sample from individuals with COVID-19 Sample collection C783 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C783_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C783_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C784 Homo sapiens 9606 2021 Japan 54 SARS-CoV-2 COVID-19 190 serum beyond Day 25 SAMD01815103 COVID-19_Lipid_C784 Serum sample from individuals with COVID-19 Sample collection C784 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C784_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C784_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C785 Homo sapiens 9606 2021 Japan 41 SARS-CoV-2 COVID-19 211 serum Days 1-3 SAMD01815104 COVID-19_Lipid_C785 Serum sample from individuals with COVID-19 Sample collection C785 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C785_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C785_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 1-3 C786 Homo sapiens 9606 2021 Japan 86 SARS-CoV-2 COVID-19 220 serum Days 7-9 SAMD01815105 COVID-19_Lipid_C786 Serum sample from individuals with COVID-19 Sample collection C786 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C786_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C786_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C787 Homo sapiens 9606 2021 Japan 83 SARS-CoV-2 COVID-19 210 serum pre-onset SAMD01815106 COVID-19_Lipid_C787 Serum sample from individuals with COVID-19 Sample collection C787 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C787_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C787_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 pre-onset C788 Homo sapiens 9606 2021 Japan 65 SARS-CoV-2 COVID-19 212 serum Days 10-12 SAMD01815107 COVID-19_Lipid_C788 Serum sample from individuals with COVID-19 Sample collection C788 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C788_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C788_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C789 Homo sapiens 9606 2021 Japan 68 SARS-CoV-2 COVID-19 209 serum Days 16-18 SAMD01815108 COVID-19_Lipid_C789 Serum sample from individuals with COVID-19 Sample collection C789 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C789_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C789_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C79 Homo sapiens 9606 2020 Japan 49 SARS-CoV-2 COVID-19 12 serum beyond Day 25 SAMD01815109 COVID-19_Lipid_C79 Serum sample from individuals with COVID-19 Sample collection C79 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C79_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C79_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C790 Homo sapiens 9606 2021 Japan 78 SARS-CoV-2 COVID-19 213 serum Days 4-6 SAMD01815110 COVID-19_Lipid_C790 Serum sample from individuals with COVID-19 Sample collection C790 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C790_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C790_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C791 Homo sapiens 9606 2021 Japan 78 SARS-CoV-2 COVID-19 213 serum Days 7-9 SAMD01815111 COVID-19_Lipid_C791 Serum sample from individuals with COVID-19 Sample collection C791 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C791_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C791_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C792 Homo sapiens 9606 2021 Japan 58 SARS-CoV-2 COVID-19 214 serum Days 1-3 SAMD01815112 COVID-19_Lipid_C792 Serum sample from individuals with COVID-19 Sample collection C792 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C792_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C792_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 1-3 C793 Homo sapiens 9606 2021 Japan 61 SARS-CoV-2 COVID-19 195 serum beyond Day 25 SAMD01815113 COVID-19_Lipid_C793 Serum sample from individuals with COVID-19 Sample collection C793 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C793_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C793_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C794 Homo sapiens 9606 2021 Japan 58 SARS-CoV-2 COVID-19 214 serum Days 4-6 SAMD01815114 COVID-19_Lipid_C794 Serum sample from individuals with COVID-19 Sample collection C794 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C794_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C794_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C795 Homo sapiens 9606 2021 Japan 65 SARS-CoV-2 COVID-19 212 serum Days 13-15 SAMD01815115 COVID-19_Lipid_C795 Serum sample from individuals with COVID-19 Sample collection C795 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C795_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C795_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C796 Homo sapiens 9606 2021 Japan 68 SARS-CoV-2 COVID-19 209 serum Days 19-24 SAMD01815116 COVID-19_Lipid_C796 Serum sample from individuals with COVID-19 Sample collection C796 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C796_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C796_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C797 Homo sapiens 9606 2021 Japan 44 SARS-CoV-2 COVID-19 194 serum beyond Day 25 SAMD01815117 COVID-19_Lipid_C797 Serum sample from individuals with COVID-19 Sample collection C797 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C797_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C797_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C798 Homo sapiens 9606 2021 Japan 83 SARS-CoV-2 COVID-19 210 serum Days 1-3 SAMD01815118 COVID-19_Lipid_C798 Serum sample from individuals with COVID-19 Sample collection C798 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C798_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C798_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 1-3 C799 Homo sapiens 9606 2021 Japan 73 SARS-CoV-2 COVID-19 215 serum Days 4-6 SAMD01815119 COVID-19_Lipid_C799 Serum sample from individuals with COVID-19 Sample collection C799 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C799_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C799_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C8 Homo sapiens 9606 2020 Japan 62 SARS-CoV-2 COVID-19 16 serum Days 13-15 SAMD01815120 COVID-19_Lipid_C8 Serum sample from individuals with COVID-19 Sample collection C8 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C8_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C8_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C80 Homo sapiens 9606 2020 Japan 71 SARS-CoV-2 COVID-19 20 serum Days 19-24 SAMD01815121 COVID-19_Lipid_C80 Serum sample from individuals with COVID-19 Sample collection C80 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C80_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C80_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C800 Homo sapiens 9606 2021 Japan 83 SARS-CoV-2 COVID-19 203 serum beyond Day 25 SAMD01815122 COVID-19_Lipid_C800 Serum sample from individuals with COVID-19 Sample collection C800 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C800_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C800_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C801 Homo sapiens 9606 2021 Japan 78 SARS-CoV-2 COVID-19 213 serum Days 10-12 SAMD01815123 COVID-19_Lipid_C801 Serum sample from individuals with COVID-19 Sample collection C801 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C801_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C801_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C802 Homo sapiens 9606 2021 Japan 58 SARS-CoV-2 COVID-19 214 serum Days 7-9 SAMD01815124 COVID-19_Lipid_C802 Serum sample from individuals with COVID-19 Sample collection C802 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C802_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C802_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C803 Homo sapiens 9606 2021 Japan 65 SARS-CoV-2 COVID-19 212 serum Days 16-18 SAMD01815125 COVID-19_Lipid_C803 Serum sample from individuals with COVID-19 Sample collection C803 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C803_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C803_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C804 Homo sapiens 9606 2021 Japan 73 SARS-CoV-2 COVID-19 215 serum Days 7-9 SAMD01815126 COVID-19_Lipid_C804 Serum sample from individuals with COVID-19 Sample collection C804 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C804_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C804_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C805 Homo sapiens 9606 2021 Japan 65 SARS-CoV-2 COVID-19 212 serum Days 19-24 SAMD01815127 COVID-19_Lipid_C805 Serum sample from individuals with COVID-19 Sample collection C805 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C805_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C805_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C806 Homo sapiens 9606 2021 Japan 48 SARS-CoV-2 COVID-19 218 serum Days 4-6 SAMD01815128 COVID-19_Lipid_C806 Serum sample from individuals with COVID-19 Sample collection C806 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C806_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C806_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C807 Homo sapiens 9606 2021 Japan 58 SARS-CoV-2 COVID-19 214 serum Days 10-12 SAMD01815129 COVID-19_Lipid_C807 Serum sample from individuals with COVID-19 Sample collection C807 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C807_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C807_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C808 Homo sapiens 9606 2021 Japan 73 SARS-CoV-2 COVID-19 215 serum Days 10-12 SAMD01815130 COVID-19_Lipid_C808 Serum sample from individuals with COVID-19 Sample collection C808 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C808_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C808_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C809 Homo sapiens 9606 2021 Japan 69 SARS-CoV-2 COVID-19 205 serum beyond Day 25 SAMD01815131 COVID-19_Lipid_C809 Serum sample from individuals with COVID-19 Sample collection C809 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C809_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C809_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C81 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 21 serum Days 13-15 SAMD01815132 COVID-19_Lipid_C81 Serum sample from individuals with COVID-19 Sample collection C81 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C81_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C81_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C811 Homo sapiens 9606 2021 Japan 57 SARS-CoV-2 COVID-19 204 serum beyond Day 25 SAMD01815133 COVID-19_Lipid_C811 Serum sample from individuals with COVID-19 Sample collection C811 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C811_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C811_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C812 Homo sapiens 9606 2021 Japan 58 SARS-CoV-2 COVID-19 214 serum Days 13-15 SAMD01815134 COVID-19_Lipid_C812 Serum sample from individuals with COVID-19 Sample collection C812 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C812_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C812_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C813 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 219 serum Days 7-9 SAMD01815135 COVID-19_Lipid_C813 Serum sample from individuals with COVID-19 Sample collection C813 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C813_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C813_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C814 Homo sapiens 9606 2021 Japan 73 SARS-CoV-2 COVID-19 215 serum Days 13-15 SAMD01815136 COVID-19_Lipid_C814 Serum sample from individuals with COVID-19 Sample collection C814 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C814_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C814_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C815 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 219 serum Days 10-12 SAMD01815137 COVID-19_Lipid_C815 Serum sample from individuals with COVID-19 Sample collection C815 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C815_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C815_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C816 Homo sapiens 9606 2021 Japan 65 SARS-CoV-2 COVID-19 212 serum beyond Day 25 SAMD01815138 COVID-19_Lipid_C816 Serum sample from individuals with COVID-19 Sample collection C816 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C816_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C816_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C817 Homo sapiens 9606 2021 Japan 75 SARS-CoV-2 COVID-19 208 serum beyond Day 25 SAMD01815139 COVID-19_Lipid_C817 Serum sample from individuals with COVID-19 Sample collection C817 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C817_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C817_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C818 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 219 serum Days 13-15 SAMD01815140 COVID-19_Lipid_C818 Serum sample from individuals with COVID-19 Sample collection C818 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C818_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C818_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C819 Homo sapiens 9606 2021 Japan 72 SARS-CoV-2 COVID-19 200 serum beyond Day 25 SAMD01815141 COVID-19_Lipid_C819 Serum sample from individuals with COVID-19 Sample collection C819 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C819_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C819_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C82 Homo sapiens 9606 2020 Japan 65 SARS-CoV-2 COVID-19 25 serum Days 4-6 SAMD01815142 COVID-19_Lipid_C82 Serum sample from individuals with COVID-19 Sample collection C82 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C82_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C82_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C820 Homo sapiens 9606 2021 Japan 31 SARS-CoV-2 COVID-19 226 serum Days 7-9 SAMD01815143 COVID-19_Lipid_C820 Serum sample from individuals with COVID-19 Sample collection C820 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C820_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C820_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C821 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 227 serum pre-onset SAMD01815144 COVID-19_Lipid_C821 Serum sample from individuals with COVID-19 Sample collection C821 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C821_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C821_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 pre-onset C822 Homo sapiens 9606 2021 Japan 24 SARS-CoV-2 COVID-19 229 serum pre-onset SAMD01815145 COVID-19_Lipid_C822 Serum sample from individuals with COVID-19 Sample collection C822 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C822_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C822_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 pre-onset C823 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 227 serum Days 1-3 SAMD01815146 COVID-19_Lipid_C823 Serum sample from individuals with COVID-19 Sample collection C823 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C823_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C823_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 1-3 C824 Homo sapiens 9606 2021 Japan 24 SARS-CoV-2 COVID-19 229 serum Days 1-3 SAMD01815147 COVID-19_Lipid_C824 Serum sample from individuals with COVID-19 Sample collection C824 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C824_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C824_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 1-3 C825 Homo sapiens 9606 2021 Japan 37 SARS-CoV-2 COVID-19 228 serum Days 4-6 SAMD01815148 COVID-19_Lipid_C825 Serum sample from individuals with COVID-19 Sample collection C825 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C825_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C825_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C826 Homo sapiens 9606 2021 Japan 77 SARS-CoV-2 COVID-19 225 serum Days 4-6 SAMD01815149 COVID-19_Lipid_C826 Serum sample from individuals with COVID-19 Sample collection C826 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C826_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C826_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C827 Homo sapiens 9606 2021 Japan 64 SARS-CoV-2 COVID-19 234 serum Days 13-15 SAMD01815150 COVID-19_Lipid_C827 Serum sample from individuals with COVID-19 Sample collection C827 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C827_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C827_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C828 Homo sapiens 9606 2021 Japan 64 SARS-CoV-2 COVID-19 234 serum Days 16-18 SAMD01815151 COVID-19_Lipid_C828 Serum sample from individuals with COVID-19 Sample collection C828 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C828_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C828_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C829 Homo sapiens 9606 2021 Japan 67 SARS-CoV-2 COVID-19 223 serum Days 10-12 SAMD01815152 COVID-19_Lipid_C829 Serum sample from individuals with COVID-19 Sample collection C829 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C829_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C829_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C83 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 21 serum Days 16-18 SAMD01815153 COVID-19_Lipid_C83 Serum sample from individuals with COVID-19 Sample collection C83 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C83_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C83_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C830 Homo sapiens 9606 2021 Japan 56 SARS-CoV-2 COVID-19 230 serum Days 1-3 SAMD01815154 COVID-19_Lipid_C830 Serum sample from individuals with COVID-19 Sample collection C830 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C830_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C830_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 1-3 C831 Homo sapiens 9606 2021 Japan 56 SARS-CoV-2 COVID-19 230 serum Days 4-6 SAMD01815155 COVID-19_Lipid_C831 Serum sample from individuals with COVID-19 Sample collection C831 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C831_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C831_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C832 Homo sapiens 9606 2021 Japan 77 SARS-CoV-2 COVID-19 225 serum Days 7-9 SAMD01815156 COVID-19_Lipid_C832 Serum sample from individuals with COVID-19 Sample collection C832 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C832_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C832_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C833 Homo sapiens 9606 2021 Japan 69 SARS-CoV-2 COVID-19 224 serum Days 13-15 SAMD01815157 COVID-19_Lipid_C833 Serum sample from individuals with COVID-19 Sample collection C833 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C833_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C833_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C834 Homo sapiens 9606 2021 Japan 56 SARS-CoV-2 COVID-19 231 serum Days 7-9 SAMD01815158 COVID-19_Lipid_C834 Serum sample from individuals with COVID-19 Sample collection C834 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C834_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C834_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C835 Homo sapiens 9606 2021 Japan 59 SARS-CoV-2 COVID-19 232 serum Days 7-9 SAMD01815159 COVID-19_Lipid_C835 Serum sample from individuals with COVID-19 Sample collection C835 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C835_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C835_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C836 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 227 serum Days 4-6 SAMD01815160 COVID-19_Lipid_C836 Serum sample from individuals with COVID-19 Sample collection C836 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C836_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C836_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C837 Homo sapiens 9606 2021 Japan 48 SARS-CoV-2 COVID-19 235 serum Days 4-6 SAMD01815161 COVID-19_Lipid_C837 Serum sample from individuals with COVID-19 Sample collection C837 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C837_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C837_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C838 Homo sapiens 9606 2021 Japan 21 SARS-CoV-2 COVID-19 233 serum Days 4-6 SAMD01815162 COVID-19_Lipid_C838 Serum sample from individuals with COVID-19 Sample collection C838 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C838_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C838_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C839 Homo sapiens 9606 2021 Japan 24 SARS-CoV-2 COVID-19 229 serum Days 1-3 SAMD01815163 COVID-19_Lipid_C839 Serum sample from individuals with COVID-19 Sample collection C839 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C839_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C839_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 1-3 C84 Homo sapiens 9606 2020 Japan 76 SARS-CoV-2 COVID-19 18 serum beyond Day 25 SAMD01815164 COVID-19_Lipid_C84 Serum sample from individuals with COVID-19 Sample collection C84 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C84_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C84_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C840 Homo sapiens 9606 2021 Japan 67 SARS-CoV-2 COVID-19 223 serum Days 13-15 SAMD01815165 COVID-19_Lipid_C840 Serum sample from individuals with COVID-19 Sample collection C840 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C840_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C840_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C841 Homo sapiens 9606 2021 Japan 69 SARS-CoV-2 COVID-19 224 serum Days 16-18 SAMD01815166 COVID-19_Lipid_C841 Serum sample from individuals with COVID-19 Sample collection C841 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C841_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C841_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C842 Homo sapiens 9606 2021 Japan 56 SARS-CoV-2 COVID-19 231 serum Days 10-12 SAMD01815167 COVID-19_Lipid_C842 Serum sample from individuals with COVID-19 Sample collection C842 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C842_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C842_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C843 Homo sapiens 9606 2021 Japan 24 SARS-CoV-2 COVID-19 229 serum Days 4-6 SAMD01815168 COVID-19_Lipid_C843 Serum sample from individuals with COVID-19 Sample collection C843 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C843_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C843_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C844 Homo sapiens 9606 2021 Japan 69 SARS-CoV-2 COVID-19 234 serum Days 19-24 SAMD01815169 COVID-19_Lipid_C844 Serum sample from individuals with COVID-19 Sample collection C844 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C844_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C844_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C845 Homo sapiens 9606 2021 Japan 48 SARS-CoV-2 COVID-19 235 serum Days 7-9 SAMD01815170 COVID-19_Lipid_C845 Serum sample from individuals with COVID-19 Sample collection C845 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C845_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C845_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C846 Homo sapiens 9606 2021 Japan 59 SARS-CoV-2 COVID-19 232 serum Days 10-12 SAMD01815171 COVID-19_Lipid_C846 Serum sample from individuals with COVID-19 Sample collection C846 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C846_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C846_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C847 Homo sapiens 9606 2021 Japan 56 SARS-CoV-2 COVID-19 230 serum Days 7-9 SAMD01815172 COVID-19_Lipid_C847 Serum sample from individuals with COVID-19 Sample collection C847 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C847_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C847_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C848 Homo sapiens 9606 2021 Japan 24 SARS-CoV-2 COVID-19 229 serum Days 7-9 SAMD01815173 COVID-19_Lipid_C848 Serum sample from individuals with COVID-19 Sample collection C848 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C848_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C848_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C849 Homo sapiens 9606 2021 Japan 69 SARS-CoV-2 COVID-19 224 serum Days 19-24 SAMD01815174 COVID-19_Lipid_C849 Serum sample from individuals with COVID-19 Sample collection C849 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C849_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C849_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C850 Homo sapiens 9606 2021 Japan 21 SARS-CoV-2 COVID-19 233 serum Days 7-9 SAMD01815175 COVID-19_Lipid_C850 Serum sample from individuals with COVID-19 Sample collection C850 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C850_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C850_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C851 Homo sapiens 9606 2021 Japan 48 SARS-CoV-2 COVID-19 235 serum Days 10-12 SAMD01815176 COVID-19_Lipid_C851 Serum sample from individuals with COVID-19 Sample collection C851 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C851_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C851_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C852 Homo sapiens 9606 2021 Japan 67 SARS-CoV-2 COVID-19 223 serum Days 16-18 SAMD01815177 COVID-19_Lipid_C852 Serum sample from individuals with COVID-19 Sample collection C852 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C852_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C852_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C853 Homo sapiens 9606 2021 Japan 77 SARS-CoV-2 COVID-19 225 serum Days 10-12 SAMD01815178 COVID-19_Lipid_C853 Serum sample from individuals with COVID-19 Sample collection C853 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C853_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C853_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C854 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 227 serum Days 7-9 SAMD01815179 COVID-19_Lipid_C854 Serum sample from individuals with COVID-19 Sample collection C854 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C854_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C854_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C855 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 227 serum Days 10-12 SAMD01815180 COVID-19_Lipid_C855 Serum sample from individuals with COVID-19 Sample collection C855 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C855_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C855_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C856 Homo sapiens 9606 2021 Japan 56 SARS-CoV-2 COVID-19 230 serum Days 10-12 SAMD01815181 COVID-19_Lipid_C856 Serum sample from individuals with COVID-19 Sample collection C856 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C856_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C856_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C857 Homo sapiens 9606 2021 Japan 21 SARS-CoV-2 COVID-19 233 serum Days 10-12 SAMD01815182 COVID-19_Lipid_C857 Serum sample from individuals with COVID-19 Sample collection C857 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C857_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C857_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C858 Homo sapiens 9606 2021 Japan 77 SARS-CoV-2 COVID-19 225 serum Days 13-15 SAMD01815183 COVID-19_Lipid_C858 Serum sample from individuals with COVID-19 Sample collection C858 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C858_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C858_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C859 Homo sapiens 9606 2021 Japan 77 SARS-CoV-2 COVID-19 225 serum Days 16-18 SAMD01815184 COVID-19_Lipid_C859 Serum sample from individuals with COVID-19 Sample collection C859 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C859_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C859_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C86 Homo sapiens 9606 2020 Japan 65 SARS-CoV-2 COVID-19 25 serum Days 7-9 SAMD01815185 COVID-19_Lipid_C86 Serum sample from individuals with COVID-19 Sample collection C86 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C86_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C86_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C860 Homo sapiens 9606 2021 Japan 56 SARS-CoV-2 COVID-19 231 serum Days 13-15 SAMD01815186 COVID-19_Lipid_C860 Serum sample from individuals with COVID-19 Sample collection C860 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C860_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C860_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C861 Homo sapiens 9606 2021 Japan 56 SARS-CoV-2 COVID-19 231 serum Days 16-18 SAMD01815187 COVID-19_Lipid_C861 Serum sample from individuals with COVID-19 Sample collection C861 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C861_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C861_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C862 Homo sapiens 9606 2021 Japan 67 SARS-CoV-2 COVID-19 223 serum Days 19-24 SAMD01815188 COVID-19_Lipid_C862 Serum sample from individuals with COVID-19 Sample collection C862 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C862_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C862_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C863 Homo sapiens 9606 2021 Japan 48 SARS-CoV-2 COVID-19 235 serum Days 13-15 SAMD01815189 COVID-19_Lipid_C863 Serum sample from individuals with COVID-19 Sample collection C863 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C863_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C863_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C864 Homo sapiens 9606 2021 Japan 56 SARS-CoV-2 COVID-19 230 serum Days 13-15 SAMD01815190 COVID-19_Lipid_C864 Serum sample from individuals with COVID-19 Sample collection C864 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C864_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C864_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C865 Homo sapiens 9606 2021 Japan 69 SARS-CoV-2 COVID-19 234 serum beyond Day 25 SAMD01815191 COVID-19_Lipid_C865 Serum sample from individuals with COVID-19 Sample collection C865 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C865_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C865_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C866 Homo sapiens 9606 2021 Japan 56 SARS-CoV-2 COVID-19 231 serum Days 19-24 SAMD01815192 COVID-19_Lipid_C866 Serum sample from individuals with COVID-19 Sample collection C866 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C866_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C866_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C867 Homo sapiens 9606 2021 Japan 77 SARS-CoV-2 COVID-19 225 serum Days 19-24 SAMD01815193 COVID-19_Lipid_C867 Serum sample from individuals with COVID-19 Sample collection C867 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C867_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C867_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C868 Homo sapiens 9606 2021 Japan 56 SARS-CoV-2 COVID-19 231 serum beyond Day 25 SAMD01815194 COVID-19_Lipid_C868 Serum sample from individuals with COVID-19 Sample collection C868 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C868_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C868_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C869 Homo sapiens 9606 2021 Japan 67 SARS-CoV-2 COVID-19 223 serum beyond Day 25 SAMD01815195 COVID-19_Lipid_C869 Serum sample from individuals with COVID-19 Sample collection C869 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C869_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C869_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C87 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 23 serum Days 10-12 SAMD01815196 COVID-19_Lipid_C87 Serum sample from individuals with COVID-19 Sample collection C87 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C87_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C87_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C870 Homo sapiens 9606 2021 Japan 79 SARS-CoV-2 COVID-19 227 serum Days 19-24 SAMD01815197 COVID-19_Lipid_C870 Serum sample from individuals with COVID-19 Sample collection C870 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C870_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C870_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24 C871 Homo sapiens 9606 2021 Japan 77 SARS-CoV-2 COVID-19 225 serum beyond Day 25 SAMD01815198 COVID-19_Lipid_C871 Serum sample from individuals with COVID-19 Sample collection C871 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C871_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C871_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C872 Homo sapiens 9606 2021 Japan 57 SARS-CoV-2 COVID-19 230 serum beyond Day 25 SAMD01815199 COVID-19_Lipid_C872 Serum sample from individuals with COVID-19 Sample collection C872 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C872_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C872_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C88 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 26 serum Days 7-9 SAMD01815200 COVID-19_Lipid_C88 Serum sample from individuals with COVID-19 Sample collection C88 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C88_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C88_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C89 Homo sapiens 9606 2020 Japan 89 SARS-CoV-2 COVID-19 27 serum Days 10-12 SAMD01815201 COVID-19_Lipid_C89 Serum sample from individuals with COVID-19 Sample collection C89 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C89_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C89_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C9 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 19 serum Days 10-12 SAMD01815202 COVID-19_Lipid_C9 Serum sample from individuals with COVID-19 Sample collection C9 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C9_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C9_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C91 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 23 serum Days 13-15 SAMD01815203 COVID-19_Lipid_C91 Serum sample from individuals with COVID-19 Sample collection C91 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C91_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C91_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C92 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 19 serum beyond Day 25 SAMD01815204 COVID-19_Lipid_C92 Serum sample from individuals with COVID-19 Sample collection C92 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C92_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C92_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 beyond Day 25 C93 Homo sapiens 9606 2020 Japan 40 SARS-CoV-2 COVID-19 28 serum Days 4-6 SAMD01815205 COVID-19_Lipid_C93 Serum sample from individuals with COVID-19 Sample collection C93 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C93_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C93_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 4-6 C94 Homo sapiens 9606 2020 Japan 69 SARS-CoV-2 COVID-19 23 serum Days 16-18 SAMD01815206 COVID-19_Lipid_C94 Serum sample from individuals with COVID-19 Sample collection C94 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C94_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C94_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 16-18 C95 Homo sapiens 9606 2020 Japan 65 SARS-CoV-2 COVID-19 25 serum Days 10-12 SAMD01815207 COVID-19_Lipid_C95 Serum sample from individuals with COVID-19 Sample collection C95 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C95_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C95_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 10-12 C96 Homo sapiens 9606 2020 Japan 65 SARS-CoV-2 COVID-19 25 serum Days 13-15 SAMD01815208 COVID-19_Lipid_C96 Serum sample from individuals with COVID-19 Sample collection C96 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C96_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C96_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C97 Homo sapiens 9606 2020 Japan 40 SARS-CoV-2 COVID-19 28 serum Days 7-9 SAMD01815209 COVID-19_Lipid_C97 Serum sample from individuals with COVID-19 Sample collection C97 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C97_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C97_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 7-9 C98 Homo sapiens 9606 2020 Japan 89 SARS-CoV-2 COVID-19 27 serum Days 13-15 SAMD01815210 COVID-19_Lipid_C98 Serum sample from individuals with COVID-19 Sample collection C98 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C98_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C98_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 13-15 C99 Homo sapiens 9606 2020 Japan 75 SARS-CoV-2 COVID-19 21 serum Days 19-24 SAMD01815211 COVID-19_Lipid_C99 Serum sample from individuals with COVID-19 Sample collection C99 Extraction methanol with 0.1% formic acid: 100 microL, acetonitrile: 80 microL C99_ext Chromatography 2 missing U-Inert Sustain Swift Amide, 3 micrometer, 2.1 x 100 mm (UP) normal-phase 50 degree Celsius Mass spectrometry 2 positive MRM mode missing electrospray ionization triple quadrupole C99_ext_LCMS_Pos_Sphingolipid Data processing 2 processed/MTBKS279_Sphingolipid.xlsx processed/MTBKS279_Processed_Data_Sphingolipid.xlsx Metabolite identification 2 Days 19-24